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Summary 
Phenazines are secondary metabolites of bacterial and archaeal origin. Involved in a 
variety of redox reactions yielding reactive oxygen species, phenazines exhibit a broad-
spectrum antibiotic activity and a high potency as virulence factors. As such, their 
biosynthesis has been studied extensively in recent years leading to the structural and 
functional characterization of most enzymes (PhzA-G) responsible for biosynthesis of the 
common phenazine scaffold. Yet, some details of the associated reaction mechanisms 
remained elusive. This study aimed at answering remaining questions about the 
potentially unique catalytic mechanism of the isomerase PhzF, the role, and significance 
of PhzAB heterodimerization and at the development of PhzB-specific inhibitors.   
This work contributed to a deeper understanding of the individual steps employed by the 
isomerase PhzF to convert DHHA, the last stable intermediate of phenazine biosynthesis, 
to a reactive ketamine. Measurement of kinetic isotope effects lent evidence that initial 
abstraction of a non-acidic proton is the rate-limiting step of catalysis. Together with 
computational data from collaborators, the complete catalytic cycle of this enzyme could 
be elucidated. It could also be shown that the substrate specificity of PhzF is narrow and 
one substrate analog revealed weak inhibitory potency, thus constituting a promising 
starting point for future drug-development studies.  
Analysis of the catalytic activity of PhzBB homodimers and PhzAB heterodimers using a 
newly developed enzymatic assay revealed similar efficiency of both dimer forms. 
Together with thermal stability data from CD-measurements showing that heterodimers 
are as stable as PhzBB homodimers, these results indicate that PhzAB heterodimers might 
be prevalent in vivo. This hypothesis is further supported by quantitative RT-PCR data from 
collaborators and as such might explain why pseudomonads, which carry genes encoding 
for PhzA and PhzB, are such efficient phenazine producers.   
New synthetic compounds, termed "phenazistatins" or "mavericks", were characterized 
regarding their inhibitory potency towards the potential drug target PhzB. To this aim, an 
in vitro assay was developed and employed for screening of more than 80 compounds. 
Combining ITC binding data, crystal structures and in cellulo activity data, a detailed 
structure activity relationship could be drawn and potent inhibitors identified.
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1. Introduction 
1.1. Phenazines 
1.1.1. Background 
Phenazines are small nitrogen-containing heterocyclic pigments, which occur in all colors 
of the rainbow. To date more than 180 naturally occurring phenazine derivatives have 
been identified (Dictionary of Natural Products, Taylor & Francis Group, available at 
dnp.chemnetbase.com). Yet, these pigments do not only show a high abundance in the 
biological world, but can be obtained via synthetic routes as well. Including all synthetic 
compounds, such as the first synthetic dye Mauveine (Hübner, 2006) or the common pH-
indicator neutral red, the number of phenazine derivatives increases to over 6000 
(Laursen and Nielsen, 2004). In the environment, more than 50 different organisms, such 
as Burkholderia species, Streptomycetaceae, Brevibacteriaceae, Enterobacteriaceae and 
most notably Pseudomonas species, were identified to produce and secrete the colorful, 
aromatic metabolites (Figure 1; Turner and Messenger, 1986). 
Recently, phenazines, specifically a membrane-bound methanophenazine, were also 
discovered in the archaeon Methanosarcina mazei Gö1, showing that phenazines are 
important secondary metabolites present in different domains of life (Abken et al., 1998). 
Over the last decades, Pseudomonas spp. were the best studied of all phenazine 
producers, in particular because one representative, Pseudomonas aeruginosa, moved 
more and more into the focus of attention. As an opportunistic human pathogen, it causes 
severe nosocomial infections in immunocompromised patients (Jimenez et al., 2012). This 
pathogen, i.e. its primarily produced phenazine, the blue pigment pyocyanin, also 
originally led to discovery of phenazines over 150 years ago. Articles in the medical 
literature of the mid-19th century reported on infected wounds covered with "blue pus" 
Figure 1: Phenazine pigments and their 
corresponding chemical structures.   
Different phenazines exhibit different colors 
when dissolved in DMSO. From left to right: 
phenazine-1-carboxylic acid (PCA), 2-hydroxy-
phenazine-1-carboxylic acid (2-OH-PCA), 
phenazine-1,6-dicarboxylic acid (PDC), 
phenazine (PHZ), 2-hydroxy-phenazine (2-OH-
PHZ) and pyocyanin (PYO). 
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(for review Blankenfeldt and Parsons, 2014). In 1859, the French pharmacist Mathurin-
Joseph Fordos was able to isolate the pigment responsible for the characteristic color. He 
called it "pyocyanin", a combination of the Greek words for "pus" (πύσ) and "cyan" 
(κυανό; Fordos, 1859 and 1860). A few years later, also the organism producing this 
pigment was discovered. Then called Bacillus pyocyaneus, it is nowadays known as 
Pseudomonas aeruginosa (Gessard, 1882). Research on the colored pigments continued 
and led to the classification of pyocyanin as a phenazine in 1924 (Wrede and Strack, 1924) 
and finally, in 1938, to its structural elucidation as a 5-N-methyl-1-hydrophenazinium 
betaine (Hillemann, 1938). Since, multiple phenazines from a variety of different bacteria 
were discovered and further characterized. 
1.1.2. Mode of action – The diverse biological functions of phenazines 
Phenazines are proposed to play multiple roles in the metabolic pathways of their 
producing organisms (Scheme 1).   
First, the small secondary metabolites are toxic to a broad range of organisms like 
bacteria, fungi or algae and thus provide a competitive advantage for space and resources 
in nature (Toohey et al., 1965). Furthermore, the phenazine pyocyanin was identified as 
an important virulence factor in human infections (Lau et al., 2004; Pierson and Pierson, 
2010; Rada and Leto, 2013).   
Recently, it was also discovered that phenazines are involved in the primary metabolism 
of their producer and therefore are crucial for its survival, e.g. by acting as respiratory 
pigments in the lower layers of biofilms (Price-Whelan et al., 2007). Phenazines were also 
found to enhance iron acquisition (Cox, 1986; Hernandez et al., 2004) and even to serve 
as terminal signaling molecules in the quorum sensing–network (Dietrich et al., 2006).  
Most of these functions are based on the redox-properties of phenazines. Phenazines are 
proposed to diffuse over or insert into membranes where they act as reducing agents of 
molecular oxygen and as such are directly involved in uncoupling of the oxidative 
phosphorylation, which in turn leads to the endogenous generation of reactive oxygen 
species, in particular superoxide radicals (•O2-) or hydrogen peroxide (H2O2).  
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Scheme 1: The diverse roles of phenazines as secondary metabolites.  
Graphical representation of different molecular functions phenazines exhibit in their source organism and its 
environment. Most of these functions rely on the redox properties of the heterocyclic phenazine core.  
As these toxic radicals are causing irreversible oxidation of DNA or proteins and major 
damage to cellular structures such as lipid bilayers, the broad-range antibiotic activity of 
phenazines and the role of pyocyanin as an important virulence factor are easily 
explained. Yet, these properties render phenazines also harmful to their source organism. 
Hence, e.g. in P. aeruginosa, a higher activity of superoxide dismutases (SOD) can be 
observed. Likewise, phenazines were identified to upregulate the expression of PA2274, 
a hypothetical monooxygenase potentially involved in redox control, and of the efflux 
pump MexGHI-OmpD, potentially protecting the phenazine producing strain from self-
intoxication (Sakhtah et al., 2016). In some phenazine producers, such as Pantoea 
agglomerans, also specific phenazine resistance proteins (EhpR) were identified (Giddens 
et al., 2002; Yu et al., 2011).   
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Despite these detrimental effects caused by phenazines, their biosynthesis also strongly 
contributes to the survival of the organism, e.g. in biofilms. Under the local anaerobic 
conditions, molecular oxygen is not available for maintaining glycolysis by reoxidation of 
NADH; instead, phenazines can serve as electron shuttles in these subzones by taking up 
electrons from NADH. These electrons might then be transported to the surface of the 
biofilm either via a phenazine relay, in which the electrons are repeatedly transferred to 
other phenazines until the aerobic zones are reached, or the reduced pigments directly 
diffuse to the surface where they get reoxidized by oxygen (Sakhtah et al., 2016).   
Additionally, phenazines are involved in iron homeostasis. On the one hand, they were 
found to downregulate the expression of genes involved in the ferric iron (Fe3+) uptake 
(Dietrich et al., 2006), on the other hand, they are able to oxidize ferric iron to ferrous iron 
(Fe2+) thus facilitating its acquisition (Cox, 1986; Hernandez et al., 2004). 
All these findings not only underline the importance of phenazine pigments for their 
producers, but also even more emphasize the necessity to further study and characterize 
these secondary metabolites and their production to gain a better understanding of the 
multifaceted roles they fulfill especially in infections by pathogenic phenazine producing 
bacteria such as P. aeruginosa. 
1.2. Phenazine biosynthesis 
1.2.1. The phz-operon  
Comparison of phenazine-producing bacterial strains led to identification of a conserved 
gene cluster responsible for biosynthesis of phenazine-1-carboxylic acid (PCA) and 
phenazine-1,6-dicarboxylic acid (PDC) (Pierson and Thomashow, 1992; Pierson and 
Pierson, 1996; Mavrodi et al., 1998). This cluster, called phz-operon, is comprised of at 
least five genes, phzCDEFG, essential for the basal biosynthetic pathway. Most phenazine 
producers possess at least one additional conserved "core" biosynthesis gene termed 
phzB. This gene, as well as the highly homologous gene phzA, seems not to be required 
for PCA or PDC synthesis, yet is able to greatly enhance the levels of these two "core" 
phenazines in vitro (Mavrodi et al., 1998; McDonald et al., 2001). However, in vivo, e.g. in 
the phenazine producer P. agglomerans, expression of the phzB-gene seems to be 
absolutely essential for phenazine biosynthesis (Giddens et al., 2002).   
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As anticipated by the structural diversity of phenazines from different bacteria, many of 
the biosynthetic clusters contain operon extensions or additional genes somewhere else 
in the genome for downstream modifications of the two "precursor" phenazines PCA or 
PDC, leading to strain-specific derivatives. Moreover, auto resistance genes, such as ehpR 
from P. agglomerans, or regulators like phzI and phzR are often located adjacent to the 
"core" biosynthesis genes (Scheme 2).  
The opportunistic pathogen P. aeruginosa represents a peculiarity among the phenazine-
producing bacteria. This organism contains two phz-operons, which are highly 
homologous (98.3 % in strain PAO1) and both contribute to PCA production in this 
bacterium. It was discovered that these two operons underlie not only a complex 
regulatory network (q.v. 1.2.4.), but also exhibit cross-regulation under certain conditions 
(Cui et al., 2016). 
 
Scheme 2: The phz-operon in different species.  
Most of the phenazine-producing organisms possess a conserved gene cluster, which encodes the enzymes of the 
biosynthetic pathway. Besides the "core" biosynthesis genes ( ), genes involved in further modifications of the basic 
scaffold ( ), regulation of the pathway ( ) or self-resistance ( ) are organized in the so-called phz-operon. For some 
bacterial species, the roles of some of the gene products are still unknown ( ). 
As mentioned before, phenazines were also discovered in archaea. However, these 
organisms lack the characteristic phz-operon. Hence, it is not clear, which pathway 
archaea use to generate phenazines or if the essential phenazine scaffold is obtained from 
other external sources (Abken et al., 1998; Deppenmeier et al., 2002).  
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1.2.2. The "core" biosynthesis pathway 
After identification of the genes involved in phenazine biosynthesis in 1996 and 1998 
(Pierson and Pierson, 1996; Mavrodi et al., 1998), further characterization of this pathway 
was initiated at the molecular level. Over the past two decades, the role of all essential 
"core" biosynthesis enzymes could be elucidated (for review: Blankenfeldt and Parsons, 
2014). It was established that phenazine biosynthesis proceeds via the shikimic acid 
pathway and finally branching from the biosynthetic pathway of aromatic amino acids at 
the stage of chorismate (Ingledew and Campbell, 1969). In fact, already in 1972, two 
groups could show that phenazines are built from two molecules of chorismic acid 
(Calhoun et al., 1972; Longley et al., 1972).  
Accordingly, PhzC was shown to be homologous to DAHP (3-deoxy-D-arabino-
heptulosonic acid 7-phosphate) synthases and to catalyze the formation of DAHP from D-
erythrose-4-phosphate (E4P) and phosphoenol pyruvate (PEP) (McDonald et al., 2001). 
DAHP is further converted via shikimic acid to chorismic acid by other enzymes of the 
shikimic acid pathway (Scheme 3). As mentioned before, chorismic acid represents the 
last common precursor of phenazines and aromatic amino acids. While for amino acid 
biosynthesis chorismate is converted either to anthranilic acid (AA) or to prephenate 
yielding tryptophan and tyrosine/phenylalanine respectively, in phenazine biosynthesis 
the homodimeric, intertwined two-domain enzyme PhzE converts chorismate to 2-amino-
2-deoxyisochorismate (ADIC) (Li et al., 2011).  
PhzE facilitates this reaction by establishing an intramolecular channel that connects the 
N-terminal menaquinone, siderophore, tryptophan synthase-like (MST) domain with the 
C-terminal type-I glutamine amidotransferase (GATase1) domain. In the latter domain, 
glutamine is hydrolyzed to glutamate leading to generation of free ammonia, which is 
transferred directly to the active site of the MST-domain in the second monomer, where 
it is used for conversion of chorismate to ADIC. Interestingly, PhzE was found to be related 
to anthranilate synthases (AS), yet, despite a very similar organization of the active site 
residues, PhzE seems not to catalyze the subsequent elimination of pyruvate that leads to 
generation of AA by these AS (Li et al., 2011).  
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Scheme 3: Overview of the "core" phenazine biosynthesis leading to production of the two phenazine precursors 
DHPCA and DHPDC.  
Phenazine biosynthesis branches from the shikimic acid pathway at the stage of chorismic acid. The first specific 
phenazine biosynthesis enzyme is PhzE, which catalyzes the conversion of chorismate to ADIC. Subsequently, ADIC is 
cleaved by the isochorismatase PhzD yielding DHHA. DHHA represents the last stable intermediate of the pathway. After 
its PhzF-catalyzed isomerization, the reactive ketamine AOCHC undergoes condensation assisted by PhzB. The final steps 
are comprised of multiple uncatalyzed and PhzG-dependent oxidation reactions leading to the two phenazine 
precursors DHPCA and DHPDC.  
The next step in the biosynthetic pathway is comprised of a hydrolysis reaction 
whereupon ADIC is converted to trans-2S,3S-dihydro-3-hydroxyanthranilic acid (DHHA; 
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Scheme 3). The α/β-hydrolase PhzD cleaves ADIC via a general acid-base catalysis 
involving a conserved aspartic acid and a lysine residue. This catalysis follows again an 
unusual mechanism, i.e. other structurally similar enzymes facilitate such reactions in a 
metal-dependent fashion and via formation of a covalent intermediate (Parsons et al., 
2003).   
Subsequently, DHHA is converted to the highly reactive amino ketone 6-amino-5-oxo-2-
cyclohexene-1-carboxylic acid (AOCHC) by the isomerase PhzF (Blankenfeldt et al., 2004; 
Parsons et al., 2004a; a more detailed description of this enzyme and its proposed catalytic 
mechanism can be found in paragraph 1.3.1.).   
In order to prevent unwanted side reactions of this ketone, the dimeric enzyme PhzB, 
which is structurally similar to enzymes from the Δ5-3-ketosteroid isomerase/nuclear 
transport factor 2 family was found to accelerate the otherwise spontaneous head-to-tail 
condensation of two identical AOCHC molecules (Ahuja et al., 2008; for further details 
please see paragraph 1.3.2.).  
Finally, PhzG, a FMN-dependent monooxygenase and the last enzyme of the "core" 
biosynthesis, is catalyzing different oxidative steps leading to formation of PCA or PDC in 
their reduced dihydro-state (Scheme 3). Two recent studies showed that PhzG is, similar 
to other enzymes of the biosynthetic pathway, a homodimeric enzyme. Structurally 
related to pyridoxine-5’-phosphate oxidase (PdxH), it contains an essential FMN-cofactor 
in its active site, which is formed by residues from both monomeric chains (Parsons et al., 
2004b; Xu et al., 2013). The study by Xu et al. (2013) also revealed that PhzG can oxidize 
different tricyclic intermediates. It either directly binds the reaction product of PhzB-
catalysis, hexahydro-phenazine-1,6-dicarboxylic acid (HHPDC), or a downstream product 
of this catalysis, tetrahydro-phenazine-1-carboxylic acid (THPCA). In the former case PhzG 
catalyzes two subsequent oxidations leading to dihydro-phenazine-1,6-dicarboxylic acid 
(DHPDC) as final product. In the other case, THPCA, which results from spontaneous, 
uncatalyzed oxidative decarboxylation of HHPDC, is converted to dihydro-phenazine-1-
carboxylic acid (DHPCA).   
The fact that PhzG can catalyze oxidations leading to two different products of the same 
biosynthetic pathway is unusual and can be explained best by the relative activities of 
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PhzG and the two preceding enzymes PhzF and PhzB. Since the final catalytic steps require 
oxygen, also the availability of oxygen might play a crucial role in PCA or PDC biosynthesis. 
1.2.3. Synthesis of more complex, strain specific phenazine derivatives 
As mentioned before, over 180 naturally occurring phenazine derivatives have been 
identified. All derive from the two precursors DHPCA or DHPDC, which are the final 
products of the "core" biosynthetic pathway (Scheme 4).  
 
Scheme 4: The variety of naturally occurring phenazines from different bacterial or archaeal organisms.  
All different phenazines, except the archaeal methanophenazine (gray), whose biosynthesis is unknown to date, are 
based on the two precursors PCA and PDC (green).  
Yet, to generate strain specific phenazines further enzymes are necessary to modify the 
basic phenazine scaffolds (Scheme 5). P. aeruginosa for instance possesses the two genes 
phzM and phzS adjacent to their "core" biosynthetic operon phz1 as well as a third DHPCA-
modifying gene, phzH, localized upstream of the phz2-operon (Chin-A-Woeng et al., 
2001a, 2001b).  
PhzM is a methyltransferase catalyzing the SAM-dependent methylation of DHPCA 
leading to formation of N-5-methyl-phenazine-1-carboxylic acid (5-Me-PCA). This 
intermediate was recently found to regulate its own transport by the MexGHI-OmpD 
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efflux pump (Sakhtah et al., 2016).  
In a subsequent reaction, 5-Me-PCA is converted to pyocyanin by the FAD-dependent 
monooxygenase PhzS, which uses NADH and molecular oxygen. PhzS can also directly 
convert DHPCA, which leads to formation of 1-hydroxy-phenazine (1-OH-PHZ; Scheme 5; 
Gohain et al., 2006; Greenhagen et al., 2008). 
 
Scheme 5: Overview of alternative phenazine modifying pathways.   
Starting from DHPCA, different phenazine modifying enzymes convert this precursor to strain specific phenazines. PhzH 
is converting DHPCA to PCN using ATP hydrolysis as energy and glutamine as ammonium source. PhzM is an SAM-
dependent enzyme leading to formation of 5-Me-PCA that can be converted, similarly to DHPCA, by PhzS using NADH 
and molecular oxygen leading to formation of pyocyanin and 1-OH-PHZ respectively. PhzO is catalyzing a similar reaction 
leading to 2-OH-PCA that, after oxidative decarboxylation, forms 2-OH-PHZ.  
Another monooxygenase termed PhzO, which can e.g. be found in P. aureofaciens, 
catalyzes a similar oxidation of DHPCA to 2-hydroxy-PCA, which spontaneously reacts 
further to form 2-OH-PHZ (Scheme 5; Delaney et al., 2001).   
The product of the phzH gene is a transamidase, which catalyzes the glutamine and ATP-
dependent synthesis of phenazine-1-carboxamide (PCN; Chin-A-Woeng et al. 2001b). 
Other bacteria, such as Streptomyces spp., produce even more complex phenazines like 
griseoluteiic acid or esmeraldins (Scheme 4; Rui et al., 2012). Their biosynthesis pathways 
contain a variety of additional modifying enzymes.  
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1.2.4. Everything under control – Regulation of phenazine biosynthesis by QS 
Phenazines are important bacterial and archaeal secondary metabolites (q.v. 1.1.2.). As 
such, it is no surprise that their biosynthesis is tightly regulated. In pseudomonads this 
regulation mainly depends on the so-called quorum sensing (QS) network (Pierson et al., 
1994; Wood et al., 1997). Quorum sensing in general enables bacteria to regulate gene 
expression of their secondary metabolism according to environmental conditions and to 
coordinate the behavior of the entire cell population (for review: Lee and Zhang, 2015; 
Papenfort and Bassler, 2016).  
In the most simple case, as it can be found e.g. in P. fluorescens 2-79, two genes, encoding 
for a so-called autoinducer synthase (PhzI) and a transcription regulator (PhzR), are 
necessary for QS control of phenazine biosynthesis. Both proteins belong to a QS system 
that uses N-acyl-L-homoserine lactones (N-AHL) as signaling molecules/autoinducer 
(Fuqua et al., 1994). In P. aeruginosa however, the network is more complex. So far, four 
quorum sensing pathways have been identified, which are hierarchically arranged but also 
highly interconnected. The two major networks, the LasI/LasR- and the RhlI/RhlR-system, 
also rely on N-AHLs as signaling molecules. In addition, there is the specific Pseudomonas 
quinolone signal (PQS) system, which plays an important regulatory role in phenazine 
biosynthesis, and the recently discovered integrated quorum sensing (IQS) system, which 
is triggered under limiting phosphate concentrations (for review: Lee and Zhang, 2015; 
Papenfort and Bassler, 2016).   
Quorum sensing is population density dependent, hence, only when the size of the 
population is large enough, the intracellular level of the signaling molecule reaches a 
certain threshold, binds to the receptor and activates the expression of genes under QS 
control.   
Interestingly, also phenazines themselves, especially the virulence factor pyocyanin, seem 
to serve as signaling molecules by reducing the redox-sensitive transcription activator 
SoxR and thus activating gene expression e.g. of PA2274, which might be involved in redox 
control (Dietrich et al., 2006).  
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1.3. Unique reactions of phenazine biosynthesis 
1.3.1. PhzF catalyzes DHHA isomerization by a suprafacial-[1,5]-hydrogen shift 
The phenazine biosynthetic pathway is characterized by some unique reaction 
mechanisms, e.g. the metal-independent hydrolysis of ADIC by the isochorismatase PhzD 
(Parsons et al., 2003). The isomerization of DHHA, the product of this hydrolysis and the 
last stable intermediate of the pathway, seems to proceed via an unusual reaction as well. 
Previous studies showed that the homodimeric isomerase PhzF catalyzes the conversion 
of DHHA to the reactive ketamine AOCHC (Blankenfeldt et al., 2004; Parsons et al., 2004a).  
In agreement with anterior predictions, crystal structures of PhzF (Figure 2) confirmed 
that the enzyme is structurally related to DapF, a diaminopimelate epimerase first 
characterized in Hemophilus influenza (Cirilli et al., 1998; Lloyd et al., 2004).  
 
Figure 2: Structure and active site of the isomerase PhzF.  
A Overall topology of the dimeric biological assembly of PhzF shown as cartoon and surface (transparent) 
representation. The individual chains are colored in blue (chain A) and light blue (chain B) respectively. The natural 
substrate DHHA is shown as ball and stick representation in black. B The PhzF monomer depicted with its secondary 
structure elements. C Close-up on the active site of PhzF in complex with DHHA. The active site residues as well as the 
ligand are shown as balls and sticks colored as described above. The important hydrogen bonds are highlighted (- - -) 
and the arrow () indicates the location of the C3 proton that is abstracted during catalysis.  
A PhzF monomer (Figure 2B) is built up by two very similar domains each comprised of 
approximately 130 amino acids, which might have arisen from ancient gene duplication. 
The two domains share a very similar topology characterized by a central α-helix (α2 and 
A 
B 
C
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α6) that is wrapped in an eight-stranded β-sheet. One of these β-strands (β15) is larger and 
spans into both domains. Additionally, each domain is flanked by small helices (α1 and α3-
α5), a short β-strand (βN and βC), and a 310-helix (η1 and η2). The substrate binding site is 
located at the interface of the domains at the bottom of a central cleft with the two 
positive central helix dipoles pointing towards it (Blankenfeldt et al., 2004). In contrast to 
DapF, PhzF lacks the two important catalytic cysteine residues in the active site. Instead, 
based on a complex structure with the substrate DHHA, E45 could be identified as catalytic 
residue. It stabilizes the substrate together with the side chains of H74, D208 and S213 as 
well as the backbone amides of G73, H74 and G212 and a water molecule, which together 
provide an extensive hydrogen-bonding network (Figure 2C). Mutagenesis studies 
confirmed the crucial role of E45, as variants, in which this residue is replaced by an 
alanine or glutamine, completely lose catalytic activity (Blankenfeldt et al., 2004).   
The essential role of residue E45 indicates a catalytic mechanism potentially involving a 
proton/hydrogen transfer whereupon the C3-proton of DHHA has to migrate to position 
C1. This [1,5]-hydrogen shift could follow two potential reaction mechanisms: a) a general 
acid-base catalysis or b) a sigmatropic reaction via a pericyclic intermediate.   
The first mechanistic hypothesis involves direct contribution of residue E45 as a general 
base, which initiates the proton abstraction that is followed by rearrangement of the π-
system of the substrate. The proton is then transferred to position C1, leading to 
formation of an enol, which subsequently tautomerizes stereospecifically to the 
respective ketone. As the migrating proton is predicted to be non-acidic, a high energy 
barrier can be expected for its initial abstraction.   
Furthermore, NMR measurements carried out in D2O revealed full recycling of the 
migrating proton without solvent exchange. Assuming that in a classical acid-base 
catalyzed reaction, possibly involving solvent molecules, incorporation of a solvent 
deuterium at position C1 is expected, this suggests that E45 is not directly involved in 
proton abstraction. Consequently, both findings render a classical acid-base catalyzed 
mechanism less likely, but offer the possibility of another mechanistic route, i.e. a 
sigmatropic [1,5]-hydrogen shift. Sigmatropic reactions are pericyclic reactions, which 
proceed in a concerted manner and are characterized by a cyclic geometry of the 
transition state (TS; Blankenfeldt et al., 2004). A pericyclic mechanism is further supported 
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by structural data of phenazine biosynthesis enzymes downstream of PhzF (Ahuja et al., 
2008; Xu et al., 2013), which, in complex with their respective substrates, revealed R-
configuration of the proton at the position equivalent to C1 in DHHA. As this 
stereochemistry would only be observed if de- and reprotonation of DHHA occur on the 
same side of the central 1,3-cyclohexadiene ring, these structures further indicate a 
suprafacial [1,5]-hydrogen shift following a sigmatropic rearrangement.   
In fact, pericyclic reactions have already been described in enzyme catalysis. Among these, 
the [3,3] Claisen rearrangement of chorismate to prephenate catalyzed by chorismate 
mutases is probably known best (Burschowsky et al., 2014). Another example is the 
asynchronous [1,5] prototropic fragmentation found in PchB, an isochorismate pyruvate 
lyase from P. aeruginosa, which catalyzes the elimination of pyruvate from isochorismate 
(DeClue et al., 2005). However, a sigmatropic [1,5]-hydrogen shift as suggested for PhzF 
has not been reported so far.  
Subsequently to the PhzF-catalyzed isomerization of DHHA, the reactive amino ketone 
product AOCHC undergoes head-to-tail condensation via a double Schiff base reaction 
leading to formation of the tricyclic phenazine scaffold (Blankenfeldt et al., 2004). As the 
amino ketone is very reactive, potentially harmful side reactions have to be prevented. It 
could be shown that PhzB is able to catalyze this reaction, however a slow, but significant 
uncatalyzed auto condensation of two AOCHC molecules could be observed as well (Ahuja 
et al., 2008).  
1.3.2. PhzB accelerates AOCHC self-condensation leading to formation of the phenazine 
scaffold 
Subsequent to PhzF catalysis, another key step of the biosynthesis pathway is the two-
fold condensation of two identical ketamine precursors leading to formation of the 
characteristic tricyclic phenazine scaffold. Although this step can proceed spontaneously 
and without further assistance of an enzyme in solution, PhzB was found to accelerate the 
bimolecular reaction several-fold (Ahuja et al., 2008). In fact, deletion of the respective 
gene from P. agglomerans (ephA) led to drastic impairment of phenazine production, 
suggesting that enzyme catalysis of this step is crucial for successful biosynthesis in vivo 
(Giddens et al., 2002).   
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Several crystal structures of PhzB from Burkholderia lata 383 (synonym: Burkholderia 
cepacia R18194) and Pseudomonas fluorescens 2-79 as well as biochemical studies 
provided a deeper insight into substrate binding and the mechanistic details of the 
enzyme catalyzed reaction (Ahuja et al., 2008; Blankenfeldt et al., unpublished).   
The structural studies identified PhzB as a small dimeric enzyme belonging to the Δ5-3-
ketosteroid isomerase/nuclear transport factor 2 family (Figure 3).  
 
Figure 3: Structure and active site of the phenazine biosynthesis protein PhzB.  
A Surface representation of Phz(A)/B from B. cepacia R18194 showing the arm-to-arm exchange between the C-termini 
of two monomers. The individual chains are colored in forest (chain A) and palegreen (chain B) respectively.  
B Overall topology of the dimeric biological assembly of Phz(A)/B shown as cartoon representation in similar colors as 
described before. Four molecules of the substrate analog 3OCHCA (3-oxo-cyclohexanecarboxylic acid) bound to the 
active site of PhzB are shown as ball and stick representation in black. C and D Close-ups on the active site of BcPhz(A)/B 
in complex with either two molecules of the substrate analog 3OCHCA (C) or a potential PhzB-inhibitor called 
phenazistatin A (D). The active site residues as well as the ligands are shown as balls and sticks colored as described 
above or in gray for phenazistatin A. The important hydrogen bonds are highlighted (- - -).  
A remarkable feature of the obligate dimer is the arm-exchange of the two C-termini 
(Figure 3A), which act as flexible lids shielding the active site from the solvent. The 
exchange was found to be essential for activity as truncations in this region led to a drastic 
decrease or even full abrogation of enzymatic activity (Ahuja et al., 2008). 
A 
B 
C 
D 
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A closer look at the active site explains this observation: PhzB provides a large cavity for 
binding of two, chemically identical substrate molecules, formed by residues from both 
monomers (Figure 3C). The first substrate molecule binds deep inside this cavity and is 
stabilized via its carboxylic acid moiety through a hydrogen-bonding network, which is 
mainly provided by a conserved arginine (R41). The binding site for the second substrate 
is located closer to the surface. The C-terminal arginine of the other monomer (R160*) is 
directly involved in binding and orienting the ligand, again by coordinating its carboxylate. 
Consequently, the two substrate molecules are perfectly oriented towards each other to 
facilitate catalysis. Two consecutive nucleophilic attacks by the 2-amino-groups lead to 
formation of a double Schiff base intermediate and release of two water molecules. After 
further rearrangements, the heterocyclic product HHPDC is formed. The active site 
residues E140, as well as H73 and S77 are involved in protonation and stabilization of the 
two different anionic intermediates (Ahuja et al., 2008).  
Surprisingly, phenazine producing pseudomonads feature a second, 70 % identical copy 
of PhzB, termed PhzA (Mavrodi et al., 1998). Yet, the function of this protein is unclear. 
Although depletion of the encoding gene leads to reduced PCA production, PhzA was 
found to be inactive in the condensation reaction (Ahuja et al., 2008). This finding can be 
explained by two mutations of the active site, where two residues involved in PhzB-
catalysis, H73 and S77, are replaced by leucines. In addition, a crystal structure of PhzA 
from P. fluorescens 2-79 revealed a dimeric organization, which does not feature the arm-
exchange found to be indispensable for catalysis (Ahuja et al., 2008). Nevertheless, due to 
the high sequence as well as structural similarity, it was proposed that both proteins could 
form heterodimers. Indeed, a crystal structure of PhzAB confirmed this hypothesis 
(Figure 4; Blankenfeldt et al., unpublished). 
However, the actual function of PhzA or PhzAB remains elusive, although it was suggested 
that heterodimer formation might be advantageous under substrate-limiting conditions 
when the substrate concentration is too low to occupy all four binding sites of an active 
homodimer (Ahuja et al., 2008). 
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Figure 4: PhzAB heterodimerization in Pseudomonas fluorescens 2-79.  
Top: Schematic representation of the phz-operon from P. fluorescens 2-79 with the genes encoding for PhzA and PhzB 
highlighted in deepteal ( ) and raspberry ( ) respectively. Bottom: Schematic representation of PhzAB 
heterodimerization as indicated by the crystal structures of dimeric PhzA (deepteal) and dimeric PhzB (raspberry) and 
the PhzAB heterodimer (colored accordingly). 
The unique role of PhzB in phenazine biosynthesis renders it an interesting drug target. In 
the first place, enzyme inhibition could lead to reduced levels of phenazine virulence 
factors. In addition, inhibition of the PhzB-catalyzed condensation reaction might trigger 
self-intoxication of the producing bacteria by accumulation of the reactive ketamine 
substrate. Studies of PhzB catalysis already provided various synthetic substrate and 
product analogs, which served as mechanistic probes (Mentel et al., 2009a). Some of 
these compounds revealed high affinity binding to the enzyme in the µM-range. As such, 
these ligands constitute promising starting points for further inhibitor development. 
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2. Research Objectives 
Phenazines are small, nitrogen-containing heterocyclic pigments. They exhibit versatile 
and sometimes pivotal roles in the primary and secondary metabolism of their producing 
organisms such as the human nosocomial pathogen P. aeruginosa. Biosynthesis of these 
important metabolites is carried out by the products of at least five highly conserved 
genes, phz(B)CDEFG, clustered in the phz-operon. Among the peculiar catalytic 
mechanisms employed in the pathway, the two reactions leading to formation of the 
tricyclic phenazine scaffold are of special scientific and/or therapeutic interest and 
therefore constituted the focus of this study, which aimed at: 
1. The elucidation of the basic principles of the PhzF-catalyzed DHHA isomerization 
The isomerase PhzF converts trans-2S,3S-dihydro-3-hydroxyanthranilic acid (DHHA) into a 
highly reactive ketamine. Previous data revealed that this isomerization requires a 
suprafacial [1,5]-shift of a non-acidic proton within the π-system of the substrate, 
followed by immediate stereospecific keto-enol tautomerization (Blankenfeldt et al., 
2004), yet the molecular details of the mechanism remained unclear. 
2. The analysis of the occurrence of PhzAB heterodimerization and its relevance for 
phenazine biosynthesis 
Following DHHA isomerization, two molecules of the ketamine product undergo diagonal-
symmetrical condensation leading to generation of the tricyclic phenazine scaffold. Due 
to the high reactivity of the ketamine, this reaction can occur spontaneously, it is however 
significantly accelerated by PhzB (Ahuja et al., 2008). Interestingly, an additional gene in 
the phz-operon of pseudomonads encodes a second, highly homologous copy of PhzB, 
termed PhzA. This protein is inactive in the condensation reaction, but, as revealed by a 
crystal structure, can form heterodimers with PhzB (Blankenfeldt et al., unpublished). 
Despite the structural insights, the physiological relevance and role of these dimers 
remained elusive. 
3. The development of specific PhzB-inhibitors to modulate phenazine biosynthesis 
In addition to the potentially special dimerization behavior of Phz(A)/B, the enzyme could 
be a promising drug target as its inhibition is supposed to cause accumulation of the highly 
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reactive ketamine substrate. Elevated levels of this substrate might promote unspecific 
side reactions and consequently trigger self-intoxication of the phenazine-producing 
bacteria. 
Altogether, by combining the information obtained from different types of experiments, 
such as enzymatic activity assays, biophysical binding studies and X-ray crystal structure 
analysis, this study provides a deeper insight into two unique steps of phenazine 
biosynthesis. A profound understanding of the generation of these virulence factors is 
essential for identification of new potential drug targets and allows further rational drug 
design to interfere with this important metabolic pathway and eventually fight infectious 
diseases caused by phenazine producing pathogens. 
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3. Methods & Materials 
3.1. Theoretical Section 
This section deals with the basic theory of the most important biochemical and biophysical 
methods used in this study. 
3.1.1. Steady-state enzyme kinetics 
Enzymes are essential components in all biological systems and understanding their 
function can provide a deeper insight into the function and regulation of the whole 
system. Enzymes, in contrast to other proteins, are molecular catalysts that can accelerate 
the rate of a (bio)chemical reaction in both, forward (substrate to product) and reverse 
(product to substrate), direction, typically at different rates. A simple and rapid way to 
study this activity is the performance of steady-state kinetic experiments. The 
experimental setup constitutes the determination of initial reaction rates under the 
assumption that at the beginning of the experiment each enzyme molecule repeatedly 
binds one substrate and catalyzes its turnover. A prerequisite for this assumption is that 
substrate is available in large excess (at least fivefold) compared to the enzyme. In this 
case, the concentration change of unbound substrate over time is negligible, i.e. the 
concentration of free substrate [S] is equal to the total substrate concentration [ST] 
([S]≈[ST]), which leads to a linear dependency. At the same time, almost no product will 
be present at this point and thus will not interfere with the monitored reaction. Under 
these conditions the Michaelis-Menten theory applies, i.e. that the rate of the enzyme-
catalyzed reaction is proportional to the concentration of the enzyme-substrate complex 
(equation 1). 
 = 	

 + 
  where 	
 =  (1) 
with  
v rate of the reaction  
kcat apparent first order rate-constant, independent of enzyme concentration  
[ET] total enzyme concentration  
[S] substrate concentration in the equilibrium  
KM Michaelis-constant ≡ substrate concentraion at vmax/2  
vmax maximal rate of reaction at a specific enzyme concentration ≡ saturaion 
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In practice, the depletion of substrate or the formation of product is followed over a 
course of time starting from different initial substrate concentrations (Scheme 6). Initial 
reaction rates are then determined from the linear portion of the resulting plots and in 
turn plotted as a function of the initial substrate concentrations (Scheme 6).  
   
Scheme 6: The principle of steady-state enzyme kinetics.  
Left panel: Depletion of a substrate at different concentrations [S] (, , , , , ) is followed over time. The slope of the 
linear portion of the resulting curves is determined (―). Right panel: The slopes are equivalent to the initial rates v and 
are plotted over the corresponding initial substrate concentration [S] yielding a Michaelis-Menten plot. The enzyme 
kinetic parameters vmax and KM are determined by fitting the data via non-linear regression using a Michaelis-Menten 
model.  
Fitting of these data using non-linear regression with equation 1 allows determination of 
the enzyme and substrate specific parameters kcat and KM and gives information about 
enzyme proficiency and substrate specificity. kcat is a measure for the slowest, i.e. rate-
limiting step of catalysis directly after formation of the productive enzyme-substrate 
complex. KM is often interpreted as the apparent "affinity" of the substrate to the enzyme, 
but it is important to note that it represents a kinetic and not an affinity constant. As such, 
it is not necessarily identical to the dissociation constant KD of the enzyme-substrate 
complex. However, the second order rate-constant kcat/KM is generally considered as most 
important because it gives information about substrate specificity, in other words the 
higher this value the more specific the enzyme.   
Steady-state kinetics can be analyzed in different ways, i.e. by continuous or end-time 
readout with different assay probes, such as fluorescence or absorbance. Steady-state 
kinetics are also applicable, if an enzyme has more than one substrate. In this case, the 
co-substrate, e.g. SAM or NADH, is given in at least tenfold excess and the turnover of the 
other substrate is studied as described above. Moreover, enzyme inhibitors and their 
mode of action can be characterized using steady-state kinetics as well. Sometimes, also 
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the shape of the plot lends information about enzyme specific characteristics; a sigmoidal 
plot for instance can indicate that the enzyme exhibits cooperativity.   
Yet, there are also limitations: Steady-state kinetics do not give information about 
fundamental rate constants and thus the obtained parameters alone do not allow to 
dissect a catalytic mechanism in detail and additional experiments are required, e.g. 
binding studies or computational methods.  
3.1.2. Studying macromolecular interactions 
Most cellular functions rely on macromolecular interactions such as protein-protein, 
protein-nucleic acid, protein-lipid or protein-small molecule interactions. Understanding 
the nature of these interactions provides crucial information on the molecular function of 
the binding partners. Various techniques exist for quantification of the interaction 
between different binding partners. Each method relies on different special 
characteristics of the studied molecules and two of these methods are presented in more 
detail below. 
3.1.2.1. Isothermal titration calorimetry 
The principle of isothermal titration calorimetry (ITC) is based on the direct measurement 
of the energetics (heat) of a non-covalent macromolecule-ligand interaction in solution. It 
allows quantitative characterization of all thermodynamic parameters of macromolecular 
complex formation such as molar enthalpy (∆H) and binding/affinity KA and, based on the 
relation depicted in equation 2, the molar Gibbs free energy (∆G) as well as the molar 
entropy (∆S): 
∆ = − ∙  = ∆ −  ∙ ∆ (2) 
with 
∆G Gibbs free energy in kcal mol-1  
R ideal gas constant = 8.3144598 J K-1 mol-1 (= 1.9872036•10−3 kcal K-1 mol-1)  
T temperature in K  
KA equilibrium constant of binding  
∆H binding enthalpy in kcal mol-1  
∆S binding entropy in kcal mol-1 
The technique is widely used due to its high sensitivity towards even small changes in the 
composition of a solution and because it requires no additional labeling or immobilization 
of one interaction partner.  
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The experimental setup of a calorimeter (Scheme 7 left panel) constitutes of a sample cell 
(S) and a reference cell (R) enclosed in an adiabatic jacket. The cells are connected via a 
temperature sensor, which monitors the temperature difference between them.  
 
Scheme 7: The principle of isothermal titration calorimetry.  
Left panel: An isothermal titration calorimeter consists of an adiabatic jacket, in which the sample (S) and the reference 
cell (R) are enclosed. Both cells are kept at a constant temperature via the cell main heater (red). The sample cell 
contains the macromolecule M at a certain concentration. Under constant stirring, the titrant T, typically ten-times the 
concentration of the macromolecule, is added to the sample cell via defined volume injections from a syringe. Complex 
formation MT either generates or absorbs heat in the sample cell causing a temperature difference between the sample 
and the reference cell. To compensate this temperature difference ΔT (ΔT = 0) a differential power DP is applied. Top 
right panel: For each individual injection, the DP that is used to keep both cells at equal temperature is recorded over a 
period of time. Bottom right panel: The integral of the DP is plotted against the molar ratio of macromolecule and 
titrant in the sample cell. The amplitude of the resulting sigmoidal binding curve yields the binding enthalpy ΔH and the 
position of the inflection point gives information about the binding affinity constant KA and binding stoichiometry N. 
At the onset of an ITC experiment both cells are heated to the experimental temperature 
T, while the reference cell is filled with water or buffer and the sample cell contains the 
macromolecule M. During the experiment, a defined amount of titrant T (small molecule 
ligand, protein, or nucleic acid) is added to the sample cell in a series of individual 
injections. For each injection, the heat that is generated or absorbed upon solvation and 
especially complex formation is recorded by the differential power (DP) that is applied to 
keep the temperature difference between the sample and neighboring reference cell 
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equal to zero (Scheme 7 top right panel). The integral of this power is plotted against the 
concentration of the titrated ligand versus the macromolecule, i.e. their molar ratio. The 
resulting curve contains information about the binding enthalpy ∆H, which is equal to the 
amplitude of the curve, as well as the binding affinity KA and stoichiometry N that can be 
deduced from the position of the inflection point and the shape of the curve (Scheme 7 
bottom right panel). The more data points describe this curve, the more accurate the 
corresponding parameters can be determined. This relation is described by the c-value, 
which links the macromolecule concentration used in the experiment (M0) to the expected 
KA (= KD-1; equation 3) and the stoichiometry of complex formation N: 
 = 
 ∙  (3) 
with  
[M0] total/starting concentration of the macromolecule M  
KD dissociation constant 
Reliable parameters can typically be obtained with a c-value in the range of 10 to 100. 
3.1.2.2. Microscale thermophoresis 
Microscale thermophoresis (MST) is a method that records the directed movement of 
particles, in this case macromolecular complexes, along a defined temperature gradient. 
Thermophoresis is dependent of the size, charge and hydration shell of the analyzed 
particle and is thus very sensitive to changes in one or all of these molecular characteristics 
e.g. upon ligand binding (for review Jerabek-Willemsen et al., 2011).   
The experimental setup (Scheme 8 left panel) consists in an array of capillaries filled with 
the analytic solution comprised of a fluorescence-labeled binding partner at constant 
concentration and its potential interaction partner as serial dilution. Irradiation of these 
capillaries with an infrared laser creates a locally defined, very steep temperature gradient 
along which the particles move either towards or out of the heat focus (Scheme 8 top 
right panel). Typically, the fluorescence signal of an intrinsic (e.g. tryptophan) or 
chemically introduced/linked fluorophore serves as an experimental probe to record 
movement of the molecules (Scheme 8 bottom right panel).  
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Scheme 8: The principle of microscale thermophoresis.  
Capillaries containing a fluorescent-labeled macromolecule (green) at constant concentration and a serial dilution of 
the interaction partner () are irradiated with an infrared laser. This induces a microscopic, steep temperature gradient. 
The movement of the molecules along the gradient depends on their size, charge, and hydration shell, as such free 
ligands or macromolecules show a different thermophoretic behavior than macromolecule-ligand complexes. As one of 
the interaction partners is containing a fluorophore, its movement can be followed using fluorescence spectroscopy. 
This signal plotted against the ligand/titrant concentration allows determination of the binding parameters. Figure 
adapted from Jerabek-Willemsen et al.(2011).  
As mentioned before, macromolecular interactions such as ligand binding influence the 
size, charge and hydration properties of a particle and hence will lead to differences in the 
thermophoretic profile between a ligand-bound and unbound state. This information, i.e. 
the fraction of bound [LB] and free ligand [LF], together with the knowledge of the 
concentration of the interaction partners in a titration experiment can be used to derive 
specific binding parameters from fitting the data to a two-state model as shown in 
equation 4: 
 !
 = " ∙  #
 +  #
 + $ (4) 
with  
[LB] fraction/concentration of ligand bound to the macromolecule  
C capacity/total amplitude of binding ≈ [LB]/[LF]  
[LF] fraction/concentration of free/unbound ligand  
KD dissociation constant  
B background = thermophoresis in the absence of any ligand 
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3.1.3. Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is a method that allows determination of the 
secondary structure composition of a protein in solution. The basic principle of this 
technique is the differential absorbance of left and right circularly polarized light (CPL) by 
chiral molecules. Since chirality is independent of the orientation of the molecule, 
randomly oriented samples such as proteins in solution can be measured.   
Circularly polarized light arises from the superposition of two linearly polarized 
electromagnetic waves with perpendicular oscillation and a phase difference of π/2. The 
electric field vector of the resulting wave rotates with constant amplitude either clockwise 
(right CPL) or counterclockwise (left CPL) in the propagation direction of the 
electromagnetic wave (Bulheller et al., 2007; Figure 5 left panel). When such a circularly 
polarized wave hits a chiral molecule, the electrons within this molecule absorb the energy 
and undergo transition from the ground to an excited state (Garab and van Amerongen, 
2009). The extent of this excitation (absorbance) depends on the handedness of the 
polarization (left or right-handed), on the wavelength as well as on the geometry of the 
chiral molecule.  
 
Figure 5: The principle of circular dichroism spectroscopy.  
Left panel: Circularly polarized light originates from two perpendicularly oscillating electromagnetic waves that are 
superposed with a phase difference of π/2. The resulting electromagnetic wave oscillates with constant amplitude, but 
the electric field vector rotates in direction of the wave propagation either clockwise (right-handed) or counterclockwise 
(left-handed). Figure reproduced from https://en.wikipedia.org/wiki/Circular_polarization (2017). Right panel: When a 
circularly polarized wave interacts with proteins in solution, the difference in absorbance of left and right circularly 
polarized light plotted against the wavelength gives characteristic spectra. The shape of these spectra depends on the 
geometry of the interacting chiral molecule. In proteins, this geometry is mainly determined by the peptide bond angles 
and hence different secondary structure elements yield specific spectra. Figure reproduced with permission from 
Biomolecular Crystallography by Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis LLC (Rupp, 2009). 
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In a typical CD-experiment, the difference in absorption of left and right CPL is recorded 
over a range of wavelengths - typically ultraviolet (UV) light in the range from 190 to 
250 nm. This difference, precisely the difference in the extinction coefficients Δε between 
left (εL) and right (εR) CPL is plotted against the corresponding wavelengths and yields the 
characteristic spectra (Bulheller et al., 2007; Figure 5 right panel). As mentioned before, 
the difference in absorbance also depends on the geometry of the chiral molecule, in 
proteins this is determined by the specific angles of the peptide backbone and thus 
explains why different types of secondary structure elements yield specifically shaped CD-
spectra (Whitmore and Wallace, 2008; Figure 5 right panel).  
3.1.4. Principles of protein X-ray crystallography 
The molecular function of a protein is closely linked to its structure. For this reason, 
determination and analysis of this structure can help to decipher and understand the 
biological function of a protein. In order to study a molecular structure in detail, 
information about the precise spatial organization of its atoms is necessary. A way to 
determine the three-dimensional structure of a protein is X-ray crystallography.  
3.1.4.1. Protein crystallization 
At the beginning of each macromolecular crystallography experiment stands the crucial 
step of crystallization. Typically, protein of high purity (≥ 95 %) and in a reasonable high 
concentration (~10 - 20 mg/mL) is needed to yield initial protein crystals. Protein 
crystallization however, is an unpredictable process that depends on many variables. In 
addition to the quality and concentration of the protein sample, a variety of external 
parameters such as temperature, pH and composition of the precipitant solution 
influence the desired phase transition of the protein from the liquid to the solid phase. 
Hence, a successful crystallization experiment often requires extensive screening and 
optimization to obtain diffraction quality crystals.  
The basic principle of protein crystallization is the stepwise reduction of protein solubility 
in a closed system. To this aim, a protein solution is mixed with precipitants to increase 
the protein concentration up to the solubility limit leading to formation of a 
supersaturated, metastable solution (Figure 6 left panel). Phase separation occurs and, if 
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so-called nuclei form, a controlled self-assembly of protein molecules into a regular and 
periodic arrangement, in other words crystallization, might be initiated. Different 
techniques exist to facilitate this phase transition; the most common are vapor-diffusion 
via sitting- or hanging drop, microbatch, or microdialysis (Figure 6 top right panel).  
 
Figure 6: The basic principles of protein crystallization.  
Left panel: Different nucleation zones in the protein crystallization diagram. Precipitant molecules are shown as dark 
blue ovals and water molecules as light blue circles. At high protein and/or precipitant concentration, the crystallization 
solution reaches the metastable phase. In this region of the diagram, spontaneous nucleation is only possible at high 
supersaturation. At lower supersaturation, crystal growth can be supported; however, nucleation requires external 
seeds. Top right panel: Schematic representation of the main macromolecular crystallization methods. Bottom right 
panel: Visualization of intermolecular contacts in a protein crystal. Three different types of interactions are symbolized 
by green, orange, and blue arrows in this two-dimensional crystalline arrangement. Figure adapted and reproduced 
with permission from Biomolecular Crystallography by Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis 
LLC. 
The former constitutes mixing the protein with precipitant solution typically in a 1:1-ratio. 
This crystallization drop of about 100 nL up to a few µL, either hanging from a siliconized 
cover-slip or sitting on a socket, is placed over a reservoir containing the precipitant 
solution. As the crystallization drop contains only half the precipitant concentration of the 
reservoir, the closed system tends to compensate this difference by evaporation of water 
and other volatile ingredients from the drop into the reservoir and thus the concentration 
of the protein-precipitant mixture increases.   
The second method of microbatch crystallization is also based on mixing the protein with 
precipitant solution, both at high concentration, which leads to immediate formation of a 
supersaturated solution. In this case, the crystallization drop is enclosed in an isolated 
environment under a layer of oil. Sometimes, a water permeable oil is used, which allows 
additional diffusion of water or other organic solvent molecules through the oil phase and 
hence lead to further concentration of the drop until the metastable phase is reached.   
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The third technique of microdialysis simply constitutes an exchange of solvent via a 
membrane. The protein solution is mixed with a precipitant solution, typically of low 
precipitant concentration, and placed into a microdialysis button. The button is sealed 
with a membrane that allows only diffusion of water or other small molecules such as 
ligands. The large proteins as well as high molecular weight polyethylene glycols (PEGs) 
cannot pass this barrier. The button is placed in a reservoir of high precipitant 
concentration and, similar to the vapor-diffusion method, the closed system tends to 
reach equilibrium by diffusion of water from the inner compartment to the outer one. 
This in turn leads to an increase of the protein concentration in the inner compartment. 
In all cases, crystal growth is followed over days or weeks until preferably single crystals 
of regular shape are obtained.  
As crystallization is a dynamic process, a grown crystal is always in equilibrium with the 
supersaturated protein solution and the stability of this equilibrium can be described by 
the mean molar Gibbs free energy of a system Ḡ and the molar fraction of the protein x1 
(equation 5): 
%&'̅&)*'+ > 0 (5) 
As long as this condition is true, the metastable phase remains in equilibrium, but if the 
protein concentration increases further, the solution becomes highly supersaturated and 
decomposes spontaneously. At this point, crystallization is no longer possible. If the 
system however remains in the metastable, supersaturated state, spontaneous formation 
of crystallization nuclei is possible. In fact, the high concentration of protein molecules 
multiplies the probability of collisions in a proper orientation and thus enables formation 
of energetically favorable interactions between them, i.e. nucleation sites can form. The 
bigger these nucleation sites are, the higher their stability and hence the better 
attachment of additional molecules. As proteins are irregular structures only weak and 
few, i.e. 3-12, intermolecular contacts are typically formed over a surface area of about 
200 to 500 Å² (Figure 6 bottom right panel). This causes formation of large voids filled with 
precipitant solution. In average, these solvent channels make up ~ 50 % of the protein 
crystal and explain why protein crystals are rather soft in comparison to salt crystals. 
Nevertheless, these large channels also allow soaking of a protein crystal with different 
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ligands or even heavy metal derivatives for de novo-phasing (see below). Despite their 
weak character, the intermolecular interactions between protein molecules are very 
specific and are typically constituted of hydrogen bonds, salt bridges, dipole-dipole 
interactions, as well as van-der-Waals or hydrophobic interactions. In order to enable 
periodic assembly of the protein molecules, it is important that the sample is very 
homogenous to ensure the same interaction scaffold and formation of periodic 
interactions across the crystal. Flexible surface loops or disordered termini as well as 
partially degraded protein might represent a problem for crystallization and thus different 
protein constructs lacking these elements might be necessary for successful 
crystallization. However, it is also possible that these flexible structure elements become 
fixed in one specific conformation in the crystal due to crystal packing (specific 
interactions) and thus present only one of many possible native conformations (in 
solution). In contrast, the protein core is usually preserved in its native conformation.  
3.1.4.2. X-ray diffraction and data collection 
Single, regularly shaped protein crystals of about 50 to 500 µm size are generally 
considered suitable for diffraction experiments. The crystals are harvested from the 
crystallization drop using a nylon-loop and immediately flash-cooled in liquid nitrogen. 
Depending on the composition of the crystallization solution, addition of a cryo-
protectant might be necessary to avoid formation of crystalline ice as this could lead to 
destruction of the periodic arrangement of the crystal and diminish its diffraction quality. 
Typical cryo-protectants are glycerol, sugars, alcohols, or short-chain PEGs. Once the 
protein crystal is preserved in this way, it can be mounted on a multi-angle goniometer 
head in front of the X-ray source (Figure 7). During a diffraction experiment, the crystal is 
constantly cooled by a nitrogen gas stream at 100 K. The X-ray source generates a focused 
X-ray beam of a defined wavelength that interacts with the crystal causing a characteristic 
diffraction pattern.   
X-rays are electromagnetic waves with energies approximately 104-times higher than 
visible light. In other words, their wavelengths range from 0.1 to 100 Å and as such are of 
similar dimension as chemical bonds, allowing analysis of molecular details of matter. 
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Figure 7: Experimental setup of a macromolecular X-ray diffraction experiment.  
A cryo-protected protein crystal harvested from the crystallization drop using a nylon-loop is mounted on a multi-angle 
goniometer in front of an X-ray source. While the crystal is constantly rotated, the X-ray source generates the incident 
X-ray beam, which is partially diffracted by the crystal. The reflections are recorded as diffraction images on a detector. 
As the intensity of the undiffracted incident beam is very high, a beam stop prevents damage of the detector.  
The principle of X-ray diffraction is the interaction of an electromagnetic wave with 
regularly arranged matter, e.g. a protein crystal that is built up by small identical unit cells 
in a periodic arrangement. Within these unit cells, the protein atoms are located in a 
three-dimensional lattice that is defined by the vectors a, b, c and the angles between 
these vectors α, β, γ. The atom positions within this lattice (relative to an origin) are 
described with the coordinates x, y, z (Figure 8 left panel). When X-rays hit a protein 
crystal, the electromagnetic waves interact with the electrons of the individual, 
periodically arranged atoms, inducing their oscillation. Consequently, this leads to 
emission of electromagnetic waves of the same frequency (elastic scattering), but with 
phase differences compared to the incoming wave. As electrons move within discrete 
orbitals (the electron cloud), only electrons in the right position r can interact with the 
waves. This can be described as a probability distribution (electron density ρ(r)) and the 
amplitude of the scattered wave depends on this density. Moreover, depending on the 
distance between the atoms, the emitted waves will display constructive or destructive 
interference and only in the former case diffraction can be observed. Constructive 
interference however will only occur in certain angles as it is described by the Bragg’s law 
(equation 6): 
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. = 20123 ∙ 456 (6) 
with  
n positive integer  
λ wavelength of incident electromagnetic wave  
dhkl path difference between hypothetical lattice planes with the Miller indices hkl  
θ diffraction angle  
In this equation, diffraction is regarded as a reflection from sets of hypothetical parallel 
planes rather than from single periodically arranged atoms or their electrons (Figure 8 top 
right panel). The lattice planes divide the crystal in a periodic way and each set of planes 
can be described by three vectors h, k, l, the so-called Miller indices, and their interplanar 
spacing dhkl. Diffraction occurs if the path difference between these planes is a multiple 
positive integer of the wavelength. This leads to two deductions: First, as λ is known and 
the diffraction angle can be measured, the distance dhkl between the lattice planes can be 
calculated. Second, this relation limits the minimum distance between the planes and 
hence the maximum resolution to dmin = ½ λ. However, as chemical bond lengths are in 
the range of 1 to 2 Å even in-house X-ray sources with CuKα-radiation of a wavelength of 
1.54 Å are sufficient for structure determination. Modern synchrotrons, in addition to 
their higher brilliance compared to in-house sources, even have tunable wavelength, 
usually optimized around 1.0 Å, and thus allow better theoretical resolution limits.   
So far, all theoretical considerations were made in real space, however in order to fully 
understand a diffraction pattern one has to comprehend another theoretical 
construction, the reciprocal space. The reciprocal space is inversely proportional to the 
real space, i.e. d*hkl = 1/dhkl. In the reciprocal space, the Bragg’s law can be illustrated with 
the mathematical construction of a three-dimensional sphere centered on the crystal with 
radius r = 1/λ, the so-called Ewald’s sphere (Figure 8 bottom right panel). The origin of the 
reciprocal lattice is positioned at the intersection of the sphere and the exiting direct X-
ray beam. In this construction, for each reciprocal lattice point laying on the surface of the 
sphere (highlighted as red dots in Figure 8 bottom right panel), the Bragg’s law is true and 
constructive interference occurs, appearing as a reflection on a detector. In other words, 
the diffraction pattern is a projection of the three-dimensional reciprocal lattice and the 
position of the reflections is related to the diffraction angle θ. Each reflection can be 
described in relation to the Miller indices hkl of the reciprocal lattice planes. The central 
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reflection (h, k, l) = (0, 0, 0) is the origin, but it can never be measured since it is masked 
by the incoming X-ray beam.  
 
Figure 8: The crystal organization and principles of X-ray diffraction.  
Left panel: The unit cell, which is translationally stacked to build the crystal, is a combination of a unit lattice that is 
defined by its three vectors a, b, c and their associated angles α, β, γ, and a motif. Top right panel: Graphical 
representation of the diffraction of X-rays as defined by the Bragg’s law. X-ray diffraction is represented as reflection on 
a set of hypothetical planes in a crystal. The path difference between scattered waves is equal to 2d∙sinθ, which must 
equal a multiple integer of the wavelength λ for maximum constructive interference. Bottom right panel: Visualization 
of the Bragg’s law in reciprocal space using the Ewald construction. The conditions for constructive interference (red 
arrows) are met, when reciprocal lattice points are located on the Ewald’s sphere of radius 1/λ that is centered on the 
crystal. During data collection, the crystal is rotated, thus other lattice points will cross the Ewald’s sphere and produce 
reflections on the detector. Figure adapted and reproduced with permission from Biomolecular Crystallography by 
Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis LLC.  
In a diffraction experiment, the crystal is usually rotated within the beam, which translates 
in satisfying the Bragg’s law for other reciprocal lattice points when they cross the Ewald’s 
sphere. A dataset represents a total rotation of the crystal from 100 to several 100 
degrees, which are split into frames, typically of 0.1 to 1 degree rotation. 
3.1.4.3. Data processing and structure determination 
The desired information from a macromolecular X-ray crystallography experiment is the 
location of the protein atoms/electrons within the crystal (real space). In order to 
reconstitute this electron density ρ(r) from the diffraction pattern, first the position and 
then the intensity of all reflections have to be determined.  
Having a diffraction dataset at hand, the first step of data processing consists in so-called 
indexing, which aims at determining the unit cell parameters as well as the space group 
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of the crystal. The space group defines the internal symmetry of a crystal lattice and 
describes the reconstruction of the unit cell starting from its smallest element, the 
asymmetric unit, by employing rotational and/or translational symmetry operators. In 
three-dimensional space, 14 crystal lattices, the so-called Bravais lattices exist. These are 
obtained by combining one of the seven crystal systems (triclinic, monoclinic, 
orthorhombic, tetragonal, hexagonal, trigonal, and cubic) with one of the centering types, 
which identify the locations of the lattice points in the unit cell (Figure 9). In the most 
simple case, the lattice points correspond to the corners of the unit cell and this centering 
is called primitive (P). Other centering types such as face (F) or body (I) centered also exist. 
Although, there are 230 space groups possible, in macromolecular crystallography, due to 
the chiral character of biomolecules, only 65 space groups are observed.  
 
Figure 9: Crystal systems and the corresponding Bravais lattices.  
Left panel: The six primitive crystal systems with their characteristic unit cell parameters. Right panel: Symmetry groups 
with non-primitive centering types, which, together with the six primitive unit cells, complete the 14 Bravais lattices. 
Figure adapted and reproduced with permission from Biomolecular Crystallography by Bernhard Rupp, © 2009-2014 
Garland Science/Taylor & Francis LLC.  
For indexing, the relative positions of the reflections in a reduced set of the diffraction 
data as well as experimental parameters such as crystal-to-detector distance, wavelength, 
and position of the incident beam are used to obtain the unit cell parameters, to define 
the orientation of the crystal and to propose possible space groups. This will allow the 
attribution of the Miller indices hkl for each reflection and, more importantly, to predict 
the position of every reflection in the dataset.   
With this knowledge, data processing software will be able to proceed with the second 
step, data integration. In brief, the software defines a zone at the location of a predicted 
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reflection, in which the intensity of this reflection is measured relative to the background. 
Given the internal symmetry, a reflection will be measured multiple times in different 
orientations of the crystal in the beam.  
Finally, the last step of data processing constitutes the reduction of the dataset to obtain 
one intensity value (with its error) for each reflection. Since the intensity of a reflection 
does not only depend on the content of the unit cell, but also on the morphology of the 
crystal or the intensity of the beam, which can vary over time, a so-called scaling 
procedure is applied to obtain an "averaged" value of the intensities.  
However, the task to reconstruct the electron density of the molecule(s) composing the 
crystal from these intensities remains. To this end, one has to consider that every scatterer 
in a unit cell influences the intensity of each recorded reflection, i.e. each atom 
contributes to every reflection. Hence, the scattering function FS of a crystal is the sum of 
individual atomic scattering factors (equation 7): 
78 = 9 :;,=
>?
=@*
∙ A'BC8DE  (7) 
with  
FS scattering function  
fs,j0 wavelength independent atomic scattering factor of the atom j  
S general scattering vector   
rj position vector of the atom j 
In reciprocal space, equation 7 can be rearranged as a function of the index vector h to 
the so-called complex structure factor Fh (equation 8): 
7F = 9 :;,=
>?
=@*
∙ A'BCFGE (8) 
with  
Fh the complex structure factor, i.e. a vector representing the diffracted X-rays in a given direction h  
fs,j0 wavelength independent atomic scattering factor of the atom j  
h reciprocal lattice vector giving the direction of scattering as hkl  
xj position of the atom j in fractional coordinates xyz 
This complex structure factor is the Fourier transform (FT) of the electron density ρ(x). In 
order to describe the content of the whole unit cell, the electron density is integrated over 
its complete volume (V), i.e. at every position x, y, and z, while the scattering vectors in 
every direction of the reciprocal space (h, k, and l) are considered (equation 9):  
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HI)JKL = 1N9997FOP ∙ AQ'BCIFROSRPTLPOF  (9) 
with  
ρ(xyz) electron density at grid point xyz  
V volume of the unit cell  
Fhkl the complex structure factor in direction hkl  
Using the Euler relation 7FOP = U123 ∙ ACVWXY, which separates the complex structure factor 
Fhkl into an explicit amplitude term Fhkl and a phase angle term αhkl, equation 9 can be 
rewritten into its final form (equation 10): 
HI)JKL = 1N999U123 ∙ ACVWXY ∙ AQ'BCIFROSRPTLPOF  (10) 
Under this form, the density summation explicitly includes both, the structure factor 
amplitude Fhkl and its associated phase αhkl. While the former can be determined from the 
measured intensities Ihkl, as these are proportional to the structure factor amplitude 
(I	=	|Fh|2), the phases, which carry most of the structural information, are lost during the 
physical process of diffraction data collection. This gives rise to the crystallographic phase 
problem. 
A variety of methods has been developed to obtain the phase information. Nowadays, the 
most commonly used one is the so-called molecular replacement (MR). Since it is assumed 
that proteins with at least 30 % sequence identity share similar folds, the structure of a 
known protein can be used as initial phasing model. To obtain an initial approximation of 
the phase, it is necessary to position the model in the unit cell of the unknown structure. 
This is achieved in two consecutive steps. The first aims at orienting the model in the unit 
cell through rotation to find then its exact position using a translational search. Once the 
model is positioned, it is indeed possible to derive the phase information that, combined 
with the intensities of the unknown structure, is necessary to calculate initial electron 
density maps.   
Although the number of structures available for MR is constantly increasing, this method 
is not always successful. In such cases, experimental phasing is employed. This typically 
involves introduction of heavy atoms or markers in the crystal either by derivatization of 
the protein during expression with e.g. selenomethionine or by co-crystallization or 
soaking with heavy metals, such as mercury, lead or gold. The process of phasing will thus 
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be simplified to the resolution of the "simpler" structure of the heavy atom(s), or so-called 
substructure. One method is the isomorphous replacement (SIR/MIR = single/multiple 
isomorphous replacement). Since structure factors contain contributions from every atom 
of the unit cell, it is conceptually possible to decompose a heavy atom derivative crystal 
(PA) as the sum of the protein atoms (P) and of the heavy atom(s) (A), i.e. FPA = FP + FA 
(Figure 10A).  
 
Figure 10: Basic principles of experimental phasing.  
A Graphical solution of the phasing equations. The left panel shows how the complex structure factors for protein (FP), 
derivative (FPA) and heavy atom (FA) are related for a reflection hkl. Intensity measurements only reveal the magnitude 
of the structure factors for the derivative FPA and the native FP, but from the difference data, the position(s) of the heavy 
atom(s) can be determined. Therefore, the entire complex structure factor for the heavy atom FA is known, and the two 
possible solutions ( ) for the protein phase angle can be determined for each reflection by the graphical procedure 
shown on the right panel. However, only one phase angle (ϕ) will be correct, the other one not.  
B Breakdown of the Friedel’s law through anomalous scattering. The vector FP represents the partial sum of all non-
anomalous contributions and the remaining vectors are the contributions from the anomalously scattering atom, FA. 
The real and imaginary components of FA are indicated in green (f0 + f′) and magenta (f″) respectively. When the indices 
hkl are inverted to –h-k-l as indicated by the "minus" superscripts, normal and anomalous scattering contributions 
become mirrored across the real and imaginary axis respectively. Consequently, in presence of anomalous scattering 
contributions, Friedel’s law (i.e. Fhkl = F-h-k-l) breaks down and the structure factor amplitude, and thus the intensities of 
Friedel pairs become different. Figure adapted and reproduced with permission from Biomolecular Crystallography by 
Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis LLC. 
By comparing the intensities obtained from a native crystal to the ones obtained from an 
isomorphous heavy metal derivative, it is possible to extract merely the contribution of 
the heavy atom(s). From this information, phasing programs will try to solve the heavy 
atom substructure, which consists in finding its location (or sites) in the asymmetric unit. 
It is achieved by using Patterson and/or direct methods. When the substructure is known, 
it is possible to derive phase information, which will be used for producing initial electron 
density maps. SIR/MIR methods can be applied with X-rays of any wavelength, however, 
one of the limitations is the necessity for isomorphism between the two crystals, i.e. both 
native and derivative crystals must belong to the same space group and their unit cell 
parameters not differ by more than a few percent. 
A B 
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The other experimental phasing method is called SAD/MAD, which stands for single or 
multiple wavelength anomalous dispersion. It uses a particular phenomenon of "heavy" 
atoms, which absorb X-rays at a certain wavelength characteristic for the element 
(absorption edge) and reemit X-rays with a phase difference, thus influencing the intensity 
and phase of the diffracted beam. Indeed, at a wavelength corresponding to the 
absorption edge of the heavy atom, the atomic scattering factor (f0) will be composed of 
two additional components, f′ and f″, the dispersive and anomalous scattering factors 
dependent of the wavelength (Figure 10B). The dispersive contribution leads to a 
difference in the intensities measured at different wavelength. The anomalous 
component is imaginary and as such has a different phase than the normal and dispersive 
contributions. Consequently, within a diffraction dataset collected at the characteristic 
absorption edge, the so-called Friedel’s law owing to which Fhkl and F-h-k-l have equal 
amplitudes but opposite phases is no longer valid. Various strategies can then be used and 
combined to obtain initial phase information. One is based on the comparison of the 
diffraction data (intensities) collected at different wavelength (MAD methods), the other 
on the comparison of the intensities of Friedel reflection pairs measured at the absorption 
edge of the heavy atom (SAD). Once again, the goal of the phasing program is to solve the 
substructure of the heavy atom that will provide an approximation of the phases for 
calculating initial electron density maps. These methods require access to X-ray sources 
with tunable wavelength such as synchrotron facilities. However, all information can be 
obtained from a single crystal and thus isomorphism is no longer limiting. Strategies, 
which combine both isomorphous replacement and anomalous scattering approaches 
(SIRAS/MIRAS) are also possible.  
At this step, further techniques aim at improving the initial phases and are commonly 
termed density modification. One of the most powerful is called solvent flattening and is 
based on the fact that protein crystals are in average composed of 50 % of disordered 
solvent and, as such, large regions of the asymmetric unit have no electron density. The 
density modification program will identify these "empty" regions and proceed with the 
"flattening" by optimizing the phase so that ρ(x) is equal to zero in these regions. In 
addition, the asymmetric unit of most protein crystals contains more than one copy of the 
macromolecule. These molecules are related to each other by so-called non-
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crystallographic symmetry and it is possible to use this information to modify the phase 
and significantly improve the quality of the initial electron density map.  
3.1.4.4. Model building, refinement and validation 
Once an electron density map of an unknown structure is obtained, it has to be 
interpreted in terms of the atomic positions giving rise to this density. To this aim, an initial 
structural model is placed and subsequently fitted into in the electron density. For each 
atom at least four different characteristic parameters will be refined, the three positional 
coordinates (x, y, z) and its temperature factors (B-factors). The latter accounts for the 
displacement of an atom from its mean position that can be caused by thermal vibrations 
or other dynamic effects. It can also arise from static disorder, i.e. the fact that each atom 
occupies slightly different positions in different unit cells that are averaged.  
Both, automated and manual model building take advantage of prior knowledge of the 
correct protein sequence and of fundamental geometrical properties of the building 
blocks including the length of a chemical bond, the angle between these bonds, as well as 
non-bonded interatomic distances or van der Waals radii. Furthermore, the planarity of 
the peptide bond and its stereo-chemical restraints in secondary structure elements like 
α-helices or β-strands are taken into account.  
In practice, the electron density is traced by building consecutive amino acids into the 
map. Depending on the resolution, different levels of molecular details are visible. At low 
resolution (~4 Å) only the peptide backbone, i.e. an array of amino acids without 
characteristic side chains can be assembled. With increasing resolution, these individual 
amino acid side chains can be identified. Potentially even their different rotameric 
conformations can be built and the corresponding occupancies attributed.   
As mentioned earlier in this section (paragraph 3.1.4.1. and 3.1.4.3.), a protein crystal 
contains large solvent channels. Typically, the solvent within these channels is disordered 
and thus not visible in the structure. However, water molecules or individual components 
of the crystallization solution, which directly interact with protein residues, e.g. via 
hydrogen bonds, are ordered and hence their corresponding electron density can be 
interpreted. Model building is an iterative step and, after several of these manual 
adjustments of the structural model, it is refined against the experimental data using a so-
called maximum-likelihood target function, an algorithm implemented in typical 
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refinement software packages. In contrast to model building, global restrained refinement 
is carried out in the reciprocal space. The theoretical structure factor Fcalc of the model is 
calculated and compared to the experimental structure factor Fobs of the data. Structure 
refinement aims at minimizing the difference between these structure factors by 
optimizing the model, i.e. the atomic positions and B-factors of each atom with regard to 
chemical plausibility (empirical chemical bond geometries). The process of refinement is 
monitored through the evolution of the so-called R-factor Rwork (equation 11) that 
represents the correlation between the model and the experimental data (electron 
density).  
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with  
Rwork R-factor assessing the correlation between model and electron density  
Fobs experimental structure factor   
kFcalc calculated structure factor of the model with the weighting factor k  
Rfree R-factor calculated with 5 % of the reflections excluded from refinement 
In order to avoid overfitting of the data, a second R-factor, the Rfree, was introduced 
(equation 12). This R-factor weighs the model against approximately 5 % of the data 
excluded from the refinement and thus is unbiased.   
Model refinement is considered as completed when each R-factor converges to a 
minimum value and the gap between both R-factors does not exceed ~5 %.  
Different criteria exist to evaluate the quality of a model. Naturally, chemical properties 
of the molecule such as bond lengths and angles have to be within a certain minimal range 
from empirical values. Furthermore, within secondary structure elements, the peptide 
bond adopts certain characteristic conformations described by the angles ϕ, ψ and ω. Due 
to the partial double-bond character of the peptide bond, ω is typically 180 °. The 
statistical distributions of the two other torsion angles in protein structures are visualized 
in the Ramachandran plot (Figure 11) that clusters secondary structure elements in 
favored or allowed regions depending on the relative conformations of the dihedral 
peptide angles ϕ and ψ. 
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Figure 11: Statistical distribution of the peptide torsion angles of protein structures in the Ramachandran plot.  
For each protein secondary structure element, the values of the backbone torsion angles ϕ and ψ cluster in 
characteristic zones of the Ramachandran plot. The colored zones represent favored backbone conformations, the 
extended areas around, additionally allowed ones. Figure adapted and reproduced with permission from Biomolecular 
Crystallography by Bernhard Rupp, © 2009-2014 Garland Science/Taylor & Francis LLC. 
3.2. Experimental Section 
3.2.1. General materials 
All chemicals, biochemicals and enzymes (except Tobacco etch virus (TEV) protease) used 
in this study were purchased in the highest purity available (p.a., pro analysis) from the 
companies AppliChem GmbH (Darmstadt, Germany), Becton Dickinson GmbH. (BD; 
Heidelberg, Germany), Bio-Rad Laboratories GmbH (Munich, Germany), Eurofins Scientific 
GmbH (Hamburg, Germany), Merck KGaA (Darmstadt, Germany), New England Biolabs 
GmbH (Frankfurt/Main, Germany), Peqlab (Erlangen, Germany), QIAGEN GmbH (Hilden, 
Germany), Carl Roth GmbH + Co. KG (Karlsruhe, Germany), SERVA Electrophoresis GmbH 
(Heidelberg, Germany), ThermoFischer Scientific Inc. (Waltham, Massachusetts, USA) and 
Sigma-Aldrich Chemie GmbH (Munich, Germany) unless otherwise noted.   
Crystallization screens were purchased from Molecular Dimensions (Newmarket, Suffolk, 
UK), QIAGEN, and Hampton Research (Aliso Viejo, California, USA).  
3.2.1.1. Oligonucleotides, plasmids and microorganisms 
For mechanistic studies of the isomerase PhzF a variety of active site variants were 
generated using a modified site-directed mutagenesis protocol (q.v. 3.2.2.3.). A detailed 
list of the oligonucleotides utilized for introduction of specific mutations can be found in 
Table 1.  
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Table 1: Overview of oligonucleotides used for site-directed mutagenesis.* 
oligo name sequence 5’  3’ length (bp) TM (°C) variant 
phzF_D208E_fw 
GCA TAC GGC GTT GTA GAG GAA GCG GCC 
ACA GGC TCC 
36 77.4 
PhzF D208E and PhzF 
E45D/D208E 
phzF_D208E_rv 
GGA GCC TGT GGC CGC TTC CTC TAC AAC 
GCC GTA TGC 
36 77.4 
PhzF D208E and PhzF 
E45D/D208E 
phzF_H74D_fw 
GAA CTG CCT TTT GCC GGG GAC CCG TTG 
CTG GGT ACA GCC 
39 78.9 PhzF H74D 
phzF_H74D_rv 
GGC TGT ACC CAG CAA CGG GTC CCC GGC 
AAA AGG CAG TTC 
39 78.9 PhzF H74D 
phzF_H74N_fw 
GAA CTG CCT TTT GCC GGG AAT CCG TTG 
CTG GGT ACA GCC 
39 76.8 PhzF H74N 
phzF_H74N_rv 
GGC TGT ACC CAG CAA CGG ATT CCC GGC 
AAA AGG CAG TTC 
39 76.8 PhzF H74N 
phzF_S213A for 
GAG GAT GCA GCC ACA GGC GCA GCC GCA 
GGA CCA TTG 
36 78.6 PhzF S213A 
phzF_S213A rev 
CAA TGG TCC TGC GGC TGC GCC TGT GGC 
TGC ATC CTC 
36 78.6 PhzF S213A 
phzF_Y4A_fw 
GGC AGC CAT ATG CAC AAC GCC GTC ATT 
ATC GAC GCC 
36 75.2 PhzF Y4A 
phzF_Y4A_rv 
GGC GTC GAT AAT GAC GGC GTT GTG CAT 
ATG GCT GCC 
36 75.2 PhzF Y4A 
*All oligonucleotides were designed using the program OligoCalc (Kibbe, 2007) and purchased from Eurofins Scientific GmbH. In general, underlined base 
triplets indicate an introduced mutation. Additional bold letters represent the specific mutation denoted in the name of the oligonucleotide while all other 
mutations are silent. The gray highlighted triplets indicate non-gene specific bases that belong to the expression plasmid. 
Expression plasmids resulting from site-directed mutagenesis as well all other expression 
constructs used in this study are listed in Table 2. 
Table 2: Overview of all plasmid constructs used in this study.* 
plasmid source application 
pET15b_phzF (WT) Mavrodi et al. 2008 biochemical assay, ITC, crystallization 
pET15b_phzF D208A MPI Dortmund biochemical assay 
pET15b_phzF D208E this study biochemical assay, crystallization 
pET15b_phzF D208T MPI Dortmund biochemical assay 
pET15b_phzF E45A MPI Dortmund biochemical assay, crystallization 
pET15b_phzF E45D Lips, 2012 biochemical assay, crystallization 
pET15b_phzF E45Q MPI Dortmund biochemical assay, ITC, crystallization 
pET15b_phzF E45D/D208E this study biochemical assay, crystallization 
pET15b_phzF H74A MPI Dortmund biochemical assay, crystallization 
pET15b_phzF H74D this study biochemical assay 
pET15b_phzF H74L Lips, 2012 biochemical assay 
pET15b_phzF H74N this study biochemical assay 
pET15b_phzF N42A Gazdag, MPI Dortmund biochemical assay 
pET15b_phzF S213A this study biochemical assay 
pET15b_phzF Y4A this study biochemical assay 
pET19TEV_BgluphzF Pfaff, MPI Dortmund biochemical assay, crystallization 
pET19TEV_BgluphzF∆123 Pfaff, MPI Dortmund biochemical assay, crystallization 
pET15b_Bcphz(A)/B Ahuja et al. 2008 biochemical assay, ITC, CD, crystallization 
pET15b_phzA Ahuja et al. 2008 Biochemical assay, ITC, CD, crystallization 
pET15b_phzB Ahuja et al. 2004 biochemical assay, MST, CD 
pET19TEV_phzAB Weikart, 2006 biochemical assay, MST, CD, crystallization 
*All plasmids were utilized for protein production and for further applications as depicted in the table. The produced protein constructs carry an N-
terminal hexahistidine-tag with either thrombin or TEV-cleavage site. MPI = Max Planck Institute 
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For amplification of expression plasmids or heterologous gene expression, different E. coli 
strains were used. Their specifications are shown in Table 3.  
In cellulo compound screening of potential PhzB-inhibitors was carried out in two different 
Pseudomonas aeruginosa strains, PAO1 and PA14 (Table 3). 
Table 3: Overview of the microorganisms used in this study.* 
bacterial strain  genotype antibiotic resistance 
E. coli DH5α 
(Invitrogen) 
fhuA2 Δ(lacZ)U169 phoA glnV44 Φ80' Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
- 
E. coli GC5 
(Gene Choice) 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80’ Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
- 
E. coli TOP10 
(Invitrogen) 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 
recA1 araD139 Δ(ara leu) 7697 galU galK rpsL (StrR) 
endA1 nupG 
streptomycin 
E. coli XL1-blue 
(Stratagene) 
F´ proAB lacIqZ∆M15 Tn10 Tetr/ recA1 endA1 gyrA96 thi-
1 hsdR17 supE44 relA1 lac  
tetracycline 
E. coli Rosetta1 
(Novagen) 
F- ompT hsdSB(rB
- mB
-) gal dcm pRARE (CamR) chloramphenicol 
E. coli Rosetta1 (DE3) pLysS 
(Novagen) 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE 
(CamR) 
chloramphenicol 
E. coli Rosetta2 
(Novagen) 
F- ompT hsdSB(rB
- mB
-) gal dcm pRARE2 (CamR) chloramphenicol 
E. coli Rosetta2 (DE3) pLysS 
(Novagen) 
F- ompT hsdSB(rB
- mB
-) gal dcm (DE3) pLysSRARE2 (CamR) chloramphenicol 
P. aeruginosa PAO1 
(Häußler, HZI Braunschweig) 
- - 
P. aeruginosa PA14 
(Häußler, HZI Braunschweig) 
- - 
*HZI = Helmholtz-Zentrum für Infektionsforschung (Helmholtz Centre for Infection Research).  
3.2.1.2. Media, buffers and stock solutions 
For media preparation distilled and deionized water (ddH2O) was used and the media 
additionally autoclaved. All other buffers and stock solutions were prepared using 
ultrapure Milli-Q® ddH2O and filter sterilized. Buffers used for protein purification and ITC 
experiments were degassed. Antibiotics were used at final concentrations of 100 μg mL-1 
and 34 μg mL-1 for ampicillin (aqueous solution) and chloramphenicol (ethanolic solution) 
respectively.  
A. Media: 
 LB-medium:  10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 NaCl 
 1.5 % (w/v) LB-agar: 10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 NaCl, 
   15 g L-1 agar 
 TB-medium: 12 g L-1 tryptone, 24 g L-1 yeast extract, 0.4 % (w/v) 
   glycerol, 170 mM KH2PO4, 720 mM K2HPO4 
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 PPGAS-medium: 20 mM NH4Cl, 20 mM KCl, 120 mM TRIS/HCl pH 7.2, 
   1.6 mM MgSO4, 1 % (w/v) tryptone, 0.5 % (w/v) 
   glucose 
 M63-medium: 15 mM (NH4)2SO4, 100 mM KH2PO4 pH 7.0, 1.8 µM 
   FeSO4 x 7H2O, 1 mM MgSO4, 0.2 % (w/v) glucose, 
   0.1 % (w/v) casamino acids 
B. Buffer: 
 PhzF-variants 
 buffer A: 50 mM NaH2PO4/Na2HPO4 pH 7.5, 300 mM NaCl, 
   10 % (v/v) glycerol 
 buffer B: 50 mM NaH2PO4/Na2HPO4 pH 7.5, 300 mM NaCl, 
   10 % (v/v) glycerol, 500 mM imidazole 
 dialysis buffer A1: 50 mM NaH2PO4/Na2HPO4 pH 7.5, 10 % (v/v) 
   glycerol 
 dialysis buffer A2: 20 mM TRIS/HCl pH 7.5, 150 mM NaCl, 10 % (v/v) 
   glycerol 
 size-exclusion buffer: equivalent to dialysis buffer A1 for enzymatic assays 
   or dialysis buffer A2 for crystallization experiments 
PhzB-orthologues 
 buffer A: 150 mM NaH2PO4/Na2HPO4 pH 8.0, 300 mM NaCl 
 buffer B: 150 mM NaH2PO4/Na2HPO4 pH 8.0, 300 mM NaCl, 
   500 mM imidazole 
 dialysis/size-exclusion buffer: 20 mM TRIS/HCl pH 8.0, 150 mM NaCl 
HeteroPhzAB 
 buffer A: 50 mM NaH2PO4/Na2HPO4 pH 8.0, 300 mM NaCl 
 buffer B: 50 mM NaH2PO4/Na2HPO4 pH 8.0, 300 mM NaCl,  
   500 mM imidazole 
 dialysis buffer A: 50 mM TRIS/HCl pH 8.0, 150 mM NaCl, (5 mM β- 
   mercaptoethanol) 
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 dialysis buffer B: 50 mM TRIS/HCl pH 8.0, 150 mM NaCl, 500 mM  
   imidazole 
 size-exclusion buffer: 20 mM TRIS/HCl pH 8.0, 150 mM NaCl 
Buffer used for enzymatic assays or other specific applications are described in the 
corresponding paragraph of each chapter. 
C. Other solutions 
 SDS-PAGE 
 4x stacking gel buffer: 0.5 M TRIS/HCl pH 6.8, 0.4 % (w/v) SDS  
 stacking gel: 1x stacking gel buffer, 5 % (w/v) acrylamide (from  
   30 % (w/v) stock solution: 37.5:1), 0.1 % (w/v) APS, 
   0.001 % (v/v) TEMED 
 4x resolving gel buffer: 1.5 M TRIS/HCl pH 8.8, 0.4 % (w/v) SDS 
 resolving gel (16 %): 1x resolving gel buffer, 16 % (w/v) acrylamide (from  
   30 % (w/v) stock solution: 37.5:1), 200 μL 10 % APS, 
   0.001 % (v/v) TEMED 
 5x SDS-PAGE sample buffer: 50 mM TRIS/HCl pH 6.8, 500 mM β-mercapto- 
   ethanol, 50 % (v/v) glycerol, 10 % (w/v) SDS, 0.05 % 
   (w/v) bromophenol blue 
 running buffer: 25 mM TRIS/HCl, 200 mM glycine, 0.1 % (w/v) SDS 
 staining solution: 0.2 % (w/v) Coomassie Brilliant Blue G-250, 30 % 
   (v/v) methanol, 10 % (w/v) glacial acetic acid 
 destaining solution: 20 % (v/v) methanol, 10 % (v/v) glacial acetic acid 
3.2.2. General molecular biology methods 
3.2.2.1. Cloning and generation of expression plasmids 
As listed in section 3.2.1.2., most of the plasmid constructs used in this study were 
generated beforehand either by Dimitri Mavrodi (Mavrodi et al., 2003) or other PhD 
students in the group of Prof. Dr. Wulf Blankenfeldt. A few additional variants of PhzF 
were generated using a modified site-directed mutagenesis protocol.  
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3.2.2.2. Extraction of plasmid DNA 
For any genetic manipulation, amplified expression plasmids need to be extracted from 
cloning strains such as E. coli DH5α. After harvesting cells from an overnight bacterial cell 
culture in LB-medium, the plasmid preparation is carried out using standardized protocols 
(including alkaline/detergent-based cell lysis and alcoholic DNA precipitation) as provided 
together with the application specific material from the manufacturer. Typically, either 
the E.Z.N.A.® Plasmid Mini Kit I from OMEGA bio-tek (Norcross, Georgia, USA) or the 
QIAGEN Plasmid Mini Kit were used for this purpose. After incubation with 50 µL elution 
buffer over a period of 20 minutes at room temperature, the extracted and purified 
plasmid DNA is eluted via centrifugation at 13000 rpm in a benchtop centrifuge. 
Determination of the concentration of the purified plasmid is done photometrically at A260 
using a NanoDropTM 2000 spectrophotometer (ThermoFischer Scientific Inc.) under the 
assumption that one absorbance unit equals 50 µg mL-1 double-stranded DNA.  
3.2.2.3. Site-directed mutagenesis 
The introduction of local specific changes to a DNA sequence can be achieved via so-called 
site-directed mutagenesis. Starting from short and specific oligonucleotides, which 
contain the desired mutation but otherwise perfectly align with the template DNA strand, 
the polymerase chain reaction (PCR) can be initiated and the new target DNA amplified. 
In this study a modified Quick change® II site-directed mutagenesis protocol (Stratagene) 
that is based on the "ligation during amplification"-method was used. A typical setup using 
the KAPAHifiTM DNA polymerase (Kapa Biosystems Ltd., London, UK) is shown in Table 4. 
Table 4: Composition of a typical setup for site-directed mutagenesis. 
reagent volume (µL) final concentration 
template DNA 1.00 ~2-4 ng µL-1 
oligonucleotide primer (sense strand) 0.75 300 nM 
oligonucleotide primer (antisense strand) 0.75 300 nM 
dNTPs 1.00 200 µM 
buffer 5.00 1x 
ddH2O to 25 µL - 
KAPAHifiTM DNA polymerase 0.75 0.03 u µL-1 
A corresponding PCR-protocol for site-directed mutagenesis is depicted in Table 5. 
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Table 5: Modified Quick change® II site-directed mutagenesis PCR-protocol. 
step temperature T (°C) time t (s) 
initial denaturation 95 120 
denaturation 98 20 
annealing 58 60 
elongation 72 270 (30s/kB) 
final elongation 72 300 
storage 8 ∞ 
During the PCR the oligonucleotide primer are extended leading to generation of a hybrid 
DNA double strand consisting of one template and one target strand. Since the 
methylated template DNA does not contain the introduced mutation, it has to be 
digested. To this aim 1 µL of the restriction endonuclease DpnI, which specifically 
recognizes and digests methylated DNA, is added to the PCR mix and the sample incubated 
for 1 h at 37 °C. After heat deactivation of the enzyme, the whole sample is transformed 
into chemically competent E. coli cells. 
3.2.2.4. Transformation of plasmid DNA in chemically competent E. coli 
Chemically competent E. coli cells used for transformation and amplification of plasmid 
DNA or protein production were prepared either by Norbert Grillenbeck (University of 
Bayreuth; calcium (Ca2+)-competent cells) or by Claudia Hanko (Helmholtz Centre for 
Infection Research, HZI; rubidium (Rb+)-competent cells) using standardized protocols.  
For plasmid transformation 50 µL of the chemically competent cells are augmented with 
5-10 µL of (purified) plasmid DNA and incubated for 30 min on ice. Subsequently, the 
whole sample is heat-shock-treated for 40 s at 42 °C and immediately thereafter placed 
on ice for 2 min. The cells are resuspended in 1 mL LB-medium and incubated for 1 h at 
37 °C and 140 rpm. Finally, 100 µL of the cell suspension are plated on LB-agar plates 
containing the respective antibiotics for selection.  
3.2.2.5. Heterologous gene expression and protein production in E. coli 
Expression plasmids for protein production are transformed in E. coli expression cell lines 
such as E. coli Rosetta2 (DE3) pLysS and plated on LB-agar plates with the corresponding 
antibiotics. For heterologous gene expression, a LB-pre-culture supplemented with the 
corresponding antibiotics is inoculated with a single colony of the expression cell line and 
incubated overnight at 37 °C and 140 rpm.   
The next day, 4 - 8 L medium complemented with the respective antibiotics are inoculated 
30 x 
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with about 10 mL L-1 of the pre-culture to yield a starting OD600 of 0.05. The cultures are 
incubated at 37 °C and 140 rpm and their OD600 followed in regular time intervals using a 
photometer blanked against pure medium. As soon as the cells reach an OD600 of 0.6 - 0.8, 
addition of IPTG to a final concentration of 0.5 mM induces gene expression. Afterwards, 
incubation of the cultures is continued for another 20 h at 140 rpm, but at a reduced 
temperature of 20 °C.  
3.2.3. General protein biochemical methods 
Unless explicitly stated otherwise, protein production and purification followed standard 
procedures and thus was very similar for all phenazine biosynthesis proteins. Claudia 
Hanko, Vanessa Hering, and Ute Widow (HZI) assisted in protein production of some of 
the used Phz-proteins. PhzF and PhzF∆123 from Burkholderia glumae BGR-1 were 
produced and purified by Christiane Pfaff (MPI Dortmund). In the following paragraphs, a 
standard protein purification is described in more detail. 
3.2.3.1. Cell lysis 
After heterologous gene expression, the cells are harvested by centrifugation for 20 min 
at 4 °C and 6000 rpm. The resulting pellets are resuspended in the respective buffer A 
supplemented with lysozyme, DNaseI, and MgSO4 to final concentrations of 200 µg mL-1, 
1 µg mL-1, and 5 mM respectively. As protease inhibitor either PMSF to a final 
concentration of 1 mM or one tablet cOmpleteTM Mini, EDTA-free protease inhibitor 
cocktail (Roche Deutschland Holding GmbH, Grenzach-Wyhlen) are added. The cell 
suspension is stirred for 45 min on ice, before complete cell lysis is achieved by sonication. 
Insoluble cell debris is removed by centrifugation for 45 min at 4 °C and 16000 rpm and 
the supernatant filtered through a 0.45 µM syringe filter.  
3.2.3.2. Immobilized metal ion affinity chromatography 
All produced proteins contain an N-terminal hexahistidine-tag that can be used for 
immobilized metal ion affinity chromatography by interaction of the imidazole groups of 
the histidine with immobilized divalent cations such as nickel Ni(II). 
For protein purification a HisTrapTM HP-column (column volume (CV) = 5 mL; GE 
Healthcare, Munich) charged with 100 mM NiSO4 is used. An ÄKTATMprime plus or 
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ÄKTATMpurifier FPLC-system (GE Healthcare, Munich) is equipped with the column and 
both are primed with 3 CV buffer A. Then, the cleared protein-containing supernatant is 
applied using a constant flow-rate of 3 mL min-1 and automatically collecting the flow 
through in fractions of 7 mL. The progress of the purification is monitored by recording 
the change in absorbance at a wavelength of 280 nm. Afterwards, the column is washed 
using 2 % buffer B (equivalent to 10 mM imidazole) keeping flow-rate and fraction size 
constant. Elution of specifically bound protein is done by applying a stepwise gradient of 
10, 20, 50, and 100 % buffer B (equivalent to 50, 100, 250, and 500 mM imidazole 
respectively) each over 5 CV. During elution, the flow-rate is reduced to 2 mL min-1 and 
fractions of 3 mL are collected. Protein containing fractions, as identified by an increased 
absorbance signal A280 are analyzed by SDS-PAGE.  
3.2.3.3. Dialysis and protein digest 
Collected fractions from the affinity chromatography step comprising the target protein 
are combined in a flexible dialysis tube with 3 kDa MWCO and dialyzed under continuous 
stirring against dialysis buffer A at 4 °C overnight to remove the residual imidazole. In 
order to ensure sufficient buffer exchange, 50 times excess volume of dialysis buffer is 
used.  
If the protein construct contains a protease recognition site for cleavage of the affinity 
tag, typically a TEV-site, the dialysis buffer A is additionally supplemented with 5 mM β-
mercaptoethanol as reducing agent and the protease added in 1:20-molar ratio regarding 
the target protein. After proteolysis, the tag-free protein is again subjected to a "reverse" 
Ni(II) ion affinity chromatography as described in paragraph 3.2.3.2. to separate the target 
protein (in the flow-through) from the affinity tag and other residual contaminants. 
3.2.3.4. Preparative size-exclusion chromatography 
Many applications, especially protein crystallization requires a homogenous protein 
sample of high purity. To this aim, all proteins after dialysis or reverse affinity 
chromatography are subjected to a final size-exclusion chromatography step. First, 
proteins are loaded on a HiLoadTM 26/600 Superdex™75 prep grade column (CV = 320 mL) 
equilibrated against size exclusion buffer and connected to an ÄKTATMpurifier FPLC-
system. Then, the column is isochratically developed in size exclusion buffer applying a 
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constant flow-rate of 2 mL min-1 to elute the protein separated in different oligomeric 
species and from residual protein contaminations. Fractions of 2 mL are collected and the 
protein samples analyzed using SDS-PAGE. Fractions containing pure and homogenous 
protein are pooled and concentrated via ultrafiltration using spin-concentrators 
(MWCO = 10 kDa). The concentration of the protein sample is determined 
photometrically at A280 using a NanoDropTM 2000 spectrophotometer and the specific 
molar extinction coefficient of the protein construct, as well as its molecular weight. 
Aliquots of the pure protein are snap-frozen in liquid nitrogen and stored at -80 °C until 
further usage. 
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CHAPTER I: 
Investigations of the isomerization reaction catalyzed by 
the phenazine biosynthesis enzyme PhzF 
4. The isomerase PhzF 
As described in detail in the introduction (cf. paragraph 1.3.1.), previous structural and 
functional studies (Mavrodi et al., 2003; Blankenfeldt et al., 2004; Parsons et al., 2004a) 
identified the phenazine biosynthesis enzyme PhzF to be an isomerase converting trans-
2S,3S-dihydro-3-hydroxyanthranilic acid (DHHA) into the highly reactive ketamine 
6-amino-5-oxo-2-cyclohexene-1-carboxylic acid (AOCHC). The reaction is proposed to 
proceed via a two-step mechanism: an isomerization, which requires the suprafacial 
movement of a non-acidic proton from position C3 to C1 along the conjugated π-system 
of the cyclohexadiene ring, and a subsequent keto-enol tautomerization of the 
intermediate 6-amino-5-hydroxy-2,4-cyclohexadiene-1-carboxylic acid (AHCDC) to the 
final reaction product. Since 1H-NMR spectra revealed full recycling of the non-acidic 
proton upon rearrangement, potential reaction pathways ensuring conservation of this 
proton were hypothesized and their energy profiles analyzed using quantum 
chemistry/molecular mechanics (QC/MM) calculations. Moreover, enzyme kinetics using 
two different substrate isotopologues as well as biophysical and crystallographic 
experiments were carried out to gain deeper insights into PhzF catalysis and find evidence 
for either a stepwise base-initiated reaction via an anionic intermediate or for a concerted 
mechanism, potentially following a pericyclic, so-called [1,5]-prototropic shift reaction, 
which has not yet been described in enzyme catalysis. 
4.1. Specific Methods & Materials 
The investigation of the catalytic mechanism of PhzF was a collaborative project. Mario 
Leypold from the group of Prof. Dr. Rolf Breinbauer at the Graz University of Technology 
synthesized and analyzed specific, enantiopure substrates, substrate analogs, and 
potential inhibitors and performed 1H-NMR experiments probing hydrogen/deuterium 
migration. Martin Culka from the Group of Prof. Dr. Matthias Ullmann at the University of 
Bayreuth carried out quantum chemistry/molecular mechanics (QC/MM) calculations to 
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analyze the different energy profiles of potential reaction pathways. Although some of 
their results are discussed in context of this work, materials and methods for these specific 
experiments are not elaborated in further detail.  
4.1.1. Protein production 
PhzF from Pseudomonas fluorescens 2-79 used in this study was produced after a modified 
protocol as described in Mavrodi et al. (2003). In brief, mutations were introduced using 
a modified Quick change® II site-directed mutagenesis protocol (Stratagene, see also 
paragraph 3.2.2.3.). Overexpression of the wild type protein (UniProt-entry: Q51792 
(PHZF_PSEFL)) and different active site variants was carried out using the pET15b 
expression vector (Novagen) in E. coli Rosetta (DE3) pLysS (Novagen) in luria bertani-
medium at 20 °C o/n after induction with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at an OD600 of 0.6. Purification of the N-terminal hexahistidine-tagged proteins 
followed standard procedures (as described in paragraph 3.2.3.), including immobilized 
Ni(II) affinity chromatography and a final size-exclusion chromatography step in standard 
assay (50 mM Na2HPO4/NaH2PO4 pH 7.5) or crystallization buffer (20 mM TRIS/HCl pH 7.5, 
150 mM NaCl) supplemented with 10 % (v/v) glycerol. Purified proteins were 
concentrated, snap-frozen in liquid nitrogen, and stored at -80 °C until further usage.  
PhzF from Burkholderia glumae BGR-1 (UniProt-entry: C5AHF3 (C5AHF3_BURGB)) was 
used from flash frozen aliquots produced and purified by Christiane Pfaff from the Max 
Planck Institute of Molecular Physiology in Dortmund, Germany 
4.1.2. Photometric assay 
Enzyme kinetic studies of the isomerase PhzF were carried out in a continuous assay 
following substrate depletion at 275 nm using an Infinite® M200 microplate reader (Tecan 
Group Ltd.). Unless explicitly stated otherwise, a standard assay mixture contained 40 nM 
PhzF dimer and substrate up to a final concentration of 1 mM in 50 mM sodium phosphate 
buffer at pH 7.5 supplemented with 1 % (v/v) dimethyl sulfoxide (DMSO). All reactions 
were carried out in a final volume of 100 µL in UV-Star® 96-Well microplates (Greiner Bio-
One) at 25 or 42 °C. The reaction was initiated by the addition of 50 µL enzyme solution 
to an equal volume of each substrate dilution and data were acquired in 30 s intervals 
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over a time course of 20 minutes. For background signal correction a reaction mixture 
lacking substrate was used. Reaction rates were determined from the slopes of the linear 
phase of each curve using a path length of 0.278 cm and an extinction coefficient of 
6500 M-1 cm-1. This extinction coefficient at 275 nm, the absorption maximum of the 
substrate trans-2S,3S-dihydro-3-hydroxyanthranilic acid (DHHA), was determined 
experimentally from standard curves of both isotopologues in standard assay and 
crystallization buffer. Each standard curve was measured in triplicate (Figure A1). Kinetic 
parameters were obtained by fitting the averaged data from three independent 
measurements to the Michaelis-Menten model using GraFit 5 (Erithacus Software Ltd.). 
In order to obtain measurable rates for the deuterium labeled, heavy substrate 
isotopologue 2S,3S-(3-2H)-DHHA (d-DHHA) or racemic O-ethylated DHHA (O-Et-DHHA), a 
synthetic substrate analog, the enzyme concentration was increased to 200 and 1000 nM 
respectively. 
4.1.3. Isothermal titration calorimetry 
Calorimetric titrations of substrate analogs to PhzF variants were carried out at 25 °C using 
a MicroCal™ VP-ITC System (GE Healthcare, now Malvern Instruments) with 10 µcal s-1 
reference power in high feedback mode. The sample cell was filled with either wild type 
PhzF or the inactive variant E45Q diluted to 50 or 100 µM final concentration in 
crystallization buffer. After an initial delay of 120 s, the proteins were titrated with 450 µM 
or 1 mM of different ligands prepared either from aqueous or DMSO stock solutions. The 
ligands were injected at a rate of 0.5 µL s-1 and a stirring speed of 307 rpm with 240 s 
intervals between individual injections. The data were analyzed and plotted using the 
programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015), SEDPHAT 
(Houtman et al., 2007; Zhao et al., 2015) and GUSSI (Brautigam, 2015; and for review 
Brautigam et al., 2016). 
4.1.4. Crystallization and structure determination  
Co-crystallization experiments of wild type protein or variant E45Q, each at 10 mg mL-1 
pre-incubated with 10 mM ligand, were carried out via sitting-drop vapor diffusion 
method at room temperature in 96-well INTELLI-PLATES® (ARI). For identification of new 
crystallization conditions either the commercial JCSG+ and the Cryos screening suites 
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(QIAGEN) or a random layer screen around the published conditions (0.1 M tri-sodium 
citrate pH 4.4-5.0 or pH 5.6; 0.2 M ammonium acetate or sulfate; 8-12 or 24-30 % (w/v) 
polyethylene glycol 4000; Mavrodi et al., 2003; Blankenfeldt et al., 2004) were used. 
Drops consisted of 200 nL protein solution and 200 nL precipitant. Initial crystals for the 
complex of PhzF E45Q with racemic O-ethylated DHHA were obtained after 12 hours from 
a reservoir comprising 0.085 M sodium acetate at pH 4.6, 0.17 M ammonium acetate, 
25.5 % (w/v) polyethylene glycol 4000 and 15 % (v/v) glycerol. First crystals for the 
putative complex of PhzF WT and the substrate analog/inhibitor H2-DHHA, were also 
obtained within 12 h from a reservoir composed of 0.1 M tri-sodium citrate pH 5.6, 
0.0556 M tri-lithium citrate, 23.3 % (w/v) polyethylene glycol 3350 and 17.8 % (v/v) 
polyethylene glycol 400.  
Diamond-shaped crystals for the complex of variant E45Q with O-Et-DHHA of a maximum 
size of 30*30*25 µm, which grew within a week, were mounted on a nylon loop and flash 
frozen in liquid nitrogen. The same procedure was followed for crystals of wild type PhzF, 
crystallized in the presence of 2,3,4,5-tetrahydro-3-hydroxy anthranilic acid (H2-DHHA) 
with dimensions of 130*130*125 µm. Diffraction data were collected at 100 K at beamline 
MX BL14.1, BESSY II at the Helmholtz Centre Berlin (complex with O-Et-DHHA) or at 
beamline X06DA (PXIII) at the Swiss Light Source (SLS) of the Paul Scherrer Institute 
(putative complex with H2-DHHA). Data reduction was carried out with XDS (Kabsch, 2010) 
followed by AIMLESS (Evans and Murshudov, 2013) of the CCP4 package (Winn et al., 
2011). Refinement and model building were achieved by alternating rounds of manual 
adjustment in COOT (Emsley et al., 2010) and maximum-likelihood refinement by 
phenix.refine (Afonine et al., 2012) of the PHENIX software suite (Adams et al., 2010). 
Ligand restraints for O-ethylated DHHA were generated using the program phenix.elbow 
(Moriarty et al., 2009) of the latter software suite. With respect to the apparent resolution 
of 1.7 Å of the complex with O-Et-DHHA structural flexibility was modelled using TLS 
(Translation/Libration/Screw) refinement (Schomaker and Trueblood, 1968). Eight TLS 
groups were identified by the program phenix.find_tls_groups, implemented in 
phenix.refine. In the last step of refinement, heteroatoms like waters and ligands were 
attributed to their nearest TLS group using a script developed in the group (Reichelt and 
Blankenfeldt, unpublished). Due to near atomic resolution of 1.18 Å of the wild type 
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dataset, anisotropic B-Factors were considered for all atoms of the protein except 
hydrogens. Waters were also excluded from anisotropic B-factor refinement. Final 
structure validation was done with MolProbity (Chen et al., 2010). Diffraction data and 
coordinates have been deposited to the Protein Data Bank (Berman et al., 2000; PDB entry 
5IWE for the complex with O-Et-DHHA). Full data collection and refinement statistics are 
shown in Table 14 (and Table A5 in the appendix for the high-resolution structure). 
4.2. Results & Discussion 
4.2.1. Development of the photometric assay 
Studies of the isomerization mechanism of PhzF required the development of a new 
activity assay. This assay should allow not only direct and continuous monitoring of the 
reaction, but also be adaptable to a semi-high-throughput setup. Many obstacles had to 
be overcome during assay development, since finding an UV-observable signal for the 
product failed. Eventually, following depletion of the substrate using its maximum 
absorption at 275 nm was the method of choice.   
Originally setup in a conventional UV-Vis spectrometer equipped with a cuvette holder, 
the assay platform was adapted to a 96-well plate format in order to facilitate rapid semi-
high-throughput measurements. A major disadvantage of the plate format was the 
concentration range of the substrate limited by the path length, i.e. the liquid level in the 
microplate. Accordingly, only substrate concentrations up to a final concentration of 
1 mM were applicable for the experiments. Nevertheless, this range was sufficient to 
obtain reproducible kinetic parameters. Interference of intrinsic protein absorption at the 
chosen wavelength of 275 nm seemed not to be an issue, since the typical protein 
concentrations in the assay mixture were in the nM or low µM-range. Thus, their 
contribution to the absorption signal was negligible. Moreover, all data were background 
corrected.  
The general assay setup was chosen such that the decrease in absorption followed a linear 
gradient over the whole time course of the experiment as shown in Figure 12A. 
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Figure 12: Typical kinetic data for the reaction of PhzF from P. fluorescens 2-79 with its natural substrate DHHA.  
A Time traces of the reaction using 40 nM PhzF dimer at different substrate concentrations ranging from  = 0 mM to 
 = 1 mM DHHA. B Time traces of the conversion of 1 mM substrate using various concentrations of dimeric PhzF 
(  = 40 nM,  = 100 nM,  = 200 nM,  = 400 nM,  = 600 nM, and  = 1 µM). The plotted curves in B are averaged 
data of three independent measurements. All data were obtained in standard assay buffer at 25 °C and normalized to 
zero. 
Linearity was observed for most measurements, although for some of them, especially at 
higher substrate concentrations, fluctuations within the first 30 s to 3 min occurred. This 
might be a sign of simple experimental errors or indicate pre-steady state processes. Yet, 
when probing the latter hypothesis by following conversion of the natural substrate using 
increasing PhzF concentrations in the standard assay buffer (50 mM sodium phosphate 
pH 7.5), no significant burst phase could be detected (Figure 12B). 
4.2.2. General buffer effects  
Many experiments addressed the question whether the nature of the buffer has an 
influence on the enzymatic activity. This was especially interesting since it was known 
from previously published structures (Blankenfeldt 
et al., 2004; Parsons et al., 2004a), that buffer ions 
such as sulfate or phosphate can bind to the active 
site of the enzyme (Figure 13). 
In contrast to what was expected from these crystal 
structures, the kinetic parameters for the substrate 
DHHA obtained in sodium phosphate buffer, 
namely a kcat of 3.23 s-1 and a kcat/KM of 6251 M-1 s-1, 
turned out to be in good agreement with the 
turnover number calculated with QC/MM methods 
of approximately 3 s-1. As such, sodium phosphate 
A B 
Figure 13: Active site of PhzF (P. fl 2-79) with 
bound sulfate ion.   
Close-up on the active site of PhzF (PDB entry 
1U1V; Blankenfeldt et al., 2004) in its open 
conformation. The sulfate ion and active site 
residues are shown as balls and sticks with the 
hydrogen-bonding network to the sulfate ion 
being highlighted as dashes (- - -). 
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appears to be an appropriate buffer substance for further mechanistic studies.  
In addition, when varying the phosphate concentration from 10 to 500 mM, no significant 
influence on kcat could be detected (Table 6 and Table A1 in appendix A1). Nonetheless, a 
small increase of KM is observed when the ionic strength of the buffer was raised (Table 6 
and Figure A2). Consequently, the overall catalytic efficiency decreased with increasing 
phosphate concentrations, suggesting a weak competitive effect of phosphate ions with 
a calculated KI of 488 mM (using a competitive inhibition model in GraFit 5). However, 
under standard assay conditions using 50 mM phosphate, a concentration ten times 
below the KI, this inhibitory effect can be neglected. 
Table 6: Enzyme kinetic parameters for PhzF (P. fl 2-79) catalyzed DHHA conversion in presence of increasing 
phosphate concentrations.* 
sodium phosphate pH 7.5 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
10 mM 3.06 ± 0.12 574 ± 40 5332 ± 426 
20 mM 2.58 ± 0.36 313 ± 61 8245 ± 1983 
50 mM 2.55 ± 0.12 623 ± 42 4096 ± 337 
100 mM 3.61 ± 0.22 779 ± 60 4637 ± 455 
200 mM 2.62 ± 0.07 715 ± 27 3667 ± 172 
500 mM 2.87 ± 0.09 866 ± 41 3315 ± 189 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
In a similar way, the effect of sulfate on PhzF activity was tested using up to 100 mM 
Na2SO4 as an additive to the standard assay buffer (50 mM sodium phosphate pH 7.5). 
Considering this series independently, increasing sulfate concentrations seem to have a 
positive influence on the turnover rate of the PhzF reaction, but no significant effect on 
KM (Table 7). When taking kcat/KM of the sulfate series in account, the acceleration of 
substrate turnover with increasing sulfate concentrations is even more distinct and thus 
showing an inverse behavior compared to phosphate.  
The increase in the overall catalytic efficiency in presence of sodium sulfate can be 
explained with the Hofmeister effect of the SO42--anion (Hofmeister, 1888 and for review 
Kunz et al., 2004). SO42- is classified as a kosmotropic anion, i.e. a highly hydrated anion 
that increases protein surface hydrophobicity and therefore, at least to some extent, 
protein stability. In addition, the Na+-counter ion, as a chaotropic cation, is also known to 
stabilize proteins (Zhao, 2016). Altogether, sodium sulfate might have a beneficial effect 
on protein stability and therefore enzymatic activity. However, from structural data it is 
known that sulfate binds to the active site of PhzF - at least under crystallization 
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conditions, i.e. 0.2 M ammonium sulfate – as such an inhibitory effect of this ion was 
anticipated. Yet, the tested concentrations of sodium sulfate were in the lower mM-range 
and therefore enzyme stabilizing effects of the SO42--ion might have outbalanced its 
inhibitory effects, which most likely would become visible only at higher sulfate 
concentrations.  
Table 7: Enzyme kinetic parameters for PhzF (P. fl 2-79) catalyzed DHHA isomerization in presence of increasing 
sulfate concentrations.* 
Na2SO4 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
0 mM 1.99 ± 0.09 506 ± 39 3923 ± 351 
1 mM 3.12 ± 0.42 765 ± 120 4078 ± 840 
10 mM 2.76 ± 0.06 443 ± 18 6240 ± 281 
100 mM 4.00 ± 0.15 565 ± 36 7086 ± 530 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in 50 mM 
sodium phosphate pH 7.5 at 25 °C supplemented with the depicted sulfate concentrations, normalized to zero, and background corrected. 
After all, an explanation for the influence of buffer ions on enzymatic activity according to 
the Hofmeister series would also account for sodium phosphate (kosmotrop  PO43- > 
SO42- > HPO42-  chaotrop). However, the differing observations for these two ions, 
namely a slight activating effect of sulfate and a weak inhibitory effect of phosphate, 
might be due to their specific affinities to the enzymes active site, which in turn might 
depend on their protonation states. At pH 7.5, the value of the standard assay buffer, the 
sulfate anion is completely deprotonated, i.e. it carries two negative charges, while 
phosphate is in equilibrium between hydrogen phosphate and dihydrogen phosphate, 
which carry two and only one negative charge respectively.   
In general, the active site of PhzF is perfectly shaped to accommodate one negatively 
charged group, which is stabilized by the positive helix dipoles of two central α-helices (α2 
and α6). Hence, the discrimination between phosphate and sulfate has to be provided by 
other active site residues. Although the two obvious candidates would be E45 and D208, 
with both amino acids theoretically bearing a negatively charged side chain at pH 7.5, 
analysis of the sulfate bound structure (Figure 13, PDB entry 1U1V, Blankenfeldt et al., 
2004) reveals that both residues mediate only indirect interactions to the sulfate ion via 
water molecules. Thus, the only other residue being able to discriminate between 
phosphate and sulfate would be H74, whose imidazole side chain was determined to be 
in its neutral Nε-protonated form by QC/MM calculations. Indeed in this form, the 
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unprotonated Nδ-atom can only be a hydrogen bond acceptor and consequently would 
preferentially bind phosphate over sulfate.  
In comparison, substrate turnover in the standard crystallization buffer (20 mM TRIS/HCl 
pH 7.5, 150 mM NaCl, 10 % (v/v) glycerol) is much slower with a kcat of only 1.61 s-1 and a 
kcat/KM of 3454 M-1 s-1 (Table 8 and Figure 14). Since this buffer, in contrast to the standard 
assay buffer, contained not only additional salt, i.e. 150 mM sodium chloride, but also 
10 % (v/v) glycerol, it was necessary to investigate whether this finding derived from 
enhanced viscosity or other salt or glycerol associated effects. Accordingly, a 50 mM 
TRIS/HCl buffer at pH 7.5 without salt or glycerol, but of similar concentration as 
phosphate in the standard assay buffer, was used. Using this buffer, the turnover rate is 
accelerated to the level of the phosphate buffer (kcat = 3.26 s-1), but, with a KM-value of 
1176 µM, almost twice as high as the one obtained for the crystallization buffer. In 
consequence, the overall catalytic efficiency (kcat/KM) is unaltered compared to the latter 
buffer. 
Table 8: Enzyme kinetic parameters for the isomerization of DHHA by PhzF (P. fl 2-79) in different buffer systems.* 
 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
sodium phosphate 3.23 ± 0.19 517 ± 57 6251 ± 773 
TRIS w/ salt and glycerol 1.61 ± 0.06 466 ± 27 3454 ± 241 
TRIS w/o salt or glycerol 3.26 ±  0.40 1176 ± 168 2768 ± 518 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
These results also indicate that the enhanced buffer viscosity in presence of 10 % (v/v) 
glycerol potentially has an impact on PhzF catalysis. In a more viscous solution, free 
diffusion of ligand and enzyme is reduced and therefore formation of a productive 
enzyme-substrate complex is impeded. This leads to a decrease in the substrate turnover 
rate and hence less overall catalytic efficiency. In addition, the presence of 150 mM 
sodium chloride leading to an increased ionic strength possibly interfered with DHHA 
isomerization by altering the electronic state of the active site, in particular that of E45 
whose protonation state is essential for catalysis. Yet, to confirm these hypotheses, an 
additional series of experiments with different glycerol and/or sodium chloride 
concentrations would be required.   
Besides the unfavorable effects on PhzF catalysis caused by enhanced viscosity or 
increased ionic strength, also an effect of TRIS as a buffer substance was observed.  
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Figure 14: Enzyme kinetics of the isomerization of DHHA by PhzF (P. fl 2-79) in different buffer systems.  
The turnover of the natural substrate DHHA was followed via substrate depletion over time at 275 nm. Kinetic plots 
(rate v as a function of substrate concentration) of the reaction in A 50 mM sodium phosphate buffer pH 7.5 ( ;  for 
comparison in plot B) and B crystallization buffer (20 mM TRIS/HCl pH 7.5, 150 mM sodium chloride, 10 % (v/v) 
glycerol, ) or 50 mM TRIS/HCl pH 7.5 ( ) are shown. After normalization to zero and background correction, averaged 
data from three independent measurements were fitted to a Michaelis-Menten model (—) using GraFit 5. All data were 
obtained at 25 °C. Inset: Structural formula of the substrate DHHA, with the migrating proton (H) highlighted. 
Despite similar substrate turnover rates in TRIS (without salt or glycerol) or phosphate 
buffer, the apparent affinity in presence of TRIS is doubled. The finding might be explained 
by the reactivity of the primary amine of this buffer substance. As mentioned earlier, the 
isomerization product AOCHC is a highly reactive ketamine, which can react with primary 
amines to form so-called Schiff bases. Accordingly, an unfavored side reaction with the 
buffer could occur (Figure A3A in appendix A1) and the resulting imine could bind to PhzF’s 
active site as shown in Figure A3B. Since it was possible to model the Schiff base in the 
active site of PhzF in such a way that proper hydrogen bonds could be established and no 
clashes were observed, it can be hypothesized that a TRIS-based buffer could lead to 
product-like inhibition. However, further mechanistic studies are required to understand 
this observation completely.  
In summary, the kinetic data show that TRIS buffer seems to be less suitable for studies of 
PhzF than phosphate, despite the weak competitive inhibition of the phosphate ion. 
4.2.3. pH-dependency 
Another aspect of PhzF catalysis, its pH-dependency, has been evaluated as well. 
Originally, a buffer consisting of a mixture of boric acid (200 mM), citric acid (50 mM) and 
tertiary sodium phosphate (100 mM), as described by Carmody (Carmody, 1961), was 
used. This unusual, yet phosphate-based buffer offers a broad buffer range from pH 2 - 12, 
however only a range between pH 4 – 10 proved to be suitable for PhzF stability as the 
protein otherwise precipitated immediately. Furthermore, when following the reaction in 
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this buffer, only pH 6.0, 7.0, and 8.0 yielded analyzable, yet noisy data (data not shown). 
A potential explanation could be the high ionic strength of this complex buffer, which 
contains a mixture of three different salts. In addition, all three substances could 
potentially bind to PhzF’s active site, depending on their respective protonation states and 
thus drastically influence PhzF catalysis.   
In order to obtain more reliable data, the standard sodium phosphate buffer was used 
within a narrow pH-range from 6.5 to 8.0 in steps of 0.25 pH-units. The kinetic parameters 
from these experiments are summarized in Table A3 in the appendix A1 and depicted in 
Figure 15A. At first glance lower pH-values (except pH 6.5) with kcat values of ~5 s-1 seem 
to be more favorable for catalysis. However, the associated Michaelis constants are higher 
the lower the pH. The decrease in apparent substrate affinity might correlate with the 
protonation states of the buffer ions and consequently their affinity to the active site of 
PhzF leading to weak competitive inhibition (cf. paragraph 4.2.2.). On that account, the 
overall catalytic efficiency kcat/KM (Figure 15B) was considered to determine a pH-
optimum for PhzF catalysis in phosphate buffer, whereupon pH 7.5 and 7.75 gave the 
highest numbers with kcat/KM values of 5329 M-1 s-1 and 5407 M-1 s-1 respectively. 
  
Figure 15: pH-dependency of PhzF-catalyzed DHHA isomerization in 50 mM sodium phosphate buffer.  
A The turnover number kcat (  ; left y-axis) and the Michaelis-constant KM (  ; right y-axis), as well as B kcat/KM (  ) 
were plotted against different pH-values ranging from pH 6.5 to 8.0 in steps of 0.25 pH-units. The plotted values were 
derived by fitting normalized, background corrected, and averaged data of three independent measurements to a 
Michaelis-Menten model using GraFit 5. All data were obtained at 25 °C. 
A broader pH-range was also screened using a TRIS-like buffer, i.e. Bis-TRIS propane (BTP). 
A first screen covered the whole pH-range of BTP from pH 6.5 to 9.5 in 0.5 pH-units (data 
not shown). From this series, it became evident, that pH-values above 7.5 are not 
applicable as they gave noisy and inaccurate data. Consequently, a narrower pH-range 
from 6.5 to 7.5 in steps of 0.1 pH-units was used for further analysis. However, the data 
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obtained in this buffer were also inconclusive and thus are not discussed in further detail, 
but can be found in the appendix A1 (Figure A4 and Table A3). 
4.2.4. Turnover of a C3-deuterated substrate – probing kinetic isotope effects 
The aim of this study was the identification of the rate-limiting step of catalysis and hence 
the determination of the fundamental reaction pathway that PhzF employs to convert 
DHHA into AOCHC. As the reaction is supposed to proceed via a hydrogen transfer, a way 
to address these questions is to probe primary kinetic isotope effects (KIEs). In theory, the 
primary kinetic isotope effect of a C-H bond cleavage in solution can be predicted with a 
semi-classical model to a value of ~7 at room temperature (300 K, Melander and 
Saunders, 1987). At this temperature the difference of the reaction rates predominantly 
depends on the differing zero point energies (ZPE) of hydrogen versus deuterium. In 
enzymatic reactions, this intrinsic primary KIE can be masked by the rates of additional, 
non-rate-limiting catalytic steps. Consequently, the apparent (observed) KIE includes 
contributions of all steps of catalysis and thus often appears smaller (Allemann and 
Scrutton, 2009).  
The studies of KIEs for PhzF catalysis required synthesis of an enantiomerically pure 
substrate isotopologue, 2S,3S-(3-2H)-DHHA (d-DHHA, Mario Leypold). As expected, 
enzymatic turnover of this heavy substrate isotopologue in sodium phosphate buffer was 
significantly decreased in comparison with the natural substrate DHHA (0.34 s-1 and 
3.23 s-1 for d-DHHA and DHHA respectively; Table 9 and Figure 16).  
Table 9: Enzyme kinetic parameters for the conversion of the light (DHHA) and heavy (d-DHHA) substrate 
isotopologues by the isomerase PhzF (P. fl 2-79) in different buffer systems.* 
  kcat (s-1) KM (µM) kcat/KM (M-1s-1) KIEapp (kcat) 
KIEapp 
(kcat/KM) 
sodium phosphate 
DHHA 3.23 ± 0.19 517 ± 57 6251 ± 773 
9.5 ±  0.6 5.7 ± 0.8 
d-DHHA 0.34 ± 0.01 311 ± 14 1099 ± 58 
TRIS w/ salt and 
glycerol 
DHHA 1.61 ± 0.06 466 ± 27 3454 ± 241 
5.4 ± 0.3 3.2 ± 0.3 
d-DHHA 0.30 ± 0.01 271 ± 14 1095 ± 65 
TRIS w/o salt or 
glycerol 
DHHA 3.26 ± 0.40 1176 ± 168 2768 ± 518 
8.4 ± 1.1 2.9 ± 0.6 
d-DHHA 0.39 ± 0.01 400 ± 23 963 ± 65 
D2O : sodium 
phosphate (9:1) 
DHHA 5.69 ± 0.41 937 ± 109 6068 ± 834 
12.8 ± 1.1 4.8 ± 0.8 
d-DHHA 0.45 ± 0.02 349 ± 25 1275 ± 108 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
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In other words, substitution of the proton at position C3 (the predicted position for initial 
deprotonation) with a heavier deuterium gives rise to a large primary deuterium kinetic 
isotope effect (kH/kD) on kcat.   
With regard to the theoretical assumptions described above, an apparent KIE of 9.5 on 
kcat indicates an even higher intrinsic KIE for the proton abstraction from C3. This 
observation cannot be explained with the differing ZPEs of the substrates alone and 
additional quantum mechanical contributions such as altered bending frequencies or 
torsional stiffness of the breaking bond, possibly even hydrogen tunneling through the 
energy barrier might be involved in the deprotonation step.  
In addition, QC/MM calculations that were employed to simulate energy profiles for PhzF 
catalysis (Martin Culka) also predict that the first deprotonation is the rate-limiting step 
of the whole catalytic cycle, but, in contrast to the experimental data, these calculations 
give intrinsic KIEs of 4.76 and 5.69 after Wigner (Wigner, 1932) or 7.36 after Bell (Bell, 
1980) tunneling correction. The cause of this large discrepancy between apparent and 
calculated KIEs is not evident, however it cannot be ruled out that despite the high 
observed KIE (9.5 on kcat) the associated intrinsic one is not significantly larger and thus 
might not differ as much from the calculated KIEs. Nevertheless, similar tendencies for 
apparent KIEs, however less pronounced, are also observed when comparable 
measurements were carried out in different TRIS buffers (Table 9). 
Since the exact reaction mechanism of PhzF catalysis was unknown, a potential 
involvement of solvent molecules was investigated as well. To study so-called solvent 
kinetic isotope effects (SIEs), the kinetic parameters of substrate turnover in a light and 
heavy solvent, here buffer or a buffer mixture comprised of D2O/ 50 mM sodium 
phosphate pH 7.5 in a 9:1-ratio, were compared (Figure 16).  
Again, when comparing the data for both isotopologues in the D2O-buffer mixture, a large 
apparent primary KIE of kH/kD = 12.6 on kcat is detected (Table 9). Although this finding 
might be a result of slightly differing pH-values of the two buffers (D2O vs. H2O), it could 
as well support the hypothesis that indeed quantum tunneling contributes to PhzF 
catalysis. Another peculiarity is the increased turnover rate of 5.69 s-1 for DHHA in 90 % 
D2O that gives rise to an inverse solvent kinetic isotope effect of 0.57 ± 0.05 on kcat.  
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Figure 16: Enzyme kinetics for the conversion of light and heavy substrate isotopologues by the isomerase PhzF 
(P. fl 2-79).   
Kinetic plots (rate v as a function of substrate concentration) showing the turnover of the natural, light substrate DHHA 
( ) and of the heavy isotopologue d-DHHA ( ) in 50 mM sodium phosphate buffer pH 7.5, as well as turnover of DHHA 
in D2O/50 mM sodium phosphate pH 7.5 (9:1) ( ). The reaction was followed via substrate depletion over time at 
275 nm. After normalization to zero and background correction, averaged data from three independent measurements 
were fitted to a Michaelis-Menten model (— for DHHA and — for d-DHHA) using GraFit 5. All data were obtained at 
25 °C. Adjacent: Structural formula of the substrates DHHA and d-DHHA, with the migrating proton (H) or deuterium (D) 
highlighted respectively.  
However, as the obtained value for kcat/KM of 6068 M-1 s-1 is in a similar range as for the 
standard assay buffer and thus correlates to a SIE of 1.03 ± 0.19 (close to unity), the 
exchange of solvent did not show any effect on the overall catalytic efficiency. Moreover, 
the deuterated substrate was affected in a different way, i.e. the reaction exhibits a 
weaker inverse SIE of 0.77 ± 0.04 regarding kcat, but in addition also a weak inverse SIE on 
kcat/KM with a value of 0.86 ± 0.09. Since reproduction of these solvent effects by QC/MM 
calculations failed, a connection between the experimental results and one of the 
proposed mechanisms cannot be made. Several explanations for an (inverse) SIE have 
been put forward previously, e.g. enhanced or altered solvent viscosity (Karsten et al., 
1995) or the impact on the pre-equilibrium protonation (H/D-exchange) to “a site involved 
in catalysis which prefers deuterium over protium” (Scheuring and Schramm, 1997), but 
the available data on PhzF catalysis do not allow a conclusive statement about the source 
of the observed inverse SIEs.  
4.2.5. A two domain PhzF orthologue from Burkholderia glumae BGR-1 
As mentioned in the introduction, the phenazine biosynthesis protein PhzF is a highly 
conserved enzyme among phenazine producing bacterial strains. To address whether 
different PhzF orthologues exhibit different reactivity, the enzyme from Burkholderia 
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glumae BGR-1 (BgluPhzF) was tested for DHHA conversion. One peculiarity of this enzyme 
is the predicted two-domain architecture, which was verified from its crystal structure 
(Sung et al., unpublished). In addition to an isomerase domain, which adopts the typical 
DapF-fold and can be found in all PhzF orthologues, BgluPhzF features a ~ 120-amino acid-
long N-terminal extension forming a domain with yet unknown function. Structural 
comparison revealed that this domain bears resemblance to a ferredoxin-like α+β-fold 
similar to YdhR (sequence identity 28 % over 39 residues according to BLAST; structural 
similarity 75 % over 97 residues according to PDBe fold), a yet biochemically 
uncharacterized protein from E. coli (PDB entries 1WD6 and 2HIQ). Furthermore, the 
domain also exhibits a structural relationship to the co-factor independent 
monooxygenase SnoaB from Streptomyces nogalater (PDB entry 3KG0; Grocholski et al., 
2010) with a sequence identity of 27 % (52 residues) and a structural identity of 57 % 
(97 residues). 
Upon following substrate depletion of DHHA with two variants of PhzF from B. glumae 
BGR-1, full length BgluPhzF and the isolated isomerase domain BgluPhzFΔ123 (amino 
acids 124-402), the first observation was that the obtained kinetic parameters for 
substrate turnover and catalytic efficiency and hence the observed KIEs for full length PhzF 
are in a similar range as the data obtained for the enzyme from P. fl 2-79 (Table 10 and 
Figure 17).  
Table 10: Enzyme kinetic parameters for the conversion of the light and heavy DHHA isotopologue by a PhzF-
orthologue from Burkholderia glumae BGR-1.* 
  kcat (s-1) KM (µM) kcat/KM (M-1s-1) KIEapp (kcat) KIEapp (kcat/KM) 
full length 
DHHA 5.93 ± 1.00 848 ± 156 6994 ± 1742 
12.4 ± 2.1 5.7 ± 1.4 
d-DHHA 0.48 ± 0.01 388 ± 17 1236 ± 65 
Δ123 
DHHA 0.23 ± 0.01 61 ± 8 3738 ± 525 
3.7 ± 0.2 4.8 ± 0.7 
d-DHHA 0.06 ± 0.00 79 ± 5 786 ±56 
* The obtained values are averaged data of three independent measurements fitted according to a Michaelis-Menten model. All data were obtained in 
50 mM sodium phosphate pH 7.5 at 25 °C, normalized to zero, and background corrected. 
Moreover, the apparent KIE on kcat for the PhzF-orthologue from B. glu BGR-1 yields a 
value of 12.4, which supports the previously made hypothesis of a tunneling contribution 
to PhzF catalysis (q.v. paragraph 4.2.4).   
In contrast, the isolated domain (BgluPhzΔ123) shows reduced enzymatic activity in 
comparison to the full-length enzyme. More precisely, DHHA isomerization with 
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kcat = 0.23 s-1 is 25-fold decreased, while turnover of the heavy isotopologue is slowed 
down only 8-fold (kcat = 0.06 s-1, Table 10 and Figure 17).  
  
Figure 17: Enzyme kinetics for the conversion of light and heavy substrate isotopologues by a PhzF-orthologue from 
Burkholderia glumae BGR-1.   
Kinetic plots (rate v as a function of substrate concentration) showing the turnover of the natural, light substrate DHHA 
(  and ) and of the heavy isotopologue d-DHHA (  and ) in 50 mM sodium phosphate buffer pH 7.5 at 25 °C. Plot A 
represents the data obtained for the full length protein, while B shows the kinetic plots for the N-terminal truncated 
variant Δ123 (isolated isomerase domain). The reaction was followed via substrate depletion over time at 275 nm. After 
normalization to zero and background correction, averaged data from three independent measurements were fitted to 
a Michaelis-Menten model (— for DHHA and - - for d-DHHA) using GraFit 5.  
An explanation for these results might be decreased protein stability due to the missing 
N-terminal domain in BgluPhzΔ123. Furthermore, since the function of the N-terminal 
domain is unknown, it cannot entirely be ruled out that it plays a direct role in catalysis. 
At this point however, no conclusive hypothesis for enzymatic function can be established, 
especially as some of the gathered data for the N-terminally truncated domain show 
unexpected characteristics, e.g. an approximately 5-10-fold smaller KM-value compared 
to the full-length enzyme, and thus have to be considered with caution. With regard to 
the current understanding of PhzF catalysis, no definite or convincing conclusion can be 
drawn from this data. Nevertheless, upon potential future uncovering of the presently 
unknown role of the N-terminal domain, additional information could contribute to this 
understanding. 
4.2.6. Temperature dependency – Evidence for cooperativity? 
4.2.6.1 Temperature dependency of apparent reaction rates and KIEs 
Typically, when enzyme kinetic experiments are carried out at elevated temperatures, an 
accelerated substrate turnover is observed. This phenomenon can be explained by the 
Arrhenius-equation (Arrhenius, 1889; equation 13), which, at a defined temperature (T), 
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links a thermal energy barrier (activation energy EA) and atomic motion (A) of a 
(bio)chemical process to its apparent reaction rate (k): 
 = c ∙ AQdef∙	  (13) 
Although an elevated temperature has no direct effect on the activation energy (EA) of an 
enzymatic reaction, the temperature factor (T) in the exponential term of the Arrhenius-
equation drastically affects the reaction rate, with the exponential function getting larger 
with higher temperatures. Additionally, the Arrhenius pre-exponential factor A, which is 
a product of the number of collisions Z and the proper orientation of the colliding 
molecules P (A = Z∙ P) also depends on the temperature in form of decreased solvent 
viscosity and consequently enhanced protein/ligand diffusion.   
Similar to individual reaction rates, kinetic isotope effects exhibit also a temperature 
dependency that can be described by the Arrhenius-equation (Arrhenius, 1889; Allemann 
and Scrutton, 2009; equation 14): 
g = hi =
chci ∙ A
∆deIjklLf∙	  (14) 
The largest contribution to a KIE comes from the difference in activation energies for the 
light (L) and heavy (H) substrate isotopologue. In turn, the magnitude of the activation 
energy EA for a specific reaction mainly depends on the different zero point energies (ZPE) 
of the reactants in the ground (GS) and transition state (TS) (Kohen and Klinman, 1999). 
Based on Heisenberg’s uncertainty principle, protium (1H), being a smaller particle, has a 
less defined location and therefore a higher ZPE than deuterium (2H = D) (Heisenberg, 
1927; Kohen and Klinman, 1999). This statement holds true for both, the ground as well 
as the transition state. However, in case of (bio)chemical reactions no atom alone, but 
rather the chemical bond, which is cleaved or formed during catalysis, accounts for 
different ZPEs of reactants. In the ground state, bond stretching (C-H or C-D) has a large 
impact on ZPE, but as the respective bond will be partially broken in the transition state, 
the influence on the ZPE will be smaller. In other words, the difference of ZPEs for light 
and heavy substrates is larger in the ground state than in the transition state and hence 
differing activation energies for two substrate isotopologues can be observed. Although, 
this relationship does not directly explain the temperature dependent reaction rates of 
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two isotopologues and their resulting kinetic isotope effect, an Arrhenius plot as shown in 
Figure 18 can promote a better understanding of this correlation.  
 
Figure 18: Theoretical, tunneling corrected Arrhenius plots for the temperature dependency of different isotopes in 
hydrogen transfer reactions.   
Logarithmic plots for A the reaction rates of light (L) and heavy (H) isotopes as a function of temperature (1/T) and  
B the temperature-dependent proportionality of their kinetic isotope effects. The three highlighted areas are colored 
corresponding to the temperature range (low, medium, high) and illustrate the contribution of quantum tunneling to 
the observed reaction rates and KIEs. *Quantum tunneling itself is considered as temperature-independent. Figure 
adapted from Alleman and Scrutton 2009 (Chapter 7 p. 173). 
The plot depicts that with increasing temperature (darker red) the reaction rates k for two 
isotopes increase until (at infinite temperature) they are uniform. It is also evident that at 
lower temperatures the rate difference for light (L) and heavy (H) isotopes is larger than 
at higher temperatures. Hence, their kinetic isotope effect (ln (kL/kH)) is close to zero at 
elevated temperatures, but large at low temperatures. A reason for this varying 
temperature dependency is not only the different activation energy for two substrate 
isotopologues, but also the influence of so-called quantum tunneling on the reaction rate. 
In principle, tunneling can be observed for all atoms, however, hydrogen transfer 
reactions were found to be especially affected by this quantum effect. Again, according to 
Heisenberg’s uncertainty principle, a particle exhibits an uncertainty in its position not 
only in the ground or transition state but also all along the reaction coordinate. This 
uncertainty might be estimated from the de Broglie wavelength of the particle (Broglie, 
1970; Kohen and Klinman, 1999). At a certain position along the energy landscape (close 
to the transition state), the wavelength of the particle will be larger than the width of the 
A 
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EA barrier and thus it can cross/tunnel the barrier leading to product formation. Since the 
probability of tunneling correlates with the de Broglie wavelength of the particle, which 
in turn depends on its mass, protium (1H), having a broader wavelength than deuterium 
(2H), can tunnel easier than its heavier isotope. Hence, the influence of tunneling on 
reaction rates will be larger on lighter isotopes. This quantum effect explains why KIEs 
tend to be larger when tunneling strongly contributes to the reaction rate. Furthermore, 
the plots in Figure 18 show that the contribution of tunneling to a reaction is reduced with 
increasing temperatures, as under these conditions excess energy is available, hence, 
thermal activation is sufficient for turnover and tunneling can be disregarded. This means 
that at low temperatures, tunneling (strongly) contributes to the reaction rate of the light 
substrate, but less to the turnover rate of the heavy one and hence the KIE is high. With 
increasing temperatures this contribution diminishes, the two rates converge and 
consequently the KIE decreases.   
It should be mentioned that the model described so far is simplified, as it considers only 
rigid EA barriers. In some cases, e.g. when a high energy barrier correlates with a high 
tunneling rate, but shows no temperature dependency, besides its height also the barrier 
width and especially fluctuations in the barrier dimensions have to be considered. 
In terms of PhzF catalysis, this means that a way to gain deeper insights into mechanistic 
details is to probe the temperature dependency of the observed kinetic isotope effects. 
As described before (q.v. paragraph 4.2.3.), the turnover of the light substrate 
isotopologue (DHHA) at 25 °C is faster than the one for the heavy isotopologue (d-DHHA) 
and hence the corresponding KIE is high (9.5 on kcat). If indeed tunneling (strongly) 
contributes to the reaction rate (as already suggested in paragraph 4.2.3.), with increasing 
temperatures, this contribution should diminish, the two rates converge and 
consequently the KIE decrease. 
In order to confirm this hypothesis, enzyme kinetic experiments using both light and heavy 
substrate isotopologue were carried out at 42 °C in two different buffer systems, the 
standard assay buffer as well as a buffer containing 90 % D2O (Figure 19). As anticipated, 
substrate turnover by PhzF is accelerated at higher temperature. In case of the natural, 
light substrate DHHA a 1.5-fold increase of the apparent rate (kcat = 5.15 s-1) is observed 
at 42 °C in phosphate buffer (Table 11). 
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Figure 19: Enzyme kinetics for the isomerization of DHHA and d-DHHA by PhzF (P. fl 2-79) at 42 °C.   
Kinetic plots (rate v as a function of substrate concentration) showing the turnover of A the light substrate DHHA and  
B the heavy isotopologue d-DHHA in 50 mM sodium phosphate buffer pH 7.5 (  = DHHA;  = d-DHHA) as well as in 
D2O/50 mM sodium phosphate pH 7.5 (9:1) (  = DHHA;  = d-DHHA) at 42 °C. The reaction was followed via substrate 
depletion over time at 275 nm. After normalization to zero and background correction, averaged data from three 
independent measurements were fitted according to the Hill-equation (— for DHHA and — for d-DHHA) using GraFit 5. 
Inset: Structural formula of the substrates DHHA and d-DHHA, with the migrating proton (H) or deuterium (D) 
highlighted respectively. 
Turnover of the heavy substrate isotopologue d-DHHA (kcat = 0.93 s-1) is even raised 2.5-
fold compared to the reaction followed at 25 °C. In turn, a decreased magnitude of the 
apparent primary KIEs is detected, thus indicating a tunneling contribution in PhzF 
catalysis. This is further supported by the data obtained in the buffer containing 90 % D2O 
which also yielded a smaller KIE than obtained at lower temperature (KIE (kcat) = 7.5 at 
42 °C vs. 12.8 at 25 °C, Table 9 and Table 11).  
Table 11: Enzyme kinetic parameters for the conversion of both substrate isotopologues by the isomerase PhzF 
(P. fl 2-79) in different buffer systems at 42 °C.* 
  kcat (s-1) K1/2 (µM) Hill-coefficient n KIEapp (kcat) 
sodium phosphate 
DHHA 5.15 ± 0.32 852 ± 80 1.27 ± 0.03 
5.5 ± 0.6 
d-DHHA 0.93 ± 0.09 1057 ± 161 1.07 ± 0.02 
D2O : sodium 
phosphate (9:1) 
DHHA 5.15 ± 0.09 424 ± 10 1.43 ± 0.02 
7.5 ± 0.6 
d-DHHA 0.69 ± 0.05 514 ± 66 1.16 ± 0.04 
* The obtained values are averaged data of three independent measurements fitted according to the Hill-equation. All data were obtained in the 
respective buffer at 42 °C, normalized to zero, and background corrected. 
In addition, when comparing the two buffer systems at 42 °C, the two rates for DHHA 
isomerization converge to a similar value and hence the corresponding solvent kinetic 
isotope effect (SIE) is completely abolished as it can be expected with increasing 
temperatures (data not shown). In case of the heavy substrate (d-DHHA), however, the 
SIE becomes inverted, i.e. a positive effect. As previously discussed in paragraph 4.2.3., 
the origin of the SIE for PhzF catalysis is still unclear, but, at least in case of d-DHHA the 
different tendencies (inverse SIE at 25 °C and normal SIE at 42 °C) might arise from the 
fact that the measured activities are much lower than for DHHA and thus lead to larger 
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uncertainties. Furthermore, the data obtained data at 42 °C displayed sigmoidal curves 
and hence were fitted using the Hill-equation (for details see below). Thus, they are not 
fully comparable to the data obtained at 25 °C (fitted to a Michaelis-Menten model) and 
hence the aforementioned interpretation of their temperature dependency should be 
considered with caution, especially regarding the absolute values. 
4.2.6.2. Sigmoidal curves indicate cooperativity in PhzF catalysis 
Another observation was made when kinetic data for the two DHHA isotopologues were 
recorded at 42 °C. The obtained plots (rate v as a function of substrate concentration) 
show a slightly sigmoidal curvature and as such are not fittable with the Michaelis-
Menten-equation. In fact, sigmoidal kinetic plots were also observed under other 
conditions, e.g. in a buffer consisting of 50 mM HEPES pH 7.5 (data not shown) or when 
different active site variants of PhzF were tested for substrate conversion (see paragraph 
4.2.9.).  
Since a sigmoidal curve is indicative of cooperative substrate binding, the data were fitted 
according to the Hill-equation to evaluate the degree of cooperativity (Table 11). In all 
four tested cases, positive cooperativity is observed. However, with Hill-coefficients 
around a value of n = 1, turnover of the deuterated substrates seems to be less influenced 
by cooperativity. Although there is no universal explanation for this small positive 
cooperativity observed under some conditions, it might be explained with regard to 
previously obtained structural data of PhzF (Blankenfeldt et al., 2004).   
From these structures, it is known that, upon substrate binding, PhzF adopts a closed 
conformation, whereupon not only the active site cleft of one monomer closes, but also 
the enclosed surface at the dimer interface increases when the two closed monomers 
rotate and tilt towards each other (see also Figure 23). This structural feature might 
indeed hint towards cooperativity such as closing of the active site of one monomer could 
influence substrate affinity and/or catalytic efficiency of the other monomer. 
Cooperativity could be mediated via the contacting surface residues such as R244 and 
E40* which are forming a salt bridge, or via Y4, which is involved in hydrogen bonding with 
its counterpart from the second monomer. Indeed, the structurally related 
diaminopimelate epimerase (DAP) was - despite previous reports (Cirilli et al., 1998; Lloyd 
et al., 2004) - not only found to be a dimer in solution, but Perugini and co-workers also 
4. The isomerase PhzF Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 
76 
discovered that its enzymatic activity strongly depends on dimerization, as a monomeric 
variant with Y268 (Y4 in PhzF) mutated to an alanine, was completely inactive (Hor et al., 
2013). As described in a subsequent paragraph, when a similar mutation (Y4A) is 
introduced into PhzF, no protein expression could be observed. Although this observation 
does not prove that cooperativity plays a role in PhzF catalysis, it at least emphasizes the 
importance of dimerization for PhzF in terms of stability and enzymatic activity.  
4.2.7. Substrate spectrum and specificity 
4.2.7.1. Finding new substrates for PhzF 
Supposed to serve as mechanistic probes, substrate analogs such as 2S,3S-dihydro-3-
hydroxysalicylic acid (DHHS) or O-alkylated derivatives of DHHA, namely 2,3-dihydro-3-
methoxy- or 2,3-dihydro-3-ethoxy anthranilic acid (O-Me-DHHA and O-Et-DHHA 
respectively) were tested for enzymatic conversion by PhzF (Figure 20).  
 
Figure 20: Enzyme kinetics for the isomerization of DHHA and two O-alkylated substrate analogs by PhzF (P. fl 2-79). 
The turnover of DHHA ( ), racemic DHHA ( ), trans-2S,3S-O-methylated DHHA (O-Me-DHHA, ), racemic O-Me-DHHA 
( ), and racemic O-ethylated DHHA (O-Et-DHHA, ) was followed via substrate depletion over time at 275 nm in 50 mM 
sodium phosphate buffer pH 7.5 at 25 °C. Kinetic plots (rate v as a function of substrate concentration) of normalized, 
background corrected, and averaged data from three independent measurements were fitted to a Michaelis-Menten 
model (— for DHHA and — for O-alkylated derivatives) using GraFit 5. Inset: Zoom on the kinetic plot of O-Et-DHHA 
(labelling as described before). Adjacent: Structural formula of the two O-alkylated substrates O-Me-DHHA (top) and O-
Et-DHHA (bottom), with the alkyl-group shown with green dashes (—). 
Among these molecules the derivative bearing a simple hydroxyl group (DHHA) is the best 
substrate for PhzF, whereas the methoxy-modification leads to a slower turnover with a 
kcat of 1.86 s-1 (KM = 437 µM) and 1.33 s-1 (KM = 622 µM) for enantiopure and racemic O-
Me-DHHA respectively. For the ethoxy-derivative, detectable conversion (kcat = 0.12 s-1 
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and KM = 1842 µM) is only seen when the enzyme concentration is increased to 1 µM 
(Table 12). For DHHS no conversion could be detected at all. 
Table 12: Enzyme kinetic parameters for the turnover of different native and synthetic substrate analogs by the 
isomerase PhzF (P. fl 2-79).* 
 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
racemic DHHA 0.97 ± 0.06 314 ± 24 3088 ± 299 
trans-2S,3S-O-Me -DHHA 1.86 ± 0.13 437 ± 47 4268 ± 545 
racemic O-Me-DHHA 1.33 ± 0.08 622 ± 56 2134 ± 231 
racemic O-Et-DHHA 0.12 ± 0.02 1842 ± 355 63 ± 17 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in 50 mM 
sodium phosphate pH 7.5 at 25 °C, normalized to zero, and background corrected. 
1H-NMR experiments confirmed these findings and showed that derivatives with an even 
larger alkoxy-substituent at C3, such as O-n-propylated DHHA (O-nPr-DHHA), are not 
converted by PhzF at all (Mario Leypold). Furthermore, these measurements revealed that 
the O-alkylated compounds cannot undergo tautomerization to form the final ketamine, 
but rather eliminate ammonia to yield aromatic products (Scheme 9). 
 
Scheme 9: Potential pathway for the PhzF (P. fl 2-79)-catalyzed isomerization of different O-alkylated DHHA 
derivatives and their modification dependent product formation.   
It can be assumed that, independent of the substituent (R), the first step of catalysis constitutes the [1,5]-hydrogen shift 
(H) to the intermediate AHCDC or to its O-alkylated derivatives. The simple 3-hydroxy-AHCDC undergoes PhzF catalyzed 
stereoselective tautomerization to the ensuing ketamine AOCHC. Intermediates with larger alkyl-substituents (R) cannot 
undergo this tautomerization, but probably eliminate ammonia instead to yield the aromatic 3-methoxy- or 3-ethoxy-
benzoeic acid respectively. 
A comparison of the kinetic parameters obtained for the enantiopure compounds or their 
corresponding racemic mixture (50:50) reveals that substrate turnover rates are lower 
with racemic mixtures. This effect is more pronounced for DHHA with kcat–values of 
3.23 s-1 and 0.97 s-1 for the enantiopure compound and the racemic mixture respectively, 
but can also be observed for the methoxy-derivative (Table 12). A similar tendency is also 
observed for kcat/KM, i.e. the catalytic efficiency decreases not only with increasing size of 
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the alkyl-substituent (kcat/KM: DHHA > O-Me-DHHA > O-Et-DHHA), but is also negatively 
affected by the presence of the other substrate enantiomorph (2R,3R) in the racemic 
mixtures.  
From calculations and the published structure (PDB entry 1U1X; Blankenfeldt et al., 2004), 
which indicate a unique stereochemistry of the reaction, it is anticipated that the 2R,3R-
enantiomer of DHHA (trans-2R,3R-dihydro-3-hydroxyanthranilc acid = ent-DHHA) and 
consequently all O-alkylated derivatives (ent-O-Me-DHHA and ent-O-Et-DHHA) with 
similar chirality cannot be converted by PhzF (P. fl 2-79). In order to confirm this 
hypothesis, conversion of DHHA, d-DHHA and their respective enantiomers was tested 
under standard assay conditions but with a 12.5-fold higher PhzF concentration (500 nM) 
to increase the probability of detecting measurable signal for conversion of the 2R,3R-
enantiomers. As shown in Figure 21, under the tested conditions no turnover of ent-DHHA 
or ent-d-DHHA was detected, whereas a fast decay of the UV-Vis signal of DHHA and d-
DHHA was observed.  
 
Figure 21: Time traces for the conversion of different substrate enantiomorphs by the isomerase PhzF from 
P. fluorescens 2-79.   
The conversion of DHHA ( ), ent-DHHA ( ), d-DHHA ( ), and ent-d-DHHA ( ), each 1 mM, using 500 nM dimeric PhzF 
was followed for 1200 s and the normalized absorbance signal was plotted as a function of time (t). All data were 
obtained in standard assay buffer at 25 °C, normalized to zero, and background corrected.  
Although the data in Figure 21 show that the 2R,3R-enantiomers are not converted by 
PhzF, it cannot be excluded that these substrate analogs still bind to the active site of the 
enzyme and thereby act as competitive inhibitors. In order to confirm this hypothesis, 
binding measurements of ent-DHHA and other substrates, substrate analogs, or potential 
inhibitors to wild type PhzF or an inactive E45Q variant were carried out using isothermal 
titration calorimetry (ITC). However, no binding of either of the two DHHA-enantiomers 
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(DHHA or ent-DHHA) is observed under the tested conditions (Figure 22A and Figure A5A). 
In a similar way, no binding to wild type PhzF is observed for DHHS and the two 
enantiomers of the potential inhibitor 2,3,4,5-tetrahydro-3-hydroxy anthranilic acid (H2-
DHHA; Figure A5B-D). Since these results were not anticipated, additional ITC experiments 
with a known PhzF binder, 3-hydroxy anthranilic acid (3OHAA; Blankenfeldt et al., 2004), 
and anthranilic acid (AA) were performed. Indeed, binding in the µM range could be 
observed for both compounds (Figure 22 and Figures A6 - A8 in appendix A1). 
  
Figure 22: ITC profiles for affinity titrations of different DHHA-substrate analogs against PhzF E45Q.   
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). A Titration of the 
2R,3R-substrate enantiomorph ent-DHHA (  = 1 mM and  = 450 µM) to PhzF E45Q (  = 100 µM and  = 50 µM). For 
both experiments, no binding event could be observed. B Titration of each 1 mM of 3-hydroxy anthranilic acid 
(3OHAA, ) and anthranilic acid (AA, ) to 100 µM PhzF E45Q. Binding of 3OHAA and AA to PhzF E45Q was exothermic, 
with 1:1 stoichiometry and occurred with KD values of 3.34 µM and 22.34 µM, respectively. All data were analyzed and 
fitted using the programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 
2007; Zhao et al., 2015) and plotted using the program GUSSI (Brautigam, 2015).  
In addition, the binding parameters and affinity constants obtained by ITC (Table 13) for 
3OHAA are in good agreement with the published values, obtained from fluorescence 
spectroscopy measurements (KD (WT) = 1.4 µM; KD (E45Q) = 4.0 µM; Blankenfeldt et al., 
2004). In comparison to 3OHAA, a decreased affinity of AA towards PhzF is observed. As 
known from PhzF wild type structures in complex with DHHA or 3OHAA (PDB entries 1U1X 
and 1U1W respectively), the C3-hydroxy group of the ligands is involved in hydrogen 
KD = 3.34 µM 
KD = 22.34 µM 
E45Q E45Q 
R = OH 
R = H 
A B
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bonding to a conserved active site water molecule (~2.7 Å). Furthermore two additional, 
however weak hydrogen bonds (~3.4 Å) between the hydroxy group and two important 
active site residues, E45 and D208, stabilize the residues in the active site. Anthranilic acid 
in contrast to 3OHAA is lacking this hydroxy group and in consequence, its affinity is 
decreased.  
Table 13: Thermodynamic binding parameters for ITC affinity titrations of 3OHAA and AA to wild type PhzF and 
variant E45Q.* 
Ligand PhzF variant KD (µM) 
∆G 
(kcal mol-1) 
∆H 
(kcal mol-1) 
-T*∆S 
(kcal mol-1) 
N c 
3OHAA 
WT 
0.99 ± 0.01 -8.19 ± 0.01 -8.55 ± 0.17 0.36 ± 0.18 1.0 ± 0.02 50.1 ± 1.09 
1.07 ± 0.21 -8.16 ± 0.12 -6.34 ± 0.48 -1.82 ± 0.55 0.93 ± 0.04 43.3 ± 8.75 
E45Q 
4.01 ± 1.22 -7.39 ± 0.17 -8.39 ± 0.80 1.00 ± 0.96 0.87 ± 0.04 10.89 ± 3.34 
2.26 ± 0.07 -7.70 ± 0.02 -5.89 ± 0.19 -1.82 ± 0.20 1.07 ± 0.02 23.77 ± 0.83 
†E45Q 100µM 3.34 -7.47 -7.83 0.36 1.15 34.32 
AA 
WT 14.10 ± 0.46 -6.62 ± 0.02 -6.07 ± 0.40 -0.55 ± 0.42 0.84 ± 0.02 2.99 ± 0.12 
E45Q 26.34 ± 2.42 -6.25 ± 0.06 -3.99 ± 0.26 -2.26 ± 0.31 0.89 ± 0.02 1.69 ± 0.16 
†E45Q 100µM 22.34 -6.35 -3.90 -2.45 1.06 4.76 
* All ITC experiments were carried out at 25 °C in 20 mM TRIS/HCl pH 7.5, 150 mM NaCl, 10 % (v/v) glycerol. 450 µM of the respective compound were 
titrated to 50 µM PhzF. The data are averaged from at least two independent measurements. † In contrast to the afore described experimental setup, 
1 mM of the respective compound were titrated to 100 µM PhzF E45Q. The presented data derive from a single titration experiment. 
The binding data for these two aromatic anthranilic acid derivatives indicate not only that 
the tested proteins were in fact stable and active, but also hint towards very week binding 
(KD >> 100 µM) of the other tested substrates or inhibitors, such as DHHA, ent-DHHA, or 
H2-DHHA. Attempts to obtain binding constants for these ligands by other methods, such 
as microscale thermophoresis (MST) remained unsuccessful, since labeling of the protein 
proved difficult and in consequence, no reliable data could be obtained from these 
experiments.  
Despite lacking affinity parameters for many of the tested substrates or substrate analogs, 
soaking experiments and co-crystallization trials of wild type protein or different active 
site variants of PhzF with various ligands were carried out. Although crystals could easily 
be grown and even yielded structures at very high resolution of up to 1.18 Å (Figure A9 
and Table A5), in most cases the electron density maps did not provide any clear evidence 
for a bound ligand. Yet finally, one new complex structure of PhzF could be obtained 
(Figure 23 and Table 14). Surprisingly, this structure of the inactive PhzF variant E45Q co-
crystallized with racemic O-Et-DHHA was found in the open conformation (RMSD = 0.128 
over 1826 atoms to PDB entry 1U1V (open) vs. RMSD = 0.736 over 1546 atoms to PDB 
Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 4. The isomerase PhzF 
81 
entry 1U1X (closed), Figure 23A), which was so far only observed in the absence of a 
specific ligand (Blankenfeldt et al., 2004). In addition, instead of the productive DHHA-
enantiomer (2S,3S), the non-convertible enantiomorph ent-O-Et-DHHA was bound to the 
active site (Figure 23B and C). 
 
Figure 23: Crystal structure of PhzF variant E45Q (P. fl 2-79) in complex with ent-O-Et-DHHA.  
A Overall topology of the biological, dimeric assembly of the complex shown in an open conformation (aquamarine). 
The ligand O-Et-DHHA is shown in dark purple. For comparison: Overlay with a closed conformation structure of PhzF 
WT in complex with the natural substrate DHHA shown in paleyellow (PDB entry 1U1X, Blankenfeldt et al., 2004). The 
ligands in both structures are highlighted as balls and sticks. B and C Close-up on the active site of the complex with O-
Et-DHHA from front (B) and side view (C). The active site residues as well as the ligand are shown as balls and sticks. 
Additionally the ligand is depicted in its Fourier difference density (mFo-DFc) omit map contoured at 3σ in green. Its 
hydrogen-bonding network formed by strong (- - -; < 3.2 Å) or weaker (- - -; ≥ 3.2 Å) interactions is highlighted.  
Upon careful inspection of the new crystal structure, it becomes evident that, in 
comparison to previously obtained complex structures of the closed conformation, e.g. 
A 
B C 
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with bound DHHA (PDB entry 1U1X; Blankenfeldt et al., 2004), the hydrogen-bonding 
pattern in the active site is slightly altered. The ligand ent-O-Et-DHHA is stabilized by 
twelve hydrogen bonds - ten strong and two weaker ones (≥ 3.2 Å) - with seven active site 
residues and one highly coordinated water molecule (water 142). The carboxyl moiety of 
the ligand is tightly bound to the active site, with one oxygen stabilized by hydrogen bonds 
to the γ-hydroxyl of S213 and the backbone amide of the same serine as well as the one 
of G73. Stabilization of the other oxygen of the carboxylate is facilitated via a hydrogen-
bonding network comprising of two strong hydrogen bonds to the backbone amides of 
G212 and H74 and additionally via a weak bond to the Nδ-moiety of H74. The C2-amino 
group of ent-O-Et-DHHA is stabilized by three strong and one weak (≥ 3.2 Å) hydrogen 
bonds. Similar to the previously published DHHA-complex (Blankenfeldt et al., 2004) H74 
and D208 are involved in binding of this moiety, but in addition a tightly bound water 
molecule (water 142) coordinates the group. Moreover, a fourth, weaker hydrogen bond 
between the ligand and the main chain carbonyl of A210 can be found. In contrast, the 
"catalytic" residue Q45 (E45 in the complex with DHHA) is no longer in hydrogen-bonding 
distance to the amino-moiety. The coordination of the C3-alkoxy group is drastically 
altered, too. The tightly bound water 142 as well as the amide group of Q45 coordinate 
the bridging oxygen of the alkoxy-group, whereas binding to D208 is no longer observed. 
An overlay of the two complex structures, with ent-O-Et-DHHA or DHHA, reveals that the 
ethyl-moiety of the former complex occupies the position of the conserved water in the 
active site of the latter complex (data not shown).  
Altogether, these findings indicate that the crystal structure with ent-O-Et-DHHA 
represents a non-productive complex. It might be possible that with O-ethylated DHHA 
bound, the protein cannot adopt the closed conformation of a productive complex. The 
open and therefore less stable conformation however might explain why turnover of the 
ethoxy-derivative is much slower and less efficient than turnover of the native substrate 
DHHA. Yet, since the obtained structure constitutes a complex of an inactive PhzF variant 
with a non-convertible substrate enantiomer, it cannot entirely be ruled out that PhzF 
might adopt a different productive conformation for complexes with convertible 
substrates bearing a bigger alkoxy-substituent at position C3. In any case, the structure 
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showed that indeed the 2R,3R-substrate enantiomers can bind to the active site of the 
enzyme, even though with weak affinity. 
Table 14: Data collection and refinement statistics for PhzF (P. fl 2-79) in complex with O-ethylated DHHA 
 Complex with O-ethylated DHHA 
Data collection1  
Beamline† MX BL14.1, BESSY II 
Wavelength (Å) 0.91841 
Resolution range (Å) 77.87 – 1.71 (1.74 – 1. 71) 
Space group P3221 
unit cell dimensions  
a, b, c (Å) 56.03, 56.03, 155.74 
α, β, γ (°) 90, 90, 120 
Mosaicity (°)‡ 0.07 
Measured reflections 164740 (7396) 
Unique reflections 31593 (1662) 
Multiplicity 5.2 (4.5) 
Mean I/σ(I) 8.9 (1.9) 
CC1/2* 0.995 (0.573) 
Completeness (%) 99.9 (99.9) 
Rmeas
§ 13.8 (86.2) 
Rp.i.m.
¶ 6.0 (40.8) 
  
Refinement  
Resolution range (Å) 46.33 – 1.71 (1.76 – 1.71) 
Rcryst (%) 14.92 (23.78) 
Rfree (%) 17.34 (27.20) 
No. of non H-atoms  
    Protein 2170 
    Ligand / Ion 47 
    Water 242 
Average B-factors (Å²)  
    Protein 16.3 
    Ligand / Ion 34.9 
    Water 33.8 
R.m.s deviations  
    Bond lengths (Å) 0.007 
    Bond angles (°) 0.945 
Ramachandran plot (%)  
   Favored regions 98.6 
   Outliers 0 
MolProbity score # 1.21 
Values in parentheses are for the highest resolution shell - 
1 The dataset was collected from a single crystal.  
† BESSY II: Berlin Electron Storage Ring Society for Synchrotron Radiation, Helmholtz Centre Berlin, Berlin, Germany.  
‡ Mosaicity values reported by XDS (Kabsch, 2010).  
* CC1/2 is the correlation coefficient between two random half datasets (Karplus and Diederichs, 2012)  
§	a? = ∑ nIℎL/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|C123 /∑ ∑ gCC123 IℎL, where N(hkl is the number of observations of the reflection with 
  index hkl and Ii(hkl) is the intensity of its ith observation (Diederichs and Karplus, 1997);   
¶	t.C.. = ∑ n1/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|/∑ ∑ gCIℎLC123C123  (Weiss, 2001)  
# As reported by MolProbity (http://molprobity.biochem.duke.edu/ (Chen et al., 2010) 
4.2.7.2. Potential PhzF-inhibitors 
In the course of investigations of PhzF’s enzymatic activity also two enantiomers of the 
substrate analog 2,3,4,5-tetrahydro-3-hydroxy anthranilic acid (H2-DHHA; Figure 24) were 
analyzed for conversion.  
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Figure 24: Overview of different PhzF substrates, substrate analogs, and inhibitors.   
The symbols illustrate the interaction of the respective compound with PhzF. The small check marks () indicate 
whether these compounds are substrates for PhzF, with the colors specifying the velocity of the turnover (fast, slow, 
very slow). The red and gray crosses () symbolize that these compounds cannot be converted by PhzF (P. fl 2-79) with 
H2-DHHA ( ) also being no inhibitor for PhzF catalysis. The blue lightning () specifies that this compound is a 
competitive inhibitor. 
However, attempts to monitor H2-DHHA depletion directly under standard assay 
conditions failed, as the compound does not show any absorption at 275 nm. Since also 
binding measurements and crystallization experiments (Figure A9 and Table A5) remained 
unsuccessful, the inhibitory potency of H2-DHHA on substrate conversion was evaluated. 
It was anticipated that, regardless of its own conversion, the high structural similarity of 
this compound to the substrate DHHA would qualify it as a potential competitive inhibitor. 
However, for the 2S,3S-enantiomer of H2-DHHA no inhibition of DHHA-isomerization is 
observed, independently of the substrate concentration used (Figure 25). Though 
surprising, these data also show that H2-DHHA is no substrate for PhzF, since otherwise it 
would compete with the native substrate for conversion. 
In contrast, when the other H2-DHHA enantiomer (ent-H2-DHHA) is titrated against high 
(1 mM) or lower (125 µM) DHHA concentrations a decrease in substrate turnover is 
observed. As estimated from the data shown in Figure 25, IC50-values for this compound 
are in the high µM-range, i.e. between 150 and 550 µM. In addition, these data confirm 
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that indeed, although not detectable with calorimetric experiments, ent-H2-DHHA can 
bind to PhzF, albeit with low affinity.  
  
Figure 25: Inhibition of PhzF catalyzed DHHA isomerization by two enantiomorphs of the substrate analog H2-DHHA.  
Residual activity of DHHA turnover as a function of inhibitor concentrations is plotted in A for the dose-response of H2-
DHHA (  ,  ) and B for the enantiomorph ent-H2-DHHA (  ,  ). Increasing inhibitor concentrations were titrated 
in presence of 1 mM (dark green/blue) or 125 µM (light green/blue) DHHA respectively. PhzF was used at a 
concentration of 40 nM (dimer) in all assays. All data were obtained in standard assay buffer consisting of 50 mM sodium 
phosphate pH 7.5 at 25 °C, normalized to zero, background corrected, and averaged from three independent 
measurements.  
Altogether, these findings suggest that ent-H2-DHHA and similar substrate analogs might 
be starting points for PhzF inhibitor development. 
4.2.8. Exploring the active site of PhzF with generated enzyme variants 
For biochemical characterization of PhzF’s isomerization mechanism various active site 
variants of the protein from Pseudomonas fluorescens 2-79 were either generated in 
context of this work or already available from a previous study (Blankenfeldt et al., 2004), 
such as the active site variants (E45Q/A, D208A/T and H74A) or a dimer interface variant 
(N42A). Mutagenesis was based on preliminary knowledge of the reactivity of the already 
available mutants. As described in Blankenfeldt et al. (2004) mutation of the catalytic 
residue E45 to alanine (E45A) or glutamine (E45Q) completely abolished enzymatic 
activity without impairing substrate binding. Indeed, when following the conversion of 
racemic DHHA using 500 nM final concentration of each variant, no conversion of this 
substrate could be observed (data not shown). Assuming that the carboxyl group of E45 
plays an important role in catalysis and thus mutations to alanine or glutamine eventually 
lead to a complete loss of activity, two additional strategies were employed. One attempt 
was a so-called chemical rescue with sodium acetate or sodium formate (10 and 50 mM) 
as additives to the assay solution containing E45A. Both anions were supposed to mimic 
A B
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the carboxyl moiety of E45 and thus restore, at least partially, catalytic activity. However, 
when incubating variant E45A with either of the two salts, no turnover of DHHA is 
observed, i.e. chemical rescue failed (data not shown). In order to test whether a 
protonation susceptible side chain alone is sufficient for catalysis or if spatial factors play 
an important role as well, the variant E45D was generated, which still bears a carboxyl 
group similar to the wild type enzyme, but with a shorter side chain. Likewise, D208, from 
previous analysis of the variants D208A/T known to be involved in substrate binding, was 
mutated to a glutamate (D208E). In addition, a double variant, carrying both mutations 
(E45D/D208E) was generated. When tested for substrate conversion, none of these five 
PhzF variants (E45D, D208A/T/E and E45D/D208E) showed enzymatic activity (data not 
shown). These results confirm the importance of a specific environment in the active site 
for PhzF catalysis and demonstrate that even "small" changes like a mutation of E45 to a 
glutamine or aspartate can cause complete depletion of enzymatic activity.   
In a way, the double variant E45D/D208E represents an inversion of the active site, hence 
this variant was not only tested for activity on the racemic mixture, but also on both 
substrate enantiomorphs (DHHA and ent-DHHA), though with similar results as observed 
for the racemic mixture, i.e. no conversion (data not shown).   
Besides E45 and D208, there are two other important active site residues, S213 and H74. 
From crystal structures (Blankenfeldt et al., 2004 and this work) it is evident that the 
serine, together with the positive helix dipoles of the two central α-helices α2 and α6, is 
mainly involved in positioning and binding of the carboxyl group of the substrate. A 
mutation to alanine (S213A) would presumably impair substrate binding and hence lead 
to complete loss of activity. The predominant role of H74 is to provide a hydrogen-bonding 
network for the substrate. Surprisingly, previously obtained biochemical data 
(Blankenfeldt et al., 2004) showed that replacement of this histidine with an alanine 
(H74A) does not abolish enzymatic activity entirely but decreases it fourfold. Indeed, 
when conversion of the racemic substrate by H74A was investigated, turnover of DHHA 
could be confirmed, albeit with a kcat of 0.07 ± 0.01 s-1 (kcat/KM = 245 ± 63 M-1 s-1) 
corresponding to a 15-fold decrease compared to wild type PhzF. This discrepancy might 
be due to the use of the racemic mixture rather than pure DHHA in the assay. However, 
an additional experiment with variant H74A and enantiopure DHHA yielded an even larger 
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difference in enzymatic activity compared to wild type PhzF (data not shown). Despite the 
order of magnitude, analysis of the structure of H74A in the open form (PDB entry 1XUB, 
Blankenfeldt et al., 2004) can explain why substrate turnover was observed after all. In 
this structure, the space that is occupied by the imidazole ring of H74 in wild type PhzF 
was filled with water molecules instead. These water molecules replace the Nδ-atom of 
the imidazole moiety as hydrogen bond acceptor and hence secure necessary formation 
of a hydrogen-bonding network for the substrate. In order to address the role of H74 
further, three additional variants, H74L, H74N, and H74D were generated and tested for 
activity on racemic DHHA. H74L did not show any activity in the assay most likely due to 
the large, yet hydrophobic sidechain of this amino acid. It occupies a similar spatial 
envelope as the imidazole ring of the histidine and thus prevents water molecules from 
binding. Introduction of an asparagine at position 74, which carries a polar, but uncharged 
sidechain of similar size to leucine aimed at restoring the hydrogen-bonding network. 
Indeed, when testing this variant in the assay, conversion of the racemic substrate is 
observed, however even slower than for variant H74A (Table 15).  
Table 15: Enzyme kinetic parameters for the turnover of racemic DHHA by different PhzF variants.* 
PhzF variant kcat (s-1) KM (µM) kcat/KM (M-1s-1) K1/2 (µM) Hill-coefficient n 
WT 1.01 ± 0.03 - - 610 ± 28 1.64 ± 0.04 
N42A 
0.18 ± 0.01 558 ± 68 328 ± 44 - - 
0.15 ± 0.00 - - 352 ± 20 1.19 ± 0.03 
H74N 
0.02 ± 0.00 31 ± 2 558 ± 34 -  
0.02 ± 0.00 -  35 ± 4 0.78 ± 0.11 
H74A 0.07 ± 0.01 284 ± 63 246 ± 63 -  
* The obtained values are averaged data of three independent measurements fitted either to a Michaelis-Menten model or to the Hill-equation as 
indicated. All data were obtained in 50 mM sodium phosphate pH 7.5 at 25 °C, normalized to zero, and background corrected. 
Finally, when an aspartate (H74D) instead of the asparagine is introduced at this position, 
substrate turnover is completely abolished. Although a polar, potentially negatively 
charged sidechain, as in case of aspartate could stabilize the positively charged amino 
group of the substrate, an exchange of the basic amino acid histidine with an acidic 
aspartate, drastically alters the overall active site protonation and charge distribution, 
which was found to be crucial for PhzF catalysis in QC/MM calculations. 
In a recent publication the enzymatic activity of the structurally related bacterial 
diaminopimelate epimerase (DAP) was analyzed (Hor et al., 2013). The authors were 
specifically interested in the interconnection of dimerization and enzymatic activity and 
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indeed found that dimer formation is essential for DAP mediated catalysis. In order to 
address whether a similar behavior could be observed for PhzF, two variants with 
mutations at the dimer interface (N42A and Y4A; Figure A10 in appendix A1) were tested 
for enzymatic activity. Variant Y4A is equivalent to the reported mutant of DAP (Y268A), 
i.e. the amino acid is located at a similar position and thus mediates a similar interaction. 
However, overexpression of the Y4A variant of PhzF remained unsuccessful and hence 
might indicate that this residue is essential for dimerization and protein stability.   
Residue N42 is located at the dimer interface of PhzF, adjacent to the entrance of the 
active site cleft (Figure A10). Consequently, a mutation at this position was not only 
expected to impair dimerization but potentially also substrate binding. Contrary to these 
expectations, variant N42A remains catalytically active, although at a 10-fold decreased 
rate compared to the wild type enzyme. This finding might support the hypothesis that 
N42 is only involved in "guiding" the substrate to the active site and not actively 
participating in its turnover. Accordingly, substitution with a smaller, apolar residue such 
as alanine would weaken the potentially important interaction and lead to decelerated 
substrate turnover.  
In course of these experiments, the kinetic plots of two out of the three active PhzF 
variants as well as the wild type enzyme exhibited a sigmoidal curve (Figure 26). 
Therefore, the experimental data for wild type PhzF, variant N42A and H74N were fitted 
to the Hill-equation (Table 15). Kinetic data for H74A could not be fitted with this equation 
and hence were analyzed with a Michaelis-Menten model. For better comparison of their 
enzyme kinetic parameters, the other two active variants (N42A and H74N) were 
additionally fitted to the latter model. Only the data of the wild type enzyme could not be 
interpreted with the Michaelis-Menten model, at least not in this experimental context. 
Because of this inconsistency, the data should be considered with caution. However, the 
phenomenon of sigmoidal kinetic plots was already observed during other kinetic 
experiments, e.g. when the temperature dependency of DHHA isomerization was studied 
(paragraph 4.2.6.), and might indicate cooperative substrate binding to PhzF.  
Overall, the results of the mutagenesis studies illustrate that the catalytic site of PhzF is a 
very sensitive environment not even permitting small changes in terms of protein 
engineering. 
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Figure 26: Enzyme kinetic plots for the isomerization of racemic DHHA by active PhzF variants.   
A Kinetic plots (rate v as a function of substrate concentration) showing the turnover of racemic DHHA in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C catalyzed by either 500 nM dimeric PhzF WT ( ), N42A ( ), H74A ( ) or H74N ( ). The 
reaction was followed via substrate depletion over time at 275 nm. After normalization to zero and background 
correction, averaged data from three independent measurements were fitted according to a Michaelis-Menten model 
(—) or to the Hill-equation (—) using GraFit 5. Inset: Close-up on the kinetic plots for variants N42A and H74A/N. B 
Obtained kcat-values from the plots in A either derived from a Michaelis-Menten (  ) or Hill-Fit (  ) using GraFit 5. 
4.2.9. In silico studies to elucidate the reaction mechanism of PhzF 
As mentioned in the beginning of this chapter, analysis of the different potential reaction 
mechanisms for PhzF catalysis was conducted in collaboration with two other groups from 
the University of Bayreuth and the Graz University of Technology. The theoretical QC/MM 
calculations carried out by Martin Culka (University of Bayreuth) are particularly 
important for the understanding of the catalytic mechanism. Hence, the results will be 
presented in this paragraph. 
Initial 1H-NMR experiments by Mario Leypold (Graz University of Technology) revealed 
that PhzF catalysis features several characteristics of a sigmatropic reaction, as reported 
for other enzymes, such as chorismate mutases (Burschowsky et al., 2014) or the 
isochorismate pyruvate lyase PchB from Pseudomonas aeruginosa (DeClue et al., 2005). 
First, when DHHA isomerization is followed in D2O, no incorporation of a deuterium at 
position C1 is observed indicating no exchange of the transferred proton with the solvent 
as would be expected for acid/base-catalyzed reactions. Instead, after transfer to position 
C1, the signal originating from the proton at position C3 is retained and hence indicates a 
concerted mechanism. In a similar way, when conversion of the selectively mono-
deuterated substrate d-DHHA was followed in aqueous solution, the characteristic 
absence of an NMR-signal for the deuterium at position C3 was preserved at position C1 
after catalysis. Second, the shifted proton at position C3 was found to be non-acidic 
(estimated pKa = 21.3 after binding to PhzF’s active site). Third, the NMR-data revealed 
A B
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that, upon tautomerization, incorporation of a solvent proton/deuterium at position C4 
leads to R-configuration of the new stereogenic center. Although these observations are 
required for validation of a sigmatropic reaction, alone they are not sufficient. Thus, after 
initial determination of the active site protonation, which identified the substrate to be 
present in its zwitterionic form with protonated amine and deprotonated carboxylate, and 
surprisingly suggests that the crucial catalytic residue E45 is protonated (pKa = 9) at the 
onset of catalysis, QC/MM calculations for different reaction trajectories were carried out 
(Scheme 10 and Scheme 11). 
To begin with, an intramolecularly concerted transfer via [1,5]-sigmatropic shift 
(Scheme 10IA) was modelled starting from either protonated, as suggested by the 
theoretical active site titrations, or deprotonated E45. In both cases the energy barrier for 
proton abstraction at C3 was found to be 32.5 kcal mol-1 (even higher under consideration 
that E45 has to be deprotonated prior to catalysis) and as such too high to be plausible in 
terms of enzyme catalysis. Consequently, a direct, intramolecularly concerted mechanism 
for PhzF catalysis is unlikely. Secondly, another concerted mechanism involving 
protonated E45 was analyzed (Scheme 10IB). In this case, when simultaneous transfer of 
a proton from E45 to C1 and abstraction of the non-acidic proton at position C3 was 
investigated, a high EA barrier of 27.2 kcal mol-1 was determined. This high energy barrier 
renders this mechanism implausible. The third mechanism, a stepwise acid/base-catalysis, 
including consecutive abstraction of the C3-proton, leading to an anionic intermediate, 
and stereoselective protonation at C1, led to an EA barrier of 13-14 kcal mol-1 (after 
refinement, including initial deprotonation of E45 and ZPE correction, 16 kcal mol-1; 
Scheme 10IC). Hence, a mechanism, in which E45 acts as proton shuttle seems to be the 
most likely for the first step of PhzF catalysis, although the necessary initial deprotonation 
of E45 still remains questionable. 
The next step in catalysis is supposed to be a tautomerization of the enol intermediate 6-
amino-5-hydroxy-2,4-cyclohexadiene-1-carboxylic acid (AHCDC). Again, NMR-
experiments showed that protonation at position C4 of AHCDC is stereospecific, 
suggesting an enzyme assisted/catalyzed mechanism. This is also supported by the fact 
that the energy barrier for a spontaneous tautomerization was calculated to be 
14.2 kcal mol-1, making an uncatalyzed step unlikely.  
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Scheme 10: Hypothetical reaction schemes for the first step of PhzF catalysis, namely DHHA isomerization to the 
reaction intermediate AHCDC.   
Three different reaction pathways were analyzed by QC/MM calculations. IA represents a concerted mechanism via a 
pericyclic [1,5]-prototropic shift with the conserved (de)protonated active site residue E45 only having a stabilizing 
function. IB shows a concerted mechanism involving protonated E45, which donates a proton to the C1-carbon of the 
substrate and simultaneously abstracts a proton from position C3. IC depicts a stepwise mechanism via an anionic 
intermediate. The deprotonated E45 acts as catalytic base abstracting the proton from the substrate carbon at position 
C3. After reorientation E45 protonates the substrate at position C1 yielding the reaction intermediate AHCDC. The 
migrating, non-acid proton from position C3 (H) as well as the proton of E45 (H) are highlighted. Figure adapted from 
Diederich et al., 2017. 
The active site of PhzF comprises only two suitable reactants in close distance to the 
reacting groups of the substrate, the carboxylate of E45 and a conserved water molecule, 
both able to perform the required steps for tautomerization of AHCDC, i.e. first 
deprotonation of the 3-hydroxy group and then protonation at position C4.  
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Scheme 11: Hypothetical reaction mechanisms for the second step of PhzF catalysis - stereoselective keto-enol 
tautomerization of the intermediate AHCDC to the ketamine product AOCHC.   
Three different reaction pathways were analyzed by QC/MM calculations. IIA shows a stepwise mechanism with the 
conserved active site residue E45 abstracting a proton from the intermediate’s 3-hydroxy group and retransferring it to 
position C4. IIB shows a similar mechanism, but here the conserved active site water molecule acts as an acid/base 
catalyst. IIC depicts a stepwise mechanism where first the water molecule abstracts a proton from the 3-hydroxy group 
of AHCDC, then transfers another proton to E45, which in finally protonates position C4 yielding the reaction product 
AOCHC. The migrating proton of the 3-hydroxy group of AHCDC’s (H) as well as from the conserved water molecule (H) 
are highlighted. Figure adapted from Diederich et al., 2017. 
Hence, the first potential mechanism involves E45. To accomplish proton abstraction from 
the 3-hydroxy group, the residue has to rotate back to its original position at the onset of 
catalysis. Then a stepwise deprotonation of the hydroxy group and subsequent 
protonation at C4 could yield the ketamine AOCHC (Scheme 11IIA). However, QC/MM-
calculations found the barrier for this reaction to be in a similar range than the 
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uncatalyzed reaction, therefore rendering this hypothesis improbable. The same holds 
true for a reaction pathway solely involving the conserved water molecule either via a 
concerted or stepwise deprotonation/protonation mechanism (Scheme 11IIB). This leaves 
only one other potential mechanism, involving both the conserved active site water and 
the catalytic residue E45 (Scheme 11IIC). QC/MM calculations established that, after back 
rotation, residue E45 repositions the conserved water molecule thus establishing a new 
hydrogen-bonding network that allows deprotonation of the 3-hydroxy group by the 
water molecule. The latter, in turn, transfers a proton to E45, which protonates the ligand 
at position C4 and yields the final reaction product AOCHC. This pathway is in good 
agreement with stereospecific pro-R-protonation of the C4-carbon as found by NOE 
(nuclear overhauser enhancement)-experiments and furthermore was found to be 
energetically most likely (EA = 9.2 kcal mol-1).  
In summary, the in silico-studies suggest that PhzF first employs acid/base catalysis 
involving the conserved catalytic residues E45 as proton shuttle to facilitate DHHA 
isomerization and then catalyzes stereoselective tautomerization of the reaction 
intermediate via a water-E45 relay. 
4.3. Conclusion 
This chapter focused on the isomerase PhzF, which functions as a key-enzyme within the 
phenazine biosynthesis pathway by converting trans-2S,3S-dihydro-3-hydroxyanthranilic 
acid (DHHA) into the highly reactive amino ketone 6-amino-5-oxo-2-cyclohexene-1-
carboxylic acid (AOCHC), the direct precursor for formation of the characteristic 
phenazine heterocycle.   
Previous data (Blankenfeldt et al., 2004) suggested that the enzyme employs a two step 
mechanism for DHHA isomerization: first, a [1,5]-hydrogen shift of a non-acidic proton 
along the cyclohexadiene ring-system and second, stereoselective tautomerization of the 
reaction intermediate to a ketamine product. However, the detailed mechanism of PhzF 
catalysis remained unclear. Therefore, different potential reaction pathways for both 
steps were hypothesized.   
The isomerization, for instance, might proceed either via a rare pericyclic reaction, which 
follows a concerted sigmatropic rearrangement of the proton from position C3 to position 
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C1, or PhzF might employ classic acid/base catalysis with the conserved active site residue 
E45 serving as proton shuttle. The subsequent tautomerization appears to be 
stereoselective, hence the question is whether this reaction is also facilitated by PhzF, e.g. 
via E45 or possibly by a conserved water molecule found in the active site.  
In a collaborative approach, comprised of QC/MM calculations (Martin Culka, University 
of Bayreuth), NMR-experiments (Mario Leypold, Graz University of Technology) as well as 
enzyme kinetic and X-ray crystallographic methods, the mechanistic details of PhzF 
catalysis were investigated.   
Primarily based on the computational calculations, a mechanism, in which PhzF first 
promotes DHHA isomerization by employing acid/base catalysis involving the conserved 
catalytic residues E45 as proton shuttle and subsequently catalyzes stereoselective 
tautomerization of the reaction intermediate via a water-E45 relay was proposed 
(Scheme 12).  
In order to support the theoretical studies, an enzymatic assay was specifically developed 
and allowed determination of a turnover rate kcat of 3.23 s-1 for DHHA isomerization. 
Furthermore, the calculations revealed that the isomerization step, with an energy barrier 
of 16 kcal mol-1, compared to EA = 9.2 kcal mol-1 for the tautomerization step, is rate 
limiting for PhzF catalysis and therefore should be susceptible for isotopic substitutions of 
the migrating proton by deuterium. NMR experiments and enzyme kinetics confirmed this 
theory, as the reaction rate was found to be decreased drastically when turnover of a C3-
mono-deuterated substrate isotopologue (d-DHHA) was analyzed.  
These results also account for a large primary kinetic isotope effect of 9.5 on kcat. The value 
is in the same order of magnitude as the one obtained from the in silico studies, although 
it has to be mentioned, that calculated intrinsic KIEs cannot directly be compared to the 
observed, apparent KIE. The latter involves contributions of all catalytic steps and not only 
of the rate-limiting one and hence the apparent KIE often appears smaller than the 
intrinsic one. Nevertheless, the dimension of the calculated/observed KIE hints towards 
tunneling contribution in PhzF catalysis.  
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Scheme 12: Overall reaction mechanism for PhzF catalyzed DHHA isomerization and subsequent keto-enol 
tautomerization to the highly reactive ketamine AOCHC.   
Zwitterionic DHHA is converted into AOCHC via a two-step mechanism: an initial base-catalyzed proton abstraction from 
position C3 (H) leads to formation of an anionic intermediate, which, after protonation, yields the reaction intermediate 
AHCDC. In the next step, this intermediate undergoes enzyme-catalyzed keto-enol tautomerization facilitated via an 
E45-water relay (H and H) to yield the final reaction product AOCHC. Figure adapted from Diederich et al., 2017. 
Beside these fundamental investigations, which were carried out in order to affirm the 
results of the QC/MM calculations, a variety of additional experiments were performed 
to explore PhzF catalysis further. pH- and temperature dependency measurements, for 
instance, revealed that PhzF has a rather narrow pH-optimum around pH 7.5, but remains 
active even at temperatures above 40 °C. This is particularly interesting, since the focus of 
this study was on the protein from the soil bacterium Pseudomonas fluorescens 2-79 
which has a temperature optimum at 28 °C. The data obtained at elevated temperatures 
additionally support the hypothesis that tunneling is involved in PhzF catalysis and suggest 
that cooperative effects could play a role in substrate binding and turnover. This 
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hypothesis is further supported as other active variants from mutagenesis studies also 
showed tendency to cooperativity. The substrate spectrum of PhzF was analyzed as well. 
Surprisingly, it was found that in addition to DHHA and its heavy isotopologue d-DHHA, 
PhzF is able to convert alkoxy-derivatives bearing a short alkyl-moiety at the 3-hydroxy 
group. For one of these alkoxy-derivatives, O-Et-DHHA, even a crystal structure in complex 
with the 2R,3R-enantiomorph could be obtained. Albeit PhzF can convert these short 
alkoxy-derivatives, the substrate spectrum of the enzyme seems to be narrow as a variety 
of other substrate analogs were not converted by PhzF. Yet, one of the tested compounds, 
ent-H2-DHHA, was identified as a potential PhzF-inhibitor. This molecule shows 
resemblance to the substrate. As such, substrate or product analogs might be developed 
into potent selective PhzF-inhibitors.  
All in all, the obtained data show that PhzF not only has a narrow pH-optimum and seems 
to be very sensitive to electronic alterations, e.g. by increasing ionic strength, but also that 
its active site promotes DHHA isomerization in a way that even "small" manipulations can 
lead to complete abolishment of catalytic activity. Together with the observed, narrow 
substrate spectrum, this finding points out that PhzF has evolved into a unique enzyme, 
perfectly adapted for the isomerization reaction of DHHA, which is crucial for phenazine 
biosynthesis.  
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CHAPTER II: 
Biochemical and biophysical characterization of PhzAB 
heterodimerization and its relevance for phenazine 
biosynthesis  
5. PhzAB heterodimerization 
Previous investigations revealed that, subsequent to PhzF catalysis, the next step of the 
phenazine biosynthesis pathway consists in the formation of the characteristic tricyclic 
"core" (Ahuja et al., 2004 and 2008). This step, which requires the symmetrical head-to-
tail double condensation of two identical, highly reactive ketamine precursor molecules, 
known as AOCHC, can proceed spontaneously in vitro. However, it was found to be 
catalyzed and thereby accelerated by the homodimeric enzyme PhzB in vivo (q.v. 
paragraph 1.3.2. and 5.2.1.). Beyond that, it was also discovered that among phenazine 
producing species, pseudomonads carry a second copy of the phzB gene, termed phzA, 
directly upstream in their highly conserved biosynthesis operon (phz-operon, Scheme 13). 
 
Scheme 13: Gene organization of the "core" phenazine biosynthesis cluster phzABCDEFG as found in the phz-operons 
from different Pseudomonas spp.  
The gene products of phzA and phzB (highlighted in darker blue) share a sequence identity of 69 % on the protein level 
and exhibit a high structural similarity. It is hypothesized that they might have arisen from ancient gene duplication. 
This enzyme was however found to be inactive in the condensation reaction, due to two 
active site mutations of the catalytic residues H73 and S77 to leucine. Nevertheless, the 
high sequence identity of 69 % between PhzA and PhzB as well as their structural 
similarity, which was uncovered from crystal structures of the two enzymes from 
P. fluorescens 2-79 (Ahuja, 2007), led to the hypothesis that both enzymes are not only 
found as homodimers, but could form heterodimers as well. Indeed, when co-expressing 
both genes, a heterodimeric protein could be isolated (Weikart, 2006) and its crystal 
structure solved. This raised questions on the physiological relevance of 
heterodimerization, i.e. whether a distinct advantage exists for phenazine biosynthesis 
when heterodimers rather than homodimers are formed, although the PhzA copy of the 
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protein was found to be inactive.   
A variety of crystal structures of the enzymes from P. fluorescens 2-79 and in particular 
B. cepacia R18194 in complex with different substrate and product analogs helped to 
understand the catalytic mechanism of PhzB, yet so far no basic enzymatic activity assay 
for determination of the kinetic reaction parameters was at hand. During this study, a new 
activity assay was developed and subsequently employed to measure and compare 
enzymatic activities of the different homo- and heterodimers. Furthermore, dimer 
stability and affinity towards previously identified PhzB ligands was evaluated using 
different biophysical methods. 
5.1. Specific Methods & Materials 
This study of the dimerization behavior of PhzAA, PhzBB and PhzAB from P. fluorescens 
2-79 is based on biochemical and X-ray crystallographic results from a number of previous 
bachelor, master and PhD theses within the group, mainly the work from Nadine Weikart, 
Sascha Fuchs, Ekta Ahuja, Arthur Porfetye, Christian Feiler and Yvonne Nerbl (Weikart, 
2006; Fuchs, 2006; Ahuja, 2007; Porfetye, 2009; Feiler, 2010; Nerbl, 2012). Furthermore, 
collaborators from the USA, Dimitri Mavrodi and Linda Thomashow, were investigating 
the abundance of PhzA/B homo-and heterodimers in vivo using RT-qPCR. Their results as 
well as the data from the other previous studies, especially the structural data including 
different apo and complex structures for PhzA, PhzB, and PhzAB from P. fl 2-79, will also 
be discussed in context of this work. 
5.1.1. Protein production 
The homodimeric protein PhzAA from Pseudomonas fluorescens 2-79 (UniProt-entry: 
Q51787 (PHZA_PSEFL)) was overexpressed from a pET15b expression vector (Novagen) in 
E. coli Rosetta2 (DE3) pLysS (Novagen) as described previously (Ahuja et al., 2004). The 
cells were grown in terrific broth medium at 20 °C o/n after induction with 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at an OD600 of 0.6. Purification of the N-
terminal hexahistidine-tagged protein followed standard procedures (as described in 
section 3 paragraph 3.2.3.), including stepwise immobilized Ni(II) affinity chromatography 
and a final size-exclusion chromatography step in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl. 
Overexpression and purification of PhzBB from P. fluorescens 2-79 (UniProt-entry: Q51788 
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(PHZB_PSEFL)) as well as of Phz(A)/B from Burkholderia cepacia R18194 (UniProt-entry: 
Q396C9 (Q396C9_BURL3)) followed the same procedures. Purified proteins were 
concentrated, snap-frozen in liquid nitrogen and stored at -80 °C until further usage.  
Heterodimeric PhzAB from P. fluorescens 2-79 was expressed and purified following 
methods similar to the ones described in Weikart (2006). In brief, the genes, phzA and 
phzB, encoding for the two proteins from P. fl 2-79 were cloned as a bicistronic gene 
construct phzAB into a modified pET19 expression system (Novagen). Co-expression of 
the two proteins, of which only PhzA carries an N-terminal hexahistidine-tag, was carried 
out in E. coli Rosetta2 (DE3) pLysS (Novagen) in TB-medium at 20 °C o/n after induction 
with 0.5 mM IPTG at an OD600 of 0.6. Protein purification followed a stepwise protocol; 
the initial immobilized Ni(II) affinity chromatography with a linear gradient to 250 mM 
imidazole resulted in the separation of two peaks, corresponding to PhzAB heterodimer 
and PhzAA homodimer. Pooled fractions containing PhzAB heterodimer were either 
directly applied to a HiLoad™ 26/600 Superdex™ 75 prep grade column for final size-
exclusion chromatography in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl or subjected to 
removal of the affinity tag by addition of tobacco etch virus (TEV) protease. After dialysis, 
a second Ni(II) affinity chromatography was performed in order to separate the TEV 
protease from the digested target protein. Cleaved protein-containing fractions were 
pooled and subjected to size-exclusion chromatography in 20 mM TRIS/HCl pH 8.0, 
150 mM NaCl. Cleaved and uncleaved proteins, termed HeteroPhzABcut and 
HeteroPhzAB respectively, were concentrated, snap-frozen in liquid nitrogen and stored 
at -80 °C until further usage. 
5.1.2. Coupled photometric assay 
Kinetic parameters for different PhzB para- and orthologues (all carrying an N-terminal 
hexahistidine-tag) were determined using a continuous photometric coupled enzyme 
assay in an Infinite® M200 microplate reader (Tecan Group Ltd.). In order to ensure that 
the coupled enzyme is not rate-limiting, control experiments with different 
concentrations of PhzF were carried out prior to all quantitative activity assays. If not 
explicitly stated otherwise, standard solutions contained 1 µM of the dimeric enzyme of 
interest (PhzA, PhzB, PhzAB, or BcPhz(A)/B), 1 µM (dimer) of the coupled enzyme PhzF 
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(from different species), and the substrate DHHA up to a final concentration of 1 mM in 
50 mM sodium phosphate buffer at pH 7.5 supplemented with 2 % (v/v) dimethyl 
sulfoxide (DMSO). All reactions were carried out in a final volume of 150 µL in UV-Star® 
96-Well microplates (Greiner Bio-One) at 25 °C. The enzymatic reaction was initiated by 
the addition of 75 µL of the pre-mixed enzyme solution to an equal volume of each 
substrate dilution and data were acquired in 40 s intervals over a 20 minutes time course. 
Increasing absorption of a metastable tricyclic phenazine intermediate, formed by 
oxidative decarboxylation downstream of the PhzB catalyzed condensation reaction, was 
followed at 330 nm. For background signal correction a reaction mixture lacking substrate 
was used. The background of the uncatalyzed auto condensation was evaluated using 
reaction mixtures lacking PhzB para- or orthologues. Reaction rates were determined 
from the slopes of the linear phase of each curve using a path length of 0.417 cm and an 
extinction coefficient of 2880 M-1 cm-1. This extinction coefficient at 330 nm was 
estimated from experimental data. Indeed, when following the kinetics of the reaction of 
PhzBB and HeteroPhzAB in presence of various substrate concentrations over 20 min, a 
plateau of the absorbance signal could systematically be observed indicating complete 
conversion of the substrate. Therefore, the maximal ΔA330 was plotted against the 
theoretical product concentration achievable given the starting substrate concentration 
and stoichiometry of the reaction ([S]/2). The data were fitted by linear regression yielding 
the aforementioned extinction coefficient.  
Kinetic parameters were obtained by fitting the averaged data from three independent 
measurements to the Hill-equation using GraFit 5 (Erithacus Software Ltd.). 
5.1.3. Circular dichroism spectroscopy 
Far ultraviolet (UV) spectra for all PhzB para- and orthologues, diluted to a final 
concentration corresponding to 1 mM amide bond, were recorded in standard assay 
buffer (50 mM sodium phosphate pH 7.5) at 10 °C in a JASCO J-815 spectropolarimeter in 
1 mm quartz cuvettes (Hellma analytics). Spectral data were collected in the range from 
260 to 190 nm in steps of 1 nm at 50 nm min-1 scanning speed and 8 s digital integration 
time (D.I.T.). Signal-to-noise correction was achieved by recording ten spectra per sample. 
For background/solvent correction, a buffer spectrum was recorded using the same 
experimental setup and the identical quartz cuvette.   
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Protein stability was addressed by recording melting/unfolding curves in the temperature 
range from 10 to 60 °C with 0.4 °C min-1 sampling rate at 212 and 222 nm; the bandwidth 
was 1 nm and the D.I.T. 16 s. For comparison of the data from different para- and 
orthologues, the measured molar ellipticity (Θ) in mdeg was converted to the mean 
residue ellipticity [Θ]MRW in deg cm2 dmol-1 (equation 15): 
Θ
fw = Θ × 0 ×  × 10 (15) 
with  
c protein concentration in M  
d path length in cm  
Naa number of amino acids per protein 
Melting temperatures (TM) in Kelvin were obtained by fitting the mean residue ellipticity 
data to a two state model using equation 16 in GraFit 5 (Erithacus Software Ltd.): 
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 (16) 
where  
y(T)  temperature dependent obtained value, here [Θ]MRW in deg cm2 dmol-1  
yN0  theoretical measure for native protein at 0 K  
yU0  theoretical measure for denatured protein at 0 K  
mN  baseline slope for the native state (K-1) 
mU  baseline slope for the unfolded/denatured state (K-1)  
ΔHD  van’t Hoff enthalpy for the unfolding transition (kJ mol-1)  
ΔCP  change in molar heat capacity (J mol-1 K-1), here empirically set to 6000 J mol-1 K-1  
R  gas constant for an ideal gas (kJ mol-1 K-1)  
T  measured temperature in K  
TM  melting temperature  
5.1.4. Microscale thermophoresis 
Affinity parameters for binding of phenazistatin A, a previously reported synthetic ligand 
and potential inhibitor for BcPhz(A)/B (Mentel et al., 2009a), to different N-terminally 
hexahistidine-tagged PhzB paralogues were determined using microscale thermophoresis 
(Wienken et al., 2010) with the protein intrinsic tryptophan fluorescence as molecular 
probe. Starting from either 160 µM (titration against PhzBB) or 4 mM (titration against 
HeteroPhzAB or PhzAA) phenazistatin A, a serial 1:1-dilution of the ligand in 20 mM 
TRIS/HCl pH 8.0, 150 mM NaCl, supplemented with 2 % (v/v) dimethyl sulfoxide (DMSO) 
was prepared. For titration series, 10 µL of each 2 µM protein stock solution (PhzBB, 
PhzAA or HeteroPhzAB) in the aforementioned buffer were mixed with 10 µL of each 
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dilution sample, yielding final protein concentrations of 1 µM and ligand concentrations 
starting from 80 µM or 2 mM in buffer containing 1 % (v/v) DMSO. The measurement was 
carried out at 25 °C in standard treated, zero background capillaries in a Monolith 
NT.LabelFree instrument (NanoTemper technologies) with 25 % LED power. After an 
initial delay of 5 s, the laser at 20 % MST power was switched on for 30 s. Back diffusion 
was recorded with a final laser-off time of 5 s. Binding parameters were obtained by fitting 
normalized, averaged data from three independent measurements to equation 17 using 
GraFit 5 (Erithacus Software Ltd.): 
 
^> =  
`]aa × "! +  
`]aa + 0 (17) 
with  
[L]bound  fraction of bound ligand  
[L]free  fraction of free ligand   
CB  binding capacity/amplitude   
KD  dissociation constant  
5.1.5. Crystallization and structure determination  
Crystallization experiments of heterodimeric PhzAB (HeteroPhzABcut) at 17 mg mL-1 were 
carried out via sitting-drop vapor diffusion method at room temperature in 96-well 
INTELLI-PLATES® (ARI) using the commercial JCSG CoreI-IV screening suites (QIAGEN). 
Drops consisted of 200 nL protein solution and 200 nL precipitant. Initial crystals grew 
within a week from a reservoir comprising 0.09 M HEPES pH 7.5, 1.26 M tri-sodium citrate 
and 10 % (v/v) glycerol. After further crystal growth for two additional weeks, crystals of 
a maximum size of 130*65*50 µm were soaked with 10 mM phenazistatin A (stock: 
100 mM in DMSO) in mother liquor supplemented with 25 % (v/v) glycerol for 2 h or o/n 
at room temperature.  
For other soaking experiments, crystals of native BcPhz(A)/B were regularly obtained at 
12 °C from a grid screen around the previously published condition (0.1 M Bis-TRIS pH 
6.1 – 6.7, 0.2 M ammonium acetate, 16 – 20 % (w/v) PEG 3350; Ahuja et al., 2008). 
Hanging drops, comprised of 1 µL protein solution (15 mg mL-1) and 1 µL precipitant 
solution were equilibrated against 500 µL reservoir. Crystals of an average dimension of 
120*120*100 µm, which appeared within a few days, were soaked in mother liquor 
supplemented with 25 % (v/v) glycerol and different concentrations (5, 10, 20, and 50 mM 
from aqueous stocks) of the two substrate analogs 3-oxo- or 2-amino-
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cyclohexanecarboxlic acid (3OCHCA/2ACHCA) at 12 °C overnight.  
Soaked crystals were mounted on a nylon loop and flash frozen in liquid nitrogen. 
Diffraction data were collected at 100 K at beamline MX BL14.1, BESSY II at the Helmholtz 
Centre Berlin (HeteroPhzAB in complex with phenazistatin A) or at beamline X06DA (PXIII) 
at the Swiss Light Source (SLS) of the Paul Scherrer Institute (BcPhz(A)/B complexes). Data 
reduction, structure refinement, and model building were carried out as described in 
paragraph 4.1.4. Ligand restraints where either downloaded from the Protein Data Bank 
(Berman et al., 2000), as in case of phenazistatin A and 3OCHCA (Ligand-IDs: AOD and 
3OC) or generated from SMILES-strings (2ACHCA) using the program phenix.elbow 
(Moriarty et al., 2009) of the PHENIX software suite (Adams et al., 2010). Structural 
flexibility was modelled using TLS refinement (Schomaker and Trueblood, 1968). In the 
last step of refinement, heteroatoms like waters and the ligand were attributed to the 
nearest TLS group using a script developed in the group (Reichelt and Blankenfeldt, 
unpublished). Final structure validation was done with MolProbity (Chen et al., 2010). Full 
data collection and refinement statistics are shown in Table A7 and A8 as well as Table 20. 
5.2. Results & Discussion 
5.2.1. Design of a coupled enzymatic assay 
In order to evaluate whether the heterodimerization of PhzA and PhzB is significant or 
even beneficial for substrate turnover - and hence for overall phenazine biosynthesis - a 
coupled enzymatic assay was established. This photometric assay constitutes a further 
adaptation of the activity assay previously developed for PhzF, the preceding enzyme in 
phenazine biosynthesis (q.v. chapter I). Multiple obstacles had to be overcome in the 
course of its development. Firstly, the reaction substrate AOCHC is a highly reactive amino 
ketone that could potentially react unspecifically with other primary amines such as the 
Nζ-atom of lysine. Hence, this instable molecule had to be generated in situ by using a 
coupled assay with the enzyme PhzF. Yet, even if unwanted side reactions with other 
primary amines could be limited by this method, auto condensation of two of these 
ketamine molecules, also leading to the reaction product hexahydro-phenazine-1,6-
dicarboxylic acid (HHPDC/HHPDC*), represented a perpetual problem that could not be 
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avoided. Consequently, this background reaction (Figure 27) had to be accounted for in 
every measurement.  
 
Figure 27: Auto condensation reaction of the highly reactive ketamine AOCHC.   
Substrate auto condensation, in dependency of the coupled enzyme (  = 1 µM PflPhzF,  = 1 µM BgluPhzFfull, 
 = 1 µM BgluPhzFΔ123,  = 2 µM PflPhzF), was followed at 330 nm by monitoring the formation of an oxidatively 
decarboxylated product downstream of the condensation reaction in 50 mM sodium phosphate buffer at 25 °C. The 
production rate dn/dt is plotted against the concentration of DHHA, the substrate of the coupled enzyme PhzF. The 
plotted curves are averaged data of three independent measurements. All data were normalized to zero. 
As illustrated in the plots in Figure 27, no difference could be observed in the AOCHC 
condensation rate, independent of the coupled enzyme used in the assay, i.e. PhzF from 
P. fluorescens 2-79 or both variants (full length and Δ123) of PhzF from 
Burkholderia glumae BGR-1. Even when increasing the concentration of one of these 
enzymes to 2 µM no increase in the auto condensation rate could be detected. This shows 
that all coupled enzymes are producing enough AOCHC not to be rate limiting for the auto 
condensation, which appears to be at its maximum rate under these conditions. This 
simplified background correction, as per substrate concentration a constant value could 
be subtracted from the PhzB-catalyzed reaction.  
The third complication of this assay setup was that HHPDC, the direct reaction product of 
the PhzB catalyzed AOCHC condensation, not only undergoes rearrangement to HHPDC*, 
but is also susceptible to oxidative decarboxylation in presence of molecular oxygen 
(Scheme 14). 
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Scheme 14: Reaction pathway within the coupled enzymatic assay employed for kinetic characterization of PhzB-
para- and orthologues.  
The continuous assay was designed in a way that PhzF as a coupled enzyme is generating the PhzB substrate AOCHC in 
situ from DHHA to avoid unfavored side reactions of this reactive molecule. AOCHC is then further converted by PhzB 
to initially form the direct condensation product HHPDC, which subsequently undergoes rearrangement, potentially 
also facilitated by PhzB, yielding HHPDC*. This rearrangement is assumed to prevent back hydrolysis of the direct 
reaction product HHPDC. The secondary reaction product of PhzB, HHPDC*, is susceptible to oxidative decarboxylation 
and hence under the assay conditions THPCA* is formed. Formation of this metastable intermediate is followed at 
330 nm. 
This phenomenon rendered direct monitoring of the reaction product impossible. Instead 
formation of the metastable intermediate after oxidative decarboxylation, tetrahydro-
phenazine-1-carboxylic acid (THPCA*), was followed at 330 nm. To minimize the potential 
influence of this enzyme-independent reaction on observed reaction rates, buffers and 
other assay solutions were not degassed and assay plates, used without lid, were shaken 
prior to each readout cycle to ensure availability of sufficient oxygen. 
Moreover, not only the experimental setup proved to be challenging, also data evaluation 
led to complications, since the proposed mechanism does not follow classical Michaelis-
Menten kinetics. Instead, it rather resembles a special case of a bisubstrate reaction 
where both substrates are identical. Consequently, none of the substrates could be 
applied in excess what would simplify data evaluation, as in such a case the Michaelis-
Menten equation could be used as approximation and the data fitted accordingly. 
Alternatively, another model to analyze PhzB catalysis is an ordered sequential bi-uni 
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mechanism as described in equation 18 or - with regard to the special case where the first 
and second substrate are identical, i.e. A = B - as shown in equation 19: 
 = c
 + C × ^c
 × $
 + ^$
 + 1
 
(18) 
 = *c
 + C × 'c
' + 'c
 + 1
 (19) 
with  
vmax  maximal turnover velocity   
Ka equilibrium constant for binding of the first substrate A (M) ≡ Ka1  
[A] concentration of the first substrate (M)  
Kia  inhibitory constant of the first substrate A on binding of the second one B (M)  
Kb equilibrium constant for binding of the second substrate B (M) ≡ Ka2  
[B] concentration of the second substrate (M) 
It is important to note that, although both substrates are identical, the respective 
equilibrium constants Ka1 and Ka2 (termed Ka and Kb in equation 18) are not the same, since 
the affinity constant for the "second" substrate Ka2 is dependent on binding of the "first" 
substrate.   
Despite the fact that this derived equation could easily be implemented in the program 
used for data analysis (GraFit 5, Erithacus Ltd.), fitting of the obtained kinetic data failed. 
Derivation of equation 19 leads to a binomial function of the type (ax²+bx+c), thus no 
simple linearization is possible and consequently no initial fitting estimates can be 
provided. However, as the obtained kinetic plots exhibited a slight sigmoidal progression 
curve, data fitting was carried out using the Hill-equation assuming cooperativity within 
an enzyme dimer might influence catalysis. Indeed, the curvature of the fit aligns well with 
the actual data points. Thus, the Hill-equation was used as approximation for further data 
analysis  
5.2.2. Catalytic activity of different PhzB para- and orthologues 
Having developed a suitable activity assay, determination of enzyme kinetic parameters 
for Phz(A)/B from B. cepacia R18194, the homodimers PhzAA and PhzBB from P. fl 2-79 as 
well as for the corresponding heterodimer PhzAB was carried out.   
As anticipated from previous studies (Ahuja et al., 2004; Fuchs, 2006; Ahuja, 2007) the 
PhzAA homodimer, which carries a variety of deleterious mutations compared to the 
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PhzBB homodimer (for details see the sequence alignment in Figure A11) showed no 
detectable activity in the assay (Figure 28).  
 
Figure 28: Enzyme kinetics for AOCHC condensation catalyzed by different PhzB para- and orthologues.   
Kinetic plots (rate v as a function of substrate concentration) showing the turnover of DHHA, the substrate of the 
preceding coupled enzyme PhzF monitored by following the increase in absorption at 330 nm of a spontaneously 
forming downstream intermediate of the condensation reaction in 50 mM sodium phosphate buffer pH 7.5. PhzF 
generates the PhzB substrate AOCHC in situ, which in turn is converted either by BcPhz(A)/B ( ), homodimeric PhzBB 
( ), or heterodimeric PhzAB ( ) from P. fl 2-79. Homodimeric PhzAA ( ) shows no catalytic activity for the condensation 
reaction. After normalization to zero and solvent/background correction, averaged data from three independent 
measurements were fitted according to the Hill-equation (—) using GraFit 5. All data were obtained at 25 °C. 
Inset: Close-up on the kinetic plots of the PhzBB and PhzAB catalyzed reaction for low substrate concentrations up to 
375 µM. Both dimers show similar turnover rates under these conditions.  
Indeed, when indirectly following product formation at 330 nm by monitoring the 
downstream intermediate of the condensation reaction, THPCA*, the level of this 
intermediate was similar to the uncatalyzed auto condensation (Figure A12A and B). 
Hence, it could be confirmed that PhzAA is catalytically inactive.  
In contrast to PhzAA, all other tested PhzB para- and orthologues showed catalytic activity 
in the enzymatic assay, but substrate turnover occurred at different rates (Figure 28 and 
Table 16). Comparing the maximum turnover rate vmax of these active enzymes revealed 
that BcPhz(A)/B is the slowest enzyme among the three, with a maximum velocity of 
10.3 nmol s-1 mg-1 and accordingly a turnover rate of 0.22 s-1. However, the apparent 
affinity of this enzyme for its substrate (K½ = 266 µM) is the highest in comparison to the 
other tested orthologues and hence the overall "catalytic efficiency", with a value of 
835 µM, is comparable to the one of the "faster" enzyme PflPhzBB (K½ = 797 µM). In fact, 
solely considering the maximum velocity, the homodimeric enzyme PhzBB was found to 
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be the fastest of the tested enzymes with a value of 27.8 nmol s-1 mg-1 for vmax, while the 
maximum velocity for PhzAB heterodimer was only 19.0 nmol s-1 mg-1 (Table 16).  
Table 16: Enzyme kinetic parameters for AOCHC condensation catalyzed by different PhzB para- and orthologues.* 
 vmax (nmol s-1 mg-1) kcat (s-1) K½ (µM) kcat/K½ (M-1 s-1) Hill-coefficient 
BcPhz(A)/B 10.3 ± 0.3 0.22 ± 0.01 266 ± 12 835 ± 46 1.37 ± 0.02 
HeteroPhzAB 19.0 ± 0.9 0.75 ± 0.03 522 ± 35 1444 ± 117 1.34 ± 0.03 
PhzBB 27.8 ± 2.3 0.58 ± 0.05 797 ± 83 731 ± 98 1.30 ± 0.02 
* The obtained values are averaged data of three independent measurements fitted to the Hill-equation. All data were obtained in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C, normalized to zero, and solvent/background corrected.  
Yet, when carefully analyzing the enzyme kinetic plots, it becomes evident that at lower 
substrate concentrations, i.e. up to 250 µM, all three studied enzymes exhibit comparable 
substrate turnover rates. In fact, for the homo- and heterodimer of the same species this 
tendency can even be observed up to a substrate concentration of 375 µM (Figure 28 
inset). This shows that, especially under substrate limitation, PhzAB heterodimers are as 
active as PhzBB homodimers. This trend is even more pronounced when, instead of 
comparing the maximum velocity, kcat is taken in account. Since kcat is a measure for 
catalytic activity per active site, the number of active sites per dimer has to be accounted 
for when analyzing the differences in enzymatic activity. PhzBB homodimers possess two 
active sites whereas PhzAB heterodimers feature only one. Consequently, the kcat-value 
for PhzBB is found to be only 0.58 s-1 compared to 0.75 s-1 for the heterodimer. 
Furthermore when taking the catalytic efficiency kcat/K½ into account, PhzAB heterodimers 
are found to be twice as efficient as PhzBB homodimers with kcat/K½-values of 1444 M-1 s-1 
and 731 M-1 s-1 respectively. The pronounced difference originates from the fact that the 
apparent substrate affinity (K½) is higher in PhzAB heterodimers than in active 
homodimers. This finding is particularly important at low substrate concentrations and 
can be explained by the peculiarity of the condensation reaction, i.e. that for generation 
of one molecule of HHPDC (or HHPDC*), two AOCHC molecules have to bind to the same 
active pocket of PhzB (Scheme 15 top). Indeed, a crystal structure of the enzyme from 
B. cepacia in complex with the substrate analog 3-oxo-cyclohexanecarboxylic acid 
(3OCHCA; PDB entry 3DLZ; Ahuja et al., 2008) revealed that two substrate molecules bind 
to each subunit and additionally suggested that one molecule binds tighter to the active 
site than the other (Scheme 15 bottom).  
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Scheme 15: PhzB-catalyzed double-condensation of the ketamine AOCHC.  
Top: Schematic representation of the PhzB- catalyzed condensation reaction. Two molecules of AOCHC undergo head-
to-tail condensation to yield the tricyclic HHPDC and two water molecules. Bottom: Structure of BcPhz(A)/B in complex 
with the substrate analog 3OCHCA as cartoon representation (PDB entry 3DLZ; Ahuja et al., 2008). Each monomer of 
the homodimer, shown in firebrick and skyblue, binds two molecules of 3OCHCA, depicted as balls and sticks in black, 
in its active site.  
In order to gain deeper insight into the different substrate binding modes, a series of 
soaking experiments of BcPhz(A)/B apo crystals with increasing concentrations (5, 10, 20, 
and 50 mM) of either 3OCHCA or another substrate analog, 2-aminocyclohexane-
carboxylic acid (2ACHCA) were carried out.  
As expected, Fourier-difference density (mFo-DFc) omit maps of the crystals soaked with 
50 mM 3OCHCA clearly show that the ligand is more tightly bound to the first binding site, 
which is closer to the interior of the protein. In fact, this tendency is more distinct the less 
compound was soaked, i.e. the occupancy for the ligand in the four binding sites decreases 
with decreasing ligand concentration (Figure 29A - D). At the same time, the average 
temperature factors of the ligand increase with reduced occupancy (Table A6 in 
appendix A2); the same holds true for crystal structures in complex with 2ACHCA  
(Figure A13). Although, it cannot be excluded that - in particular in crystals soaked with 
low ligand concentrations (5 mM) - acetate from the crystallization solution is occupying 
the second binding site rather than the substrate analog 3OCHCA (or 2ACHCA), for 
comparison of the soaking experiments with different concentrations, the ligand was built 
in all potential binding sites and its occupancy as well as its temperature factors (B-factors) 
refined. Furthermore, feature enhanced maps (FEM; Afonine et al., 2015) for the low 
concentration (5 mM) crystal structure give additional evidence that indeed the ligand 
and not acetate is at least partially occupying the second binding site (data not shown).  
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Figure 29: Crystal structures of BcPhz(A)/B in complex with the substrate analog 3OCHCA after soaking with increasing 
concentrations.  
Close-ups on the active site (chain B) of different BcPhz(A)/B complex structures each with two molecules of the 
substrate analog 3OCHCA bound to the active site. The structures were obtained after soaking of apo crystals with 
increasing concentrations of the analog overnight (A = 5 mM, B = 10 mM, C = 20 mM and D = 50 mM). The ligands as 
well as the coordinating active site residues are shown as ball and stick representation (* indicates that this residue is 
belonging to the second protein chain). The ligands are additionally depicted in their Fourier difference density (mFo-DFc) 
omit map contoured at 3σ in green. Hydrogen bonds (- - -) and coordinating water (red balls) are highlighted as well.  
Altogether, the results of these soaking experiments confirm that each subunit of an 
active PhzBB homodimer has one high- and one low affinity binding site. This means that 
for catalysis at first all high affinity binding sites (one in each monomer) will be loaded 
before substrate molecules will occupy the second binding site and generate a productive 
complex. As shown in detail in paragraph 5.2.4, the PhzA subunit of the heterodimer is 
not only catalytically inactive but, in addition, shows no or only very low affinity towards 
the tested ligand. Accordingly, a heterodimer is assumed to have only one catalytic center 
with a high- and low-affinity binding site. This also means that as soon as the high-affinity 
binding site is occupied the second molecule can bind to the low-affinity binding site to 
form a productive complex and lead to product formation. Hence, a lower effective 
substrate concentration is needed. This explains why PhzAB heterodimers are found to be 
more effective than homodimers in vitro. It also suggests an important role of the 
heterodimer in vivo, where phenazine biosynthesis is a coupled process, i.e. the substrate 
A B
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of PhzB is produced in dependence of the catalytic activity of the preceding enzymes and 
possibly does not reach the higher effective concentration needed for PhzBB-catalyzed 
condensation. 
In order to investigate whether further factors influence PhzB catalysis and to assess the 
accuracy of the previously obtained catalytic parameters, additional enzymatic assays 
were performed (Figure 30). For this second set of experiments, the catalytic efficiency of 
1 and 2 µM of each active dimer (BcPhz(A)/B, PhzBB, and PhzAB) was compared. 
  
Figure 30: Enzyme kinetics for AOCHC condensation catalyzed by 1 or 2 µM of different PhzB para- and orthologues. 
Kinetic plots (rate v as a function of substrate concentration DHHA = AOCHC) showing substrate turnover by following 
the increase in absorption at 330 nm of a spontaneously forming downstream intermediate of the condensation 
reaction. A 1 µM and B 2 µM of PhzF were added to generate the PhzB substrate AOCHC in situ, which in turn is 
converted by 1 µM BcPhz(A)/B ( ), 1 ( , ) or 2 µM ( , ) homodimeric PhzBB and 1 ( , ) or 2 µM ( , ) 
heterodimeric PhzAB from P. fl 2-79. After normalization to zero and solvent/background correction, averaged data 
from three independent measurements were fitted according to the Hill-equation (— and —) using GraFit 5. All data 
were obtained in 50 mM sodium phosphate buffer pH 7.5 at 25 °C. 
The kinetic parameters for 1 µM active PhzB para- and orthologues are in very good 
agreement with the parameters reported before (Table 16) and attest of the good 
experimental reproducibility (Table 17).  
Table 17: Enzyme kinetic parameters for the repeated analysis of AOCHC condensation catalyzed by different PhzB 
para- and orthologues at final enzyme concentrations of 1 and 2 µM.* 
 vmax (nmol s-1 mg-1) kcat (s-1) K½ (µM) kcat/K½ (M-1 s-1) Hill-coefficient 
1 µM BcPhz(A)/B 8.8 ± 0.2 0.19 ± 0.00 230 ± 9 822 ± 35 1.50 ± 0.03 
1 µM HeteroPhzAB 17.7 ± 0.5 0.70 ± 0.02 476 ± 19 1470± 70 1.36 ± 0.02 
1 µM PhzBB 27.4 ± 2.4 0.57 ± 0.05 688 ± 80 836 ± 122 1.38 ± 0.04 
2 µM HeteroPhzAB 13.6 ± 0.9 0.54 ± 0.04 451 ± 50 1190 ± 154 1.31 ± 0.05 
2 µM PhzBB 17.5 ± 3.2 0.37 ± 0.07 824 ± 210 445 ± 140 1.24 ± 0.06 
* The obtained values are averaged data of three independent measurements fitted to the Hill-equation. All data were obtained in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C, normalized to zero, and solvent/background corrected.  
However, using 2 µM of PhzAB heterodimer or PhzBB homodimer leads to an unexpected 
drastic decrease of the substrate turnover when compared to the setup using 1 µM of the 
respective dimer. At the same time, the magnitude of the equilibrium constant K½ was not 
A B
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exceptionally affected, however, its accuracy declined remarkably by a factor of two to 
three. A reduced turnover rate can be observed over the whole concentration range and 
thus might hint towards limited substrate availability or insufficient subsequent oxidative 
decarboxylation (Figure 30A).   
In order to assess the potentially limiting substrate availability and to exclude that the 
coupled enzyme is rate-limiting, additional coupled enzyme kinetic experiments with two 
concentrations of each PhzB dimer were performed in presence of 2 µM PhzF 
(Figure 30B). The results are comparable to the ones obtained in presence of 1 µM 
coupled enzyme and hence strongly suggest that in situ AOCHC production by PhzF is not 
rate-limiting (Table 18). 
Table 18: Enzyme kinetic parameters for PhzA/B catalyzed AOCHC condensation in presence of increased final 
concentration of the coupled enzyme PhzF.* 
2 µM PhzF vmax (nmol s-1 mg-1) kcat (s-1) K½ (µM) kcat/K½ (M-1 s-1) Hill-coefficient 
1 µM HeteroPhzAB 17.6 ± 4.3 0.70 ± 0.17 415 ± 145 1679 ± 717 1.32 ± 0.12 
2 µM HeteroPhzAB 16.6 ± 1.3 0.66 ± 0.05 628 ± 68 1047± 140 1.35 ± 0.05 
1 µM PhzBB 26.6 ± 0.9 0.56 ± 0.02 593 ± 25 940 ± 51 1.46 ± 0.02 
2 µM PhzBB 22.5 ± 4.1 0.47 ± 0.09 846 ± 214 557 ± 174 1.36 ± 0.07 
* The obtained values are averaged data of three independent measurements fitted to the Hill-equation. All data were obtained in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C, normalized to zero, and solvent/background corrected.  
Thus, evidence suggests that in fact oxygen availability is the main obstacle in these 
experiments. Although, the experimental setup was created in such way that oxygen 
availability was maximized, it cannot be excluded that under the aforementioned 
conditions it is not sufficient for a rapid oxidative decarboxylation. Consequently, the 
intermediate HHPDC* would accumulate and could undergo unspecific side reactions 
diverging from the route leading to the assay probe THPCA*. As such, the obtained data 
for 2 µM of the dimers should be considered with caution.  
5.2.3. Stability of the different PhzA/B dimers 
Although the enzyme kinetic data on their own strongly support the hypothesis that 
PhzAB heterodimers are the prevalent form in vivo, it is important to analyze if 
heterodimers are stable and do not spontaneously dissociate into PhzAA and PhzBB 
homodimers. In order to address this question, enzymatic assays were carried out 
whereupon, additionally to 1 and 2 µM of HeteroPhzAB, also mixtures of PhzAA and PhzBB 
homodimers were tested for catalytic activity. Mixtures of a 1:1 ratio of the two native 
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homodimers were prepared in such a way that 1 and 2 µM PhzAB heterodimers would be 
present in the assay solution if dimerization is dynamic.   
As seen in Figure 31, under the tested assay conditions no dynamic homo- and 
heterodimerization can be observed, as in this case the kinetic curves for native PhzAB 
heterodimers and mixed dimers, reconstituted from native homodimers, should be 
similar.  
 
Figure 31: Kinetic plots of the enzyme catalyzed condensation of AOCHC for evaluation of dimerization dynamics in 
PhzA/B homo- and heterodimers.   
In presence of 1 µM PhzF as coupled enzyme, PhzB catalyzed substrate turnover was followed via the increase in 
absorption at 330 nm of the downstream intermediate THPCA*. Kinetic plots (rate v as a function of substrate 
concentration DHHA = AOCHC) of the reaction catalyzed by 1 ( ) or 2 µM ( ) heterodimeric PhzAB from P. fl 2-79 or by 
1:1-mixtures of homodimeric PhzAA and PhzBB, theoretically yielding heterodimer concentrations similar to the native 
heterodimer (  = 1 µM;  = 2 µM), are presented. All date were normalized to zero and the solvent/background 
subtracted. Averaged data from three independent measurements were fitted according to the Hill-equation (—) using 
GraFit 5. All data were obtained in 50 mM sodium phosphate buffer pH 7.5 at 25 °C. 
Instead, substrate turnover for the mixture shows a remarkable decrease in comparison 
to the one corresponding to the heterodimer (Table 19).  
Table 19: Kinetic parameters for AOCHC condensation catalyzed by native PhzAB heterodimers or 1:1 mixtures of the 
respective, native homodimers.* 
 vmax (nmol s-1 mg-1) K½ (µM) Hill-coefficient 
1 µM HeteroPhzAB 15.4 ± 0.7 317 ± 26 1.52 ± 0.10 
2 µM HeteroPhzAB 18.5 ± 1.7 653 ± 103 1.26 ± 0.08 
1 µM PhzAA:PhzBB (1:1) 12.2 ± 1.3 374 ± 57 1.55 ± 0.14 
2 µM PhzAA:PhzBB (1:1) 12.3 ± 1.0 572 ± 68 1.34 ± 0.04 
* The obtained values are averaged data of three independent measurements fitted to the Hill-equation. All data were obtained in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C, normalized to zero, and solvent/background corrected.  
This observation can logically be explained by the fact that within the enzyme mixtures, 
the actual concentration of the active homodimer PhzBB is only half the one of the 
theoretically reconstituted heterodimer, i.e. 0.5 or 1 µM respectively. As the remaining 
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PhzAA homodimer was found to be inactive, the turnover rate is reduced.  
In addition, doubling of the enzyme concentration again led to a decrease in catalytic 
efficiency, i.e. substrate turnover is less efficient when 2 µM heterodimer or 2 µM of the 
mixture (accordingly 1 µM PhzBB) are used in the assay. Although attempts to address 
this observation were made before (q.v. paragraph 5.2.2.), it is especially surprising for 
the 2 µM mixture. This mixture comprises 1 µM PhzBB homodimer and as such should 
yield similar progression curves as 1 µM heterodimer (cf. Figure 28). As with doubled 
enzyme concentration, also larger values of the equilibrium constant K½ were obtained 
for both the heterodimer and the mixture, a possible explanation could be that PhzA 
subunits bind the substrate (or other intermediates and products of the reaction), too, 
thus reduce the levels of free substrate and hence interfere with the condensation 
reaction. Yet, this behavior was not observed in experiments using PhzAB dimers before 
(cf. paragraph 5.2.2.) and binding data as well as a crystal structure (see paragraph 5.2.4.) 
do not support this mechanism. 
Although the kinetic data alone implicate that heterodimers - once formed - are stable, 
dimer stability was additionally addressed by recording melting curves using CD 
spectroscopy. As verified by standard CD spectra that were recorded prior to the unfolding 
experiment, all four PhzB para- and orthologues, BcPhz(A)/B, PhzBB, PhzAA and 
HeteroPhzAB, are correctly folded (Figure 32). 
  
Figure 32: Structural integrity and thermal stability of different PhzB para- and orthologues.  
A Far-UV CD spectra of BcPhz(A)/B (), HeteroPhzAB w/ () and w/o N-terminal hexahistidine-tag (), PhzBB () and 
PhzAA () dimers obtained at 10 °C in 50 mM sodium phosphate pH 7.5. B Melting curves of the PhzB para- and 
orthologues (colors according to plot A) recorded within a temperature range from 10 to 60 °C using the CD signal at 
222 nm. The signal was converted to mean residue ellipticity [Θ]MRW and plotted against the temperature T (°C).  
Furthermore, the spectral data in Figure 32A show no major difference between a 
hexahistidine-tagged and tag-free HeteroPhzAB dimer, hence it appears that the N-
A B 
Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 5. PhzAB heterodimerization 
115 
terminal His6-tag does not significantly affect dimer stability. Likewise, the spectra show 
that the organization of secondary structure elements of PhzAB heterodimers and PhzBB 
homodimers is very similar. Both enzymes resemble a typical mixed α-β-type. This 
observation is in good agreement with previously obtained crystal structures (Ahuja et al., 
2004; Ahuja, 2007; Porfetye, 2009).  
Based on these findings, melting curves were determined at two different wavelengths, 
222 and 212 nm as shown in Figure 32B and Figure A14 (appendix A2) respectively. The 
calculated melting temperatures revealed that the enzyme from B. cepacia R18194, with 
an average melting temperature of 43.8 °C, is less stable than the similar homodimer from 
P. fluorescens 2-79 (TM (Ø) = 48.6 °C), while the heterodimer of the latter species shows 
no significant difference in thermal stability (TM (Ø) = 48.8 °C). The PhzAA homodimer is 
found to be less stable enzyme, with an average melting temperature of 40.4 °C. This 8 K 
lower stability suggests that PhzAA homodimers are unlikely to be found in vivo. Since 
heterodimers appear as stable as active homodimers, this result provides additional 
evidence that in fact heterodimers could be the predominant dimerization form in 
P. fluorescens 2-79 in vivo.  
5.2.4. One or two? – A closer look at active site(s) of PhzAB heterodimers 
In order to verify the assumption that the A subunit of PhzAB is not only catalytically 
inactive, but cannot bind substrate molecules either, binding experiments of PhzAA and 
PhzBB homodimers as well as of PhzAB heterodimers were carried out. Originally, 
isothermal titration calorimetry (ITC) was chosen for this purpose. However, initial 
experiments yielding no interpretable binding information revealed that the 
aforementioned enzymes are not compatible with this method. This unusual behavior was 
also reported previously (Porfetye, 2009) and presumably is an intrinsic property of these 
enzymes. Instead, affinity parameters for a known PhzB ligand (phenazistatin A) were 
determined for either of the dimers from P. fluorescens 2-79 using microscale 
thermophoresis (MST). As the dissociation constant for its complex with phenazistatin A 
was known from previous ITC experiments, the homodimeric enzyme from B. cep R18194 
was supposed to serve as internal reference, however it proved to be incompatible with 
the MST setup. Hence, only the three dimers of interest were analyzed using this method. 
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Figure 33 shows that, among the tested paralogues, the active homodimer PhzBB has the 
highest affinity towards phenazistatin A (KD = 1.47 µM). 
 
Figure 33: Affinity titrations of phenazistatin A to different PhzB paralogues from P. fluorescens 2-79.   
Microscale thermophoresis measurements of 80 µM PhzBB () and each 2 mM PhzAA () and PhzAB () incubated with 
the indicated concentrations of Phenazistatin A were carried out in 20 mM TRIS/HCl pH 7.5, 150 mM at 25 °C. The 
protein intrinsic tryptophan fluorescence was used as molecular probe. All data were normalized and the averaged 
values from three independent measurements fitted according to a two-state-model (—) using GraFit 5. 
Since MST measurements for the known phenazistatin A binding protein BcPhz(A)/B 
failed, this value cannot be compared to the known affinity of 64 nM, however it suggests 
that binding of phenazistatin A to PhzBB is less strong than binding to the enzyme from 
the Burkholderia species. This is also in good agreement with the kinetic data (q.v. 
paragraph 5.2.2.), which showed that the enzyme from B. cep R18194 has a three-fold 
higher apparent affinity for its substrate than the enzyme from P. fl 2-79 (approximately 
250 and 800 µM respectively).   
The KD of phenazistatin A for the inactive PhzAA was found to be ≥ 2 mM (2.25 mM) and 
thus more than three orders of magnitude higher than for the corresponding active 
paralogue PhzBB. This indicates that, besides lacking catalytic activity, binding of 
substrates to the PhzAA homodimer might be drastically impaired as well. Finally, the KD 
for the PhzAB heterodimer is 162 µM. Although this value is also two orders of magnitude 
higher than the one for the PhzBB homodimer, it can be explained by the fact that this 
observed KD represents an average KD of the high affinity binding site in the active B-
subunit and the very weak-affinity binding site in the inactive A-subunit. Indeed, the plot 
in Figure 33 for the PhzAB heterodimer shows a small double transition curve with a step 
KD () = 1.47 ± 0.27 µM 
KD () = 162.40 ± 15.08 µM 
KD () = 2.25 ± 0.67 mM 
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~1-2µM (arrow), but this is mostly "masked" by the weak binding event of the ligand to 
the A-subunit.  
In addition, biochemical activity assays and IC50 determinations with the potential 
inhibitor phenazistatin A were carried out. Although, these results will only be presented 
in the next chapter (chapter III), it can already be stated, that they are in good agreement 
with the binding data. 
In order to analyze binding of phenazistatin A to the PhzAB heterodimer further, co-
crystallization experiments with HeteroPhzABcut were carried out. The structure of the 
complex could be solved at 1.53 Å resolution using molecular replacement with the 
previously obtained apo structure (Blankenfeldt et al., unpublished) as a search model 
(Figure 34 and Table 20).   
The heterodimer crystallized in space group P1 with two heterodimers in the asymmetric 
unit. These two heterodimers are related by non-crystallographic two-fold symmetry 
(Figure 34A). After soaking with 10 mM of the ligand for 2 h, positive difference electron 
density (mFo-DFc), which is exclusively observed in the active site of B-subunits of the 
heterodimer, was attributed to the presence of phenazistatin A (Figure 34B and C). 
Moreover, since the diffraction data were collected at a wavelength corresponding to the 
K-edge of bromine, the anomalous signal, again only found in the B-subunits of the 
protein, allowed unambiguous positioning of the Br-atom of phenazistatin A (Figure 34D). 
Analysis of the binding site reveals that the ligand is bound in a very similar way as 
reported previously for the Burkholderia enzyme (PDB entry: 3JUM; Mentel et al., 2009), 
i.e. mainly via its carboxylic acid moieties. The carboxylic acid group attached to the 
aromatic ring of the ligand is coordinated by Q144, as well as R160*, the C-terminal 
arginine from the A-subunit, and a water molecule, which in turn is stabilized via hydrogen 
bond to Y117 and E137. This glutamate further accepts a hydrogen bond from the bridging 
amino group of phenazistatin A. The second carboxylate of the ligand is primarily 
stabilized via a salt bridge to the guanidine moiety of R38. Further hydrogen bonds 
stabilizing this group are involving the hydroxyl-group of S74 and two additional water 
molecules. 
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Figure 34: Crystal structure of the PhzAB heterodimer from P. fluorescens 2-79 in complex with the potential inhibitor 
phenazistatin A.  
A Surface representation of two PhzAB heterodimers as found in the asymmetric unit of the crystal. The A-subunits are 
colored in deepteal and palecyan respectively, while the B-subunits are shown in raspberry and lightpink. B The two 
PhzAB heterodimers of the asymmetric unit are shown as cartoon representation with the active site residues of all 
subunits highlighted as balls and sticks (colors as described previously). Additionally, the ligands Fourier difference 
density (mFo-DFc) omit map contoured at 3σ is shown in green. C Overall view of a PhzAB heterodimer and D close-up 
on the active site of the B-subunit with the ligand highlighted as balls and sticks in dark gray and the anomalous map 
for the bromine atom countered at 8σ shown in purpleblue. The protein is again shown as cartoon and the active site 
residues as balls and sticks colored in a similar way as described before. 
Analysis of the active site pocket using the program KVFinder (Oliveira et al., 2014) 
revealed that the pocket in the B-subunit of the heterodimer has a volume of ~500 Å³ and 
as such is 60 Å³ smaller than the one in BcPhz(A)/B. Interestingly the pocket in the inactive 
A-subunit is way larger with a volume of 765 Å³. This difference is mainly due to a 
substitution of tyrosine 117 to cysteine in PhzA and the displacement of the C-terminus 
leading to an opening of the pocket (Figure A15 in appendix A2). Consequently, less 
hydrogen bonds for stabilization of the ligand can be established and thus no binding of 
phenazistatin A to the A-subunit can be observed. 
A B 
C 
D
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Table 20: Data collection and refinement statistics for HeteroPhzABcut (P. fl 2-79) in complex with phenazistatin A.ǂ 
 Complex with phenazistatin A 
Data collection1  
Beamline† MX BL14.1, BESSY II 
Wavelength (Å) 0.91841 
Resolution range (Å) 49.63 – 1.53 (1.56 – 1.53) 
Space group P1 
unit cell dimensions  
a, b, c (Å) 46.03, 55.61, 65.45 
α, β, γ (°) 72.00, 70.73, 65.65 
Mosaicity (°)‡ 0.20 
Measured reflections 156883 (7859) 
Unique reflections 79502 (3896) 
Multiplicity 2.0 (2.0) 
Mean I/σ(I) 9.8 (2.0) 
CC1/2* 0.996 (0.567) 
Completeness (%) 96.4 (95.1) 
Rmeas
§ 8.1 (62.8) 
Rp.i.m.
¶ 5.5 (42.6) 
  
Refinement  
Resolution range (Å) 49.63– 1.53 (1.55 – 1.53) 
Rcryst (%) 18.00 (28.12) 
Rfree (%) 20.26 (30.90) 
No. of non H-atoms  
    Protein 5083 
    Ligand / Ion 40 
    Water 602 
Average B-factors (Å²)  
    Protein 17.6 
    Ligand / Ion 13.3 
    Water 30.3 
R.m.s deviations  
    Bond lengths (Å) 0.009 
    Bond angles (°) 0.902 
Ramachandran plot (%)  
   Favored regions 98.9 
   Outliers 0 
MolProbity score # 1.14 
ǂValues in parentheses are for the highest resolution shell - 
1 The dataset was collected from a single crystal.  
† BESSY II: Berlin Electron Storage Ring Society for Synchrotron Radiation, Helmholtz Centre Berlin, Berlin, Germany.  
‡ Mosaicity values reported by XDS (Kabsch, 2010).  
* CC1/2 is the correlation coefficient between two random half datasets (Karplus and Diederichs, 2012)  
§	a? = ∑ nIℎL/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|C123 /∑ ∑ gCC123 IℎL, where N(hkl is the number of observations of the reflection with 
  index hkl and Ii(hkl) is the intensity of its ith observation (Diederichs and Karplus, 1997);   
¶	t.C.. = ∑ n1/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|/∑ ∑ gCIℎLC123C123  (Weiss, 2001)  
# As reported by MolProbity (http://molprobity.biochem.duke.edu/ (Chen et al., 2010) 
Overall, the binding data as well as the new crystal structure support the hypothesis that 
PhzAB heterodimers indeed have only one active site, which provides them with an 
advantage over PhzBB homodimers especially under substrate limitations. At the same 
time, since PhzAB heterodimers feature only one active site (B-subunit) that binds 
substrates or other ligands such as the inhibitor phenazistatin A a lower effective 
concentration of this inhibitor will be needed to suppress Phz(A)/B activity (see also 
paragraph 6.2.2.). 
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5.2.5. Addressing a potential protein-protein interaction between the two subsequent 
enzymes of phenazine biosynthesis, PhzF and PhzB  
Several steps of phenazine biosynthesis involve instable intermediates. One of these is the 
product of the isomerase PhzF, AOCHC. This highly reactive amino ketone undergoes not 
only PhzB-catalyzed or uncatalyzed condensation to the tricyclic phenazine precursor 
HHPDC, but is also expected to unspecifically react with other free primary amines. In 
order to reduce or even circumvent these unfavored side reactions, nature might have 
developed different strategies such as the formation of protein-protein complexes 
between the two consecutive enzymes PhzF and PhzB to facilitate direct transfer of the 
instable intermediate between the two active sites without releasing it to the 
environment.   
In order to probe whether PhzF and PhzB and/or the respective dimers form protein-
protein complexes, a variety of experiments such as affinity titrations via ITC, analytical 
size-exclusion chromatography (SEC) or dynamic light scattering (DLS) were carried out. 
However, none of these studies yielded any evidence for the presence of such complexes 
in vitro (data not shown). Yet, it might be possible that these multiprotein complexes form 
only transiently and in presence of the intermediate AOCHC. To test this hypothesis, 
enzymatic assays were carried out whereupon PhzF – as the coupled enzyme - and PhzB-
orthologues from two different species, namely P. fluorescens and Burkholderia spp., were 
alternatively combined and the mixtures’ catalytic efficiencies, regarding formation of the 
tricyclic phenazine precursor HHPDC (and accordingly THPCA*), compared (Table 21 and 
Figure 35). It is assumed that enzymatic turnover of AOCHC is only accelerated if a 
favorable interaction between the two enzymes of the same species is established. In that 
case AOCHC would be directly transferred from one active site (PhzF) to the next one 
(PhzB) instead of being released in the environment. The results of experiments with PhzF 
from P. fluorescens 2-79 in combination with both PhzB orthologues were already 
discussed in a previous paragraph (paragraph 5.2.2.). Yet for better comparison, they are 
also shown in Figure 35 together with the data obtained when using PhzF from B. glumae 
BGR-1 as coupled enzyme.  
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Table 21: Enzyme kinetic parameters for AOCHC condensation catalyzed by two different PhzB orthologues in 
dependency of the origin of species of the coupled enzyme PhzF.* 
 kcat (s-1) K½ (µM) kcat/K½ (M-1 s-1) Hill-coefficient 
PflPhzF 
BcPhz(A)/B 0.22 ± 0.01 266 ± 12 835 ± 46 1.37 ± 0.02 
PhzBB 0.58 ± 0.05 797 ± 83 731 ± 98 1.30 ± 0.02 
BgluPhzF 
BcPhz(A)/B 0.18 ± 0.01 231 ± 15 792 ± 59 1.54 ± 0.08 
PhzBB 0.62 ± 0.08 907 ± 168 687 ± 155 1.24 ± 0.05 
BgluPhzFΔ123 
BcPhz(A)/B 0.19 ± 0.01 233 ± 14 832 ± 63 1.73 ± 0.07 
PhzBB 0.44 ± 0.04 593 ± 74 751 ± 120 1.39 ± 0.04 
* The obtained values are averaged data of three independent measurements fitted to the Hill-equation. All data were obtained in 50 mM sodium 
phosphate buffer pH 7.5 at 25 °C, normalized to zero, and solvent/background corrected.  
Furthermore, not only full length BgluPhzF was used in these studies, but also the isolated 
isomerase domain BgluPhzΔ123 (for details see chapter I, paragraph 4.2.5.). The idea 
behind the usage of these two variants was to figure out whether the additional non-
isomerase domain of the enzyme from the Burkholderia species plays a specific role in a 
potential protein-protein interaction or influences PhzB catalysis by other means. 
 
Figure 35: Kinetic plots of the enzyme catalyzed condensation of AOCHC by two PhzB orthologues in dependency of 
the origin of species of the coupled enzyme PhzF.  
Following the increase in absorption at 330 nm of the downstream intermediate THPCA*, PhzB catalyzed substrate 
turnover is visualized in kinetic plots (rate v as a function of substrate concentration DHHA = AOCHC). The PhzB substrate 
AOCHC is generated in situ by 1 µM of the coupled enzyme PhzF, either from P. fluorescens 2-79 ( ; ) or B. glumae 
BGR-1 ( ;  = full length protein; ;  = isolated isomerase domain) and in turn converted by 1 µM BcPhz(A)/B (circles) 
or 1 µM (squares) homodimeric PflPhzBB. The data were normalized to zero and solvent/background corrected. 
Averaged data from three independent measurements were fitted according to the Hill-equation (— = PflPhzF and 
— = BgluPhzF) using GraFit 5. All data were obtained in 50 mM sodium phosphate buffer pH 7.5 at 25 °C. 
However, as shown in Figure 35 and Table 21, no matter which PhzF/PhzB protein-protein 
combination was tested, no significant difference in the enzyme kinetic parameters could 
be observed, all values were within the range of their standard deviation.   
Hence, also the kinetic data cannot positively confirm that PhzF and PhzB form a 
multiprotein complex in order to optimize phenazine biosynthesis. Yet, since all previously 
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described data were only obtained with isolated enzymes in vitro, it cannot fully be 
excluded that complex formation might occur in vivo - potentially even assisted by an 
additional interaction partner - and thereby assist in efficient phenazine production. 
5.3. Conclusion 
Based on the previously identified catalytic mechanism of PhzB (Ahuja et al., 2008) and 
the description of its role in phenazine biosynthesis a coupled enzymatic assay was 
developed to further characterize this enzyme. Not only kinetic parameters regarding the 
head-to-tail double condensation of the ketamine substrates should be studied, but also 
in particular the occurrence of different dimeric enzyme species in pseudomonads, one 
group of phenazine producing bacteria. Indeed, it was found that Pseudomonas spp. carry 
a second copy of the phzB-gene called phzA in their genome. Previous data as well as 
experiments undertaken in this study showed that this copy is catalytically inactive in the 
condensation reaction. In addition, quantitative real-time PCR experiments from 
collaborators (Dimitri Mavrodi and Linda Thomashow, unpublished) revealed that, at least 
in Pseudomonas fluorescens 2-79, only one transcript of the phz-operon can be found. 
This suggests simultaneous translation of the resulting full length mRNA, leading to similar 
protein levels in the cell. This raised the question about the biological role of PhzA, 
especially in P. fluorescens, as it seems energetically unfavorable that nature spends 
metabolic resources for production of an inactive "enzyme". However, from a closer look 
at the two gene products, it becomes clear that the resulting proteins share a high 
sequence similarity of almost 70 % and as such, it is not surprising that they also exhibit a 
high structural similarity (Ahuja, 2007). This peculiarity in mind and knowing that all other 
enzymes of the "core" phenazine biosynthesis pathway are active dimers, it was 
hypothesized that PhzA and PhzB form PhzAB heterodimers.  
Indeed, after heterologous co-expression of both genes simultaneously in E. coli, a PhzAB 
heterodimer could be isolated (Weikart, 2006) and even crystallized (Blankenfeldt et al., 
unpublished). Yet, a more detailed biochemical and biophysical characterization of this 
heterodimer was lacking, especially regarding its enzymatic activity in comparison to 
PhzBB homodimers. To this aim, a new activity assay was developed and used for enzyme 
kinetic experiments. These experiments resulted in the finding that in fact PhzAB 
heterodimers are, regarding their turnover rate, more active (higher kcat-value), but also 
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overall more efficient in catalysis (larger kcat/K½-values) than PhzBB homodimers, 
especially at low substrate concentrations (Figure 36).  
  
Figure 36: Direct comparison of the key kinetic parameters kcat and kcat/K½ for different PhzB para- and orthologues.  
A Comparison of the catalytic turnover rate (kcat) for heterodimeric PhzAB (  = 1 µM;  = 2 µM), homodimeric PhzBB 
(  = 1 µM;  = 2 µM) and BcPhz(A)/B (  = 1 µM). B Overall catalytic efficiency kcat/K½ compared for different PhzB 
para- and orthologues. (color scheme as described in A). The data were normalized to zero and solvent/background 
corrected. Averaged data from three independent measurements were fitted according to the Hill-equation using GraFit 
5. All data were obtained in 50 mM sodium phosphate buffer pH 7.5 at 25 °C. 
Together with the observation that the heterodimer is as stable as the PhzBB homodimer 
and both show an increased stability of 8 °C in comparison to the inactive homodimer 
PhzAA, these data strongly support the hypothesis that PhzAB heterodimers might be the 
prevalent form in vivo. However, it cannot fully be excluded that also PhzBB homodimers 
are present under physiological conditions or that pseudomonads can switch between 
production of homo- and heterodimers. Since the homodimers carry two active sites each 
baring two substrate-binding sites, the maximal catalytic velocity (vmax) that can be 
reached is higher. This might especially be important at higher substrate levels as the 
substrate AOCHC is highly reactive and thus unfavored side reactions, which might be 
harmful to the phenazine producer itself, could be minimized.  
In addition to the kinetic characterization of PhzB para- and orthologues, binding studies 
and crystallographic experiments were carried out. The purpose of these experiments was 
mainly the characterization of the interaction between a previously identified synthetic 
Phz(A)/B ligand, called phenazistatin A, and the homodimeric proteins PhzAA and PhzBB 
or the PhzAB heterodimer. In line with previously made mechanistic assumptions, the 
absence of a ligand in the inactive A-subunit of the heterodimer crystal structure 
confirmed that specific ligands can only bind to active B-subunits. This study also revealed 
A B
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phenazistatin A as a promising starting point for further inhibition studies (as discussed in 
detail in the next chapter), since it binds very tightly to PhzBB homodimers (KD ~1.5 µM).  
Furthermore, it is not yet fully understood how phenazine-producing organisms ensure 
efficient condensation of the highly reactive amino ketone substrate while limiting its 
potentially harmful side reactions. A proposed mechanism of a direct interaction between 
the two subsequent enzymes in the biosynthesis pathway, PhzF and PhzB, could not be 
detected so far, although it cannot be ruled out that additional partners are involved in 
vivo. This hypothesis and the actual in vivo abundance of homo- and heterodimers have 
to be evaluated further, for example using additional techniques such as proteomics. 
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CHAPTER III: 
Triggering self-intoxication – Development of synthetic 
PhzB product analogs into inhibitors of phenazine 
biosynthesis 
6. PhzB-inhibitors 
Phenazines, such as the blue pigment pyocyanin produced by the human pathogen 
Pseudomonas aeruginosa, are important virulence factors in nosocomial infections. 
Hence, their biosynthesis is a potential drug target to fight infectious diseases caused by 
phenazine producing pathogens. Phenazine biosynthesis is characterized by five enzyme-
catalyzed steps leading from chorismate to formation of two core phenazines, dihydro-
phenazine-1-carboxylic acid (DHPCA) or dihydro-phenazine-1,6-dicarboxylic acid (DHPDC) 
(cf. paragraph 1.2.2.). One step catalyzed by the small dimeric protein PhzB (q.v. 
chapter II) involves the symmetrical head-to-tail double condensation of two identical 
ketamine precursor molecules. For mechanistic studies of this reaction, a variety of 
substrate and product analogs were synthesized. Specifically, two classes of these 
analogs, termed "mavericks" and "phenazistatins", turned out to bind the enzymes from 
B. cepacia and P. fluorescens tightly, i.e. in low µM- or even nM-range. Despite having 
some preliminary binding data (Mentel, 2008), no information was available for these 
ligands regarding their inhibitory potency in vitro or in cellulo.   
In order to conduct a comprehensive structure-activity-relationship study, a new library 
composed of approximately 80 compounds was synthesized and about ⅓ of these ligands 
were analyzed in binding assays using isothermal titration calorimetry (ITC). In addition, 
the binding mode of several ligands to the active site of Phz(A)/B from B. cep R18194 was 
revealed by X-ray crystallography. The inhibitory potency of the complete library was also 
evaluated using a newly developed enzyme inhibition assay allowing rapid screening of 
this large number of compounds.  
A selection of the most promising compounds together with bioisosteres and prodrug 
esters was analyzed regarding their efficacy for reduction of pyocyanin levels in 
Pseudomonas aeruginosa cultures.  
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6.1. Specific Methods & Materials 
The investigation of potential PhzB-inhibitors is based on previous data, in particular the 
work from Matthias Mentel (Mentel, 2008; Mentel et al., 2009a and 2009b). Some 
experiments were carried out in collaboration with other groups: Florian Gräf, a PhD 
student in the group of Prof. Dr. Claus-Michael Lehr from the Helmholtz Institute for 
Pharmaceutical Research Saarland, evaluated membrane permeability of some of the 
identified inhibitors. The in cellulo compound screening was carried out in collaboration 
with the group of Prof. Dr. Rolf Hartmann of the same institute based on an assay 
developed by Dr. Christine Maurer and with special assistance by Antonio Martins.   
Finally, the work from Jakob Pletz from the group of Prof. Dr. Rolf Breinbauer at the Graz 
University of Technology deserves a special mentioning as he synthesized the majority of 
the compounds tested in the course of this study.   
Parts of their data and results will be presented within the framework of this thesis 
without discussing their employed experimental techniques.  
6.1.1. Protein production 
The dimeric enzymes, BcPhz(A)/B, PhzBB and HeteroPhzAB were produced as described 
in the previous chapter (paragraph 5.1.1.). The coupled enzyme PhzF was expressed as 
presented in paragraph 4.1.1 in chapter I.  
6.1.2. Isothermal titration calorimetry 
Affinity titrations were carried out at 25 °C using a MicroCal™ VP-ITC System (GE 
Healthcare, now Malvern Instruments). In all experimental setups, the sample cell 
contained BcPhz(A)/B at a final concentration of 100 µM (active site) in 20 mM TRIS/HCl 
pH 8.0, 150 mM NaCl. After an initial delay of 60 s, the protein was titrated with 2 mM 
ligand prepared either from aqueous (10 mM in 200 mM TRIS/HCl pH 9.0) or from DMSO 
(200 mM) stock solutions. If residual DMSO (up to 1 % (v/v)) was present in the syringe, 
the same amount was added to the sample cell to ensure buffer homogeneity. Using 
10 µcal s-1 reference power in high feedback mode, the ligands were injected at a rate of 
0.5 µL s-1 and a stirring speed of 307 rpm with 240 s gaps between individual injections. 
The data were analyzed and plotted using the programs NITPIC (Keller et al., 2012; 
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Scheuermann and Brautigam, 2015), SEDPHAT (Houtman et al., 2007; Zhao et al., 2015), 
and GUSSI (Brautigam, 2015; and for review Brautigam et al., 2016). 
6.1.3. Crystallization and structure determination 
All soaking experiments were carried out using crystals of native BcPhz(A)/B which could 
regularly be obtained at 12 °C from a grid screen of 0.1 M Bis-TRIS pH 6.1 – 6.7, 0.2 M 
ammonium acetate, 16 – 20 % (w/v) PEG 3350 (Ahuja et al., 2008) as described in 
paragraph 4.1.5. Crystals were soaked overnight in mother liquor supplemented with 
25 % (v/v) glycerol and 10 mM of the respective compound at 12 °C. Co-crystallization 
attempts with 10 or 40 mM compound WB086 (stock solution: 500 mM in pure DMSO) 
were carried out in a grid screen with 0.1 M Bis-TRIS pH 6.6 – 7.0, 0.2 M ammonium 
acetate, 18 – 28 % (w/v) PEG 3350 (Mentel et al., 2009a). Cryo protection of these crystals 
was achieved similarly to the soaks.  
Crystals were mounted on nylon loops and flash frozen in liquid nitrogen. Diffraction data 
were collected at 100 K at beamline MX BL14.1, BESSY II at the Helmholtz Centre Berlin, 
at beamline X06DA (PXIII) at the Swiss Light Source (SLS) of the Paul Scherrer Institute, at 
the European Synchrotron Radiation Facility (ESRF), Grenoble or at beamline P11, 
PETRA-III at DESY (Deutsches Elektronen-Synchrotron), Hamburg. Data reduction, 
structure refinement, and model building were carried out as described in 
paragraph 4.1.4. Ligand restraints where generated from SMILES-strings using the 
program phenix.elbow (Moriarty et al., 2009) of the PHENIX software suite (Adams et al., 
2010). Structural flexibility was modelled using TLS refinement (Schomaker and 
Trueblood, 1968). In the last step of refinement, heteroatoms like waters and the ligand 
were attributed to the nearest TLS group using a script developed in the group (Reichelt 
and Blankenfeldt, unpublished). Final structure validation was done with MolProbity 
(Chen et al., 2010). Full data collection and refinement statistics are shown in 
Tables A11-A16 in the appendix.  
6.1.4. In vitro inhibition assay  
In order to evaluate the inhibitory effect of different compounds on PhzB catalysis, the 
previously described coupled photometric condensation assay (q.v. paragraph 5.1.2.) was 
adapted. In brief, standard solutions containing both 1 µM (dimer) of the coupled enzyme 
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PhzF and the target BcPhz(A)/B) were used for dose-response experiments. A serial ten 
times dilution (from aqueous or DMSO stock solutions) of the respective compound, i.e. 
100, 10, 1, and 0.1 µM, was tested in presence of either 125 µM or 1 mM DHHA. All 
experiments were carried out in UV-Star® 96-Well microplates (Greiner Bio-One) at 25 °C 
in an Infinite® M200 microplate reader (Tecan Group Ltd.). A final reaction volume of 
150 µL in 50 mM sodium phosphate buffer at pH 7.5 supplemented with 2 % (v/v) DMSO 
was obtained by addition of 75 µL pre-mixed enzyme solution to an equal volume of each 
substrate/inhibitor dilution. The increasing absorption of the metastable tricyclic 
phenazine intermediate THPCA*was monitored at 330 nm over a 20 minutes time course 
and in 40 s intervals. As reference, a reaction mixture lacking inhibitor was used. The 
background of the uncatalyzed auto condensation was evaluated with reaction mixtures 
lacking BcPhz(A)/B and the potential inhibitor. Reaction rates were determined from the 
slopes of the linear phase of each curve after normalization to zero. After background 
correction, the residual enzyme activity was calculated in relation to the inhibitor free 
sample. All samples were analyzed in triplicate.  
6.1.5. In cellulo pyocyanin assay 
In cellulo, the influence of the inhibitors on pyocyanin production was analyzed according 
to a previously described protocol (Klein et al., 2012, Essar et al., 1990). In brief, cultures 
of Pseudomonas aeruginosa PA14 or PAO1 in PPGAS- (20 mM NH4Cl, 20 mM KCl; 120 mM 
TRIS/HCl pH 7.2, 1.6 mM MgSO4, 1 % (w/v) tryptone, 0.5 % (w/v) glucose) or M63-medium 
(15 mM (NH4)2SO4, 100 mM KH2PO4 pH 7.0, 1.8 µM FeSO4 x 7H2O, 1 mM MgSO4, 
0.2 % (w/v) glucose, 0.1 % (w/v) casamino acids) were grown in presence of 100 µM of 
each inhibitor. CELLSTAR® 24-well plates (Greiner Bio-One) were filled with 1.5 mL 
bacterial culture (OD600 = 0.02) per well. 10 mM inhibitor solution (in pure DMSO) was 
added to the cultures to yield a final concentration of 100 µM inhibitor in 1 % (v/v) DMSO, 
for control experiments, pure DMSO was added. Culture plates were sealed with an air-
permeable membrane and incubated at 37 °C, 200 rpm, and ~75 % humidity for 16 h. 
After that, the OD600 of the samples was determined. For pyocyanin quantification, 900 μL 
of each culture were extracted with 900 μL chloroform and the phases separated by 
centrifugation at 14 000 rpm for 15 min. 800 μL of the organic phase were taken off, 
mixed with 250 μL of 0.2 M HCl and centrifuged at 14 000 rpm for 15 min. 80 μL of the 
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aqueous phase were transferred to Nunc U96 MicroWell™-plates and the OD520 measured 
using a FLUOstar Omega (BMG Labtech) or an Infinite® M200 (Tecan Group Ltd.) 
microplate reader. For each sample, cultivation and extraction were performed in 
triplicates. Percent inhibition was calculated in relation to the DMSO control after growth 
correction.  
6.2. Results & Discussion 
6.2.1. Binding behavior of PhzB product analogs  
In order to optimize ligand efficiency, new potential PhzB-inhibitors were synthesized 
following a rational design approach (Jakob Pletz) and analyzed regarding their affinity 
towards Phz(A)/B from B. cepacia R18194. As a proof of concept, the already determined 
dissociation constant for the pure S,R-isomer (WB001) of a compound called 
phenazistatin A, was confirmed by ITC experiments (KD = 63.7 ± 10.7 nM compared to 
51 nM as determined by Matthias Mentel).  
Having successfully repeated this titration experiment, binding affinities of overall 30 
different newly synthesized compounds were investigated. Differing in the derivatization 
of the characteristic anthranilic acid either by an N-piperidinyl- or N-carboxycycloalkyl-
moiety, these compounds can be divided in two sub-groups, which are termed 
"mavericks" and "phenazistatins" respectively (Figure 37). "Phenazistatins" with affinities 
in the low µM- or even nM-range (Figure 38, Table 22 and Table A9 in appendix A3) 
appeared to be generally more potent binders than "mavericks" with KD-values of 
approximately 10 - 20 µM (see below). 
 
Figure 37: Schematic representation of the two sub-groups of anthranilic acid derived PhzB ligands.   
The figure shows the chemical formula of 5-bromo-2-(piperidin-3-ylamino)benzoic acid (WB078), a representative of 
the N-piperidinyl anthranilic acid derivatives called "mavericks’, and 5-bromo-2-((3-carboxycyclohexyl)amino)benzoic 
acid (rac-WB001), a member of the N-carboxycycloalkyl anthranilic acid derivatives called "phenazistatins’. The 
characteristic moiety allowing differentiation of these two groups is highlighted.  
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Five compounds (WB019, WB020, WB035, WB067, and WB071) showed either no affinity 
towards BcPhz(A)/B or accurate data evaluation failed (q.v. Figure A17C and D, 
Figure A19A and D and Figure A20B in the appendix A3). Three compounds, termed 
WB025, WB047, and WB073 yielded unusual binding curves (Figure A18A, Figure A19B, 
and Figure A20C). Nevertheless, either parts of these curves, as in case of WB047 or 
WB073, or the whole data range, in case of WB025, have been fitted for KD-estimation 
and comparison to related compounds. Furthermore, three "phenazistatin" compounds, 
WB011, WB077, and WB082, yielded clear double transition curves in ITC experiments 
(Figure 38B and Figures A22-A24). This behavior could already be observed for racemic 
phenazistatin A (Mentel, 2008) and hints towards differing affinities of the enantiomers. 
With the exception of WB001, all tested compounds are racemic mixtures of the cis (S,R 
and R,S)- or trans (S,S and R,R)-isomers; as such, the obtained dissociation constant 
represents rather a "mixed" affinity than a specific one. For comparison with titration 
series where no or only a weak second transition at the onset or at the end of the binding 
curve is observed, all double transition data were fitted as one transition curve as shown 
in Figure 38B. This method however, might lead to underestimation of the actual KD (q.v. 
Table A6). Nevertheless, a detailed evaluation for individual transitions can be found in 
the appendix in Table A10 and Figures A17-A19. In these cases, all curves from individual 
titration experiments were fitted at once and the confidence level of the fit evaluated for 
the full range of the curve as well as single transitions.   
As described by Fokkens and Klebe (2006) the shape of the titration curve allows an 
estimation of the difference in binding affinity of the strong and weak binding enantiomer. 
The authors suggested that a clear double transition, as observed especially for WB011 
and WB077, indicates a 50 to 200-fold difference in binding affinity with the first transition 
representing a "mixed" association/dissociation event of both enantiomers and the 
second rather the affinity of the stronger binding enantiomer. Similarly to phenazistatin A, 
analysis of the double transition curves of WB011, WB077, and WB082, resulted in 
comparable affinity parameters for the weak binding enantiomers (approximately 
1 – 2 µM; Table A10). Hence, with the expected 50 to 200-fold higher affinity of the S,R-
enantiomer, these values should be comparable to phenazistatin A.  
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Figure 38: ITC profiles for affinity titrations of different "phenazistatin"-type substrate analogs against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for three of the represented 
compounds: A WB001 (phenazistatin A), B WB011, and D WB070; and endothermic for WB024 (C). Stoichiometries are 
ranging from approximately 1:1 (D) up to 2.5:1 (B) and binding affinities were determined to 63.7 ± 10.7 nM (A), approx. 
9.4 ± 1.5 µM (B), 5.1 ± 0.4 µM (C) and 47.1 ± 0.9 nM (D). The symbols ,  and  (and ) represent individual 
experiments All data were analyzed and fitted using the programs NITPIC (Keller et al., 2012; Scheuermann and 
Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI 
(Brautigam, 2015). 
KD = 63.7 ± 10.7 nM KD = 9.4 ± 1.5 µM 
KD = 5.1 ± 0.4 µM 
KD = 47.1 ± 0.9 nM 
A B 
C D 
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This finding was unexpected especially in case of WB077, which bears a much larger 
substitution (phenylethyl-) at position five of the anthranilic acid moiety than e.g. WB001 
(Br-), WB011 (Cl-) or WB082 (H-). Yet, binding of WB077 could also be confirmed by a 
crystal structure of the complex with BcPhz(A)/B (Figure 41D, see below).   
Table21 shows an overview of well binding compounds of the "phenazistatins" (a more 
detailed overview can be found in Table A9 in the appendix A3).  
Table 22: Thermodynamic binding parameters for ITC affinity titrations of various newly synthesized product analogs 
of the "phenazistatin" sub-group to BcPhz(A)/B.# 
Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
WB001 
6.4 ± 1.1 • 10-2 -9.8 ± 0.1 -10.3 ± 0.2 0.5 ± 0.2 1.8 ± 0.1 1610.6 ± 242.7 
WB011‡ 
9.4 ± 1.5 -6.9 ± 0.1 -10.2 ± 0.5 3.4 ± 0.6 2.4 ± 0.0 10.9 ± 1.8 
 
WB012 
5.8 ± 0.2 -7.1 ± 0.0 -9.4 ± 0.2 2.3 ± 0.2 2.8 ± 0.0 17.3 ± 0.7 
WB013 
1.7 ± 0.2 -7.9 ± 0.1 -8.7 ± 0.4 0.8 ± 0.4 1.9 ± 0.0 58.4 ± 5.8 
 
WB024 
5.1 ± 0.4 -7.2 ± 0.0 4.3 ± 0.1 -11.5 ± 0.1 1.3 ± 0.0 19.7 ± 1.5 
 
WB025 
4.0 ± 0.6 • 10-1 -8.7 ± 0.1 1.3 ± 0.0 -10.0 ± 0.1 1.0 ± 0.0 255.8 ± 39.0 
WB026 
13.0 ± 0.1 -6.7 ± 0.0 5.0 ± 0.0 -11.7 ± 0.0 1.9 ± 0.2 7.7 ± 0.1 
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Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
WB027 
16.9 ± 1.8 -6.5 ± 0.1 3.3 ± 0.2 -9.8 ± 0.3 2.4 ± 0.1 6.0 ± 0.7 
 
WB047 
4.7 ± 0.3 • 10-1 -8.6 ± 0.0 -1.3 ± 0.0 -7.3 ± 0.1 3.0 ± 0.1 212.2 ± 14.1 
 
WB069 
1.0 ± 0.2 -8.2 ± 0.1 -10.8 ± 0.4 2.6 ± 0.3 1.3 ± 0.0 103.7 ± 16.2 
 
WB070 
4.7 ± 0.1 • 10-2 -10.0 ± 0.0 -5.0 ± 0.3 -5.0 ± 0.3 1.1 ± 0.1 2126.1 ± 41.9 
WB077‡ 
5.6 ±0.4 -7.2 ± 0.0 -8.0 ± 0.4 0.9 ± 0.4 1.7 ± 0.0 17.9 ±1.2 
 
WB082 
3.6 ± 0.4 -7.4 ± 0.1 -8.4 ± 0.3 1.0 ± 0.3 1.3 ± 0.1 28.5 ± 3.4 
 
WB083 
1.2 ± 0.3 • 10-1 -9.4 ± 0.1 -3.2 ± 0.0 -6.3 ± 0.1 1.2 ± 0.0 855.8 ± 176.9 
WB084 
4.5 ± 0.3 • 10-1 -8.7 ± 0.0 -7.3 ± 0.1 -1.3 ± 0.1 0.9 ± 0.0 222.3 ± 16.0 
# All ITC experiments were carried out at 25 °C in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl (if necessary supplemented with up to 1 % DMSO). 2 mM of the 
respective compound were titrated to 100 µM BcPhz(A)/B. The data are averaged from at least two independent measurements. ‡ The given values arise 
from fitting of the complete binding curve similar to other compounds. Highlighted are compounds with trans-configuration in green, endothermic binders 
with shaded areas in light orange and compounds with different ring sizes of the cycloalkane moiety with shaded areas in lightblue.  
Besides phenazistatin A (WB001) and WB011, compounds bearing another halogen at the 
position of the bromine/chlorine group, such as fluorine (WB069) or iodine (WB012) seem 
to show a similar affinity towards BcPhz(A)/B with KD-values of 1.0 µM and 5.8 µM 
respectively. Although no double transition curve was observed for these compounds, it 
seems that ligands bearing a smaller halogenic group tend to bind slightly tighter to the 
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enzyme. However, the individual thermodynamic parameters ΔG, ΔH and –T*ΔS, obtained 
from these calorimetric titrations (Figure 39) as well as structural (see below) and 
biochemical assay data (q.v. paragraph 6.2.2) show no significant difference in binding 
and/or inhibitory potency of these different halogenated compounds or any other 
substitution at the same position.  
 
Figure 39: ITC data analysis of characteristic thermodynamic parameters for different "phenazistatin" derivatives. 
Plotted are the values for the Gibb’s free energy ΔG (  ), which in turn is the sum of the enthalpy ΔH (  ) and the 
entropy, expressed as –T*ΔS (  ), in kcal*mol-1. All derivatives share a common chemical core as depicted by the inset 
in the lower area of the graph. Their individual groups are highlighted in blue above the respective data columns.  
In general, a strong enthalpic (ΔH) contribution to ligand binding can be explained with 
regard to the structural data. All crystal structures of BcPhz(A)/B in complex with different 
"phenazistatins" show the formation of up to eleven hydrogen bonds, ranging from 2.6 to 
3.2 Å, stabilizing the ligand via its carboxylic acid moieties and the bridging amine as 
shown in Figure 41 (Figures A31 and A32 in appendix A3). Even a crystal structure of 
BcPhz(A)/B in complex with WB077 (Figure 41D), a ligand bearing a large phenylethyl-
substitution at position five, shows a very similar hydrogen-bonding pattern as for WB001 
(PDB entry 3JUM; Mentel et al., 2009a). However, the characteristic phenylethyl-group 
induces a 100-degree rotation of H73 and simultaneously a displacement of two 
coordinating water molecules in comparison to the published complex. In turn, the new 
position of H73 is stabilized by two new hydrogen bonds to the backbone carbonyls of K69 
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and P164. Together these data explain why WB077, despite its large substitution, binds to 
BcPhz(A)/B with similar affinity as observed for smaller "phenazistatins".   
A positive value for the entropic factor (–T*ΔS) indicates unfavorable conformational 
changes upon ligand binding. However, in comparison to the apo structure (PDB entry 
3B4O; Ahuja et al., 2008) only minor conformational differences can be observed and this 
does not seem to affect ligand binding as much as the enthalpic contribution.  
 
Figure 40: ITC data analysis of characteristic thermodynamic parameters for different cycloalkane derivatives of 
phenazistatin A.  
Plotted are the values for the Gibb’s free energy ΔG (  ), which is the sum of the enthalpy ΔH (  ) and the entropy, 
expressed as –T*ΔS (  ), in kcal*mol-1. All derivatives share a common bromo-anthranilic acid moiety with different 
carboxycycloalkyl moieties attached via the amino group, shown as insets in the lower area of the graph. Their 
individual, characteristic rings are highlighted in green. 
Besides the series of modifications at position five of the anthranilic acid moiety, the 
influence of the ligand’s N-carboxycycloalkyl moiety was also analyzed. To this aim, Jakob 
Pletz synthesized a cyclopentane- (WB047) and cycloheptane-derivative (WB084) of 
phenazistatin A. Although WB047 produced an unusual titration curve (see before) and its 
KD should be considered with caution, both ligands were found to bind with a comparable 
affinity of approximately 450 nM (Table 22). Further analysis of the individual 
thermodynamic parameters (Figure 40) indicates that binding is entropically driven, which 
indicates formation of favorable hydrogen bonds as well as stabilizing hydrophobic 
interactions. At first sight, the structural data (Figure 41) suggest no difference compared 
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to phenazistatin A, regarding space requirements or the hydrogen-bonding network of 
these ligands.  
 
Figure 41: Crystal structures of BcPhz(A)/B in complex with different synthetic "phenazistatin" derivatives.  
Close-ups on the active site (chain A or B) of different BcPhz(A)/B complex structures with potential PhzB-inhibitors of 
the "phenazistatin"-class after soaking with 10 mM of the respective ligand overnight. The ligands are highlighted as 
balls and sticks in different colors and depicted in their Fourier difference density (mFo-DFc) omit map contoured at 3σ 
in green: A cis-methyl-phenazistatin (WB013), B cis-tetrazole-phenazistatin (WB025), C cis-penta-phenazistatin 
(WB047), D cis-phenylethyl-phenazistatin (WB077), E cis-hepta-phenazistatin (WB084), and F: trans-methoxy-
phenazistatin (WB089). The protein is shown as cartoon and the coordinating active site residues as balls and sticks 
colored in yellow and forest (for residues belonging to the second chain, depicted with *). Hydrogen bonds (- - -) and 
coordinating water (red balls) are highlighted as well. 
WB047 and WB084, similarly to the reference structure (PDB entry: 3JUM, Mentel et al., 
2009a), were observed in their cis-S,R-configuration. Yet, upon a closer look, the electron 
difference density for WB084 is ambiguous. Seemingly, the trans-isomer in S,S-
A B
C D 
E F 
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configuration could be bound to the active site as well. In fact, it is known from crystal 
structures of BcPhz(A)/B in complex with different trans-isomers (Figure 41F and 
Figures A31 and A32 in the appendix), that the enzyme can bind these isomers as well. 
However, these ligands bind in the trans-R,R-configuration. It is possible that the ring-size 
directs binding of one or the other isomer, yet, from currently available data, no 
conclusive hypothesis for the preferentially bound configuration of WB084 can be made. 
In general, affinity titrations suggest slightly tighter binding to BcPhz(A)/B for the trans-
stereoisomers than for the respective cis-isomers, e.g. cis-fluoro-phenazistatin (WB069) 
binds with a KD of 1.0 µM, while the KD for trans-fluoro-phenazistatin (WB070) is 47 nM. 
The thermodynamic parameters (Figure 42) indicate that binding of the cis-isomer is 
enthalpically driven, while binding of the trans-isomers seems to have a larger entropic 
contribution. 
 
Figure 42: Characteristic thermodynamic parameters for different cis- and trans-isomers of "phenazistatin" 
derivatives as derived from ITC experiments.  
Plotted are the values for the Gibb’s free energy ΔG (  ), which in turn is the sum of the enthalpy ΔH (  ) and the 
entropy, expressed as –T*ΔS (  ), in kcal*mol-1. All derivatives share a common chemical core as depicted by the insets 
in lower area of the graph. Bioisosteres of phenazistatin A with tetrazole- or oxadiazolone modification are depicted on 
the left. 
Yet, crystal structures of different cis-/trans-isomer pairs do not allow a distinct 
explanation for this observation, as the spatial requirements as well as the hydrogen-
bonding patterns are very similar for both stereoisomers. 
cis 
trans 
cis 
trans trans 
trans 
cis 
cis 
WB025/024 WB027/026 WB069/070 WB082/083
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Future drug application requires good bioavailability of the administered compound and 
thus the most potent inhibitors have to be tested in vivo eventually. Anticipating 
permeability issues for compounds bearing free carboxylic acids and aiming to improve 
drug uptake without loss of inhibitory potency, some bioisosteres of phenazistatin A were 
synthesized (Jakob Pletz). Two of these derivatives with the aromatic carboxylic acid 
replaced either by a tetrazole-(WB024 and WB025) or by an oxadiazolone-group (WB026 
and WB027), were analyzed with ITC and crystallographic methods. Based on previous 
binding and structural data, which revealed that the carboxylic acid moiety is a central 
node in the hydrogen-bonding network of the ligand, it was expected that binding of these 
ligands should drastically be impaired. Yet, when analyzing the respective racemic cis- and 
trans-isomers, binding in the µM-range could be observed for all four ligands (Table 22). 
The tetrazole-derivatives with KD-values in the low µM- and nM-range show tighter 
binding to BcPhz(A)/B than the oxadiazolone-derivatives (KD-values of 13.0 and 16.9 µM 
for the trans- (WB026) and cis-isomer (WB027) respectively). Furthermore, for the first 
time endothermic binding (Figure 38C and Figure 42), which probably indicates major 
conformational changes of BcPhz(A)/B, was observed. Indeed, crystal structures in 
complex with WB024 (trans-tetrazole-phenazistatin), WB025 (cis-tetrazole-phenazistatin, 
Figure 41B) or WB026 (trans-oxadiazolone-phenazistatin) reveal that, for these larger 
compounds, the C-terminus, which acts as flexible lid to shield the active site, is less well 
defined and thus flexible. For cis-oxadiazolone-phenazistatin (WB027) two crystal 
structures could be obtained as well, however in both structures residual difference 
electron density did not allow a clear attribution to this ligand. This might indicate weak 
binding of WB027 in multiple conformations, which is supported by the binding data. The 
hydrogen-bonding network for the other three ligands of this class is however very similar 
to other "phenazistatin"-derivatives. Together, these structures explain why binding of 
these bioisosteres to BcPhz(A)/B is still possible yet with lower affinity.  
As mentioned in the beginning of this paragraph also a second class of PhzB-binders, the 
"mavericks", were characterized biophysically. Eight members of this class were tested 
regarding their binding affinity towards BcPhz(A)/B (Table 23), yet for two, WB019 and 
WB020 no reliable binding data could be obtained. Nevertheless, a crystal structure of 
BcPhz(A)/B in complex with WB019 verified binding of this compound to the enzyme, 
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though the structure revealed that the ligand adopts a different conformation than other 
members of this compound class (Figure 43A).  
 
Figure 43: Crystal structures of BcPhz(A)/B in complex with different synthetic "maverick" derivatives.  
Close-ups on the active site (chain A or B) of different BcPhz(A)/B complex structures with potential inhibitors of the 
"maverick"-class after soaking with 10 mM of the respective ligand overnight or, in case of D WB086, co-crystallization 
with 40 mM. The ligands are highlighted as balls and sticks in different colors and depicted in their Fourier difference 
density (mFo-DFc) omit map contoured at 3σ in green: A rac-nitroBoc-maverick (WB019), B rac-hydroxyethyl-maverick 
(WB015), C rac-methyl-maverick (WB017), and D rac-H-maverick (WB086). The protein is shown as cartoon and the 
coordinating active site residues as balls and sticks colored in orange and forest (for residues belonging to the second 
chain, depicted with *). Hydrogen bonds (- - -) and coordinating water (red balls) are highlighted as well. 
The aromatic carboxylic group of WB019 is coordinated via a hydrogen bond to Q147, as 
observed for other PhzB binding compounds such as WB017 (Figure 43C). Yet, 
coordination of this group by a water molecule or residue R160* from the second protein 
chain is no longer observed, instead the ligand is stabilized via its nitro group at position 
five and two hydrogen bonds to Y120. As no further stabilization of this ligand can be seen, 
this weak hydrogen-bonding network might indicate low affinity for the enzyme and 
hence explain why no reliable binding affinity could be determined using ITC. 
Furthermore, when superimposing ligand WB019 on other ligands of the same class, e.g. 
WB017, it becomes evident, that the tert-butyloxycarbonyl-(Boc) protecting group at the 
piperidin-ring impairs binding of this compound in a similar orientation than related ones, 
as it would induce clashes with the side chains of W86 and R41 (data not shown). 
A B 
C D 
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Table 23: Thermodynamic binding parameters for ITC affinity titrations of synthetic substrate analogs of the 
"maverick" class to BcPhz(A)/B.# 
Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
 
WB014 
27.7 ± 0.7 -6.2 ± 0.0 8.1 ± 0.2 -14.3 ± 0.2 1.8 ± 0.0 3.6 ± 0.1 
WB015 
2.4 ± 0.5 -7.7 ± 0.1 -6.7 ± 0.9 -1.0 ± 1.0 4.2 ± 0.5 43.1 ± 8.0 
 
WB017 
11.3 ± 0.1 -6.7 ± 0.0 -10.8 ± 0.1 4.0 ± 0.1 2.6 ± 0.1 8.8 ± 0.1 
 
WB018 
36.4 ± 9.4 -6.1 ± 0.1 -9.5 ± 0.6 3.5 ± 0.8 3.7 ± 0.9 2.9 ± 0.7 
 
WB085 
6.1 ± 0.2 -7.1 ± 0.0 4.7 ± 0.1 -11.9 ± 0.1 1.7 ± 0.1 16.5 ± 0.5 
 
WB086 
22.9 ± 0.5 -6.3 ± 0.0 -8.9 ± 0.1 2.6 ± 0.2 3.3 ± 0.1 4.4 ± 0.1 
# All ITC experiments were carried out at 25 °C in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl (if necessary supplemented with up to 1 % DMSO). 2 mM of the 
respective compound were titrated to 100 µM BcPhz(A)/B. The data are averaged from at least two independent measurements.  
In contrast to this unexpected binding behavior of WB019, other ligands, such as WB017 
or WB086 bind to the enzyme‘s active site in a similar way (Figure 43C and D) as seen for 
a complex structure of BcPhz(A)/B and the so-called S-Br-maverick (PDB entry 3JUP; 
Mentel et al., 2009a). These ligands are stabilized via three to four hydrogen bonds 
coordinating the aromatic carboxylic acid group and partially via an additional hydrogen 
bond to the nitrogen of the piperidinyl moiety.   
As seen for WB019, the reduced hydrogen-bonding network could explain the general 
weaker affinity of this compound class, e.g. 11.3 ± 0.1 µM for WB017 (Table 23 and 
Figure 45). Previous investigations of the binding behavior of the "mavericks" also 
revealed that the active site of PhzB can bind the two enantiomers of a racemic mixture 
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simultaneously (Figure 44A; PDB entry 3JUN, Mentel et al., 2009a). Based on these data, 
"maverick" derivatives that represent a fusion of two single "mavericks" into one were 
synthesized (Figure 44). Two of these fused ligands, carrying either two chlorine (WB014) 
or two bromine groups (WB086) as characteristic modification (Figure 44B), were 
analyzed regarding their binding behavior towards BcPhz(A)/B. 
 
Figure 44: Schematic representation of the ligand development of fused "maverick" derivatives.  
A Close-up on the active site (chain B) of BcPhz(A)/B crystallized in a simultaneous complex with racemic Br-maverick 
after soaking with 4 mM of the mixture overnight. The two ligand-stereoisomers are highlighted as balls and sticks. The 
protein is shown as cartoon and the coordinating active site residues as balls and sticks colored in olive and forest (for 
residues belonging to the second chain, depicted with *). Hydrogen bonds (- - -) and coordinating water (red balls) are 
highlighted as well. B The figure shows the chemical formula of two fused "maverick"-derivatives, WB014 and WB085. 
The characteristic moiety allowing differentiation of these two ligands is highlighted. 
As shown in Figure 45, WB086 exhibits endothermic binding to BcPhz(A)/B. A Similar 
behavior could also be observed for WB014 (Figure A16D). In both cases, also an altered 
binding stoichiometry can be observed. While the calorimetric data suggest that small 
"mavericks" bind in a 3:1 or even 4:1-ratio, the larger coupled "mavericks" appears to bind 
only in a 2:1-stoichiometry that is consistent with the fact that they consist of the fusion 
of two smaller units. However, X-ray crystallographic experiments could not confirm these 
stoichiometries, since neither multiple binding of smaller ligands could be observed, nor 
unambiguous structural data for larger Mavericks such as WB014 or WB085 were 
obtained. Different datasets for a putative complex of BcPhz(A)/B and WB014 were 
collected, but the residual positive electron density present in the active site did not allow 
unequivocal building of the ligand. 
Despite missing crystal structures for WB014 or WB085, endothermic binding of these 
ligands might be explained by comparing the complex of BcPhz(A)/B and racemic-Br-
maverick (PDB entry 3JUN, Mentel et al., 2009a) to the complex with phenazistatin A 
(PDB entry 3JUM, Mentel et al., 2009a) or the apo structure (PDB entry 3B4O, Ahuja et al., 
A B 
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2008). In case of the racemic complex, H73 and W76 are displaced from their original 
position in the active site and the C-terminus of both chains is disordered. Together these 
data reveal conformational changes, similarly to what could be expected when the larger, 
fused ligands bind to the enzyme.  
  
Figure 45: ITC profiles for affinity titrations of two different ligands of the "maverick"-class against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for A WB017 with a KD of 
11.3 ± 0.1 µM and endothermic for B WB085 (KD = 6.1 ± 0.2 µM). Stoichiometries are approx. 2.6:1 for WB017 and 1.7:1 
for WB085. The symbols ,  and  represent individual experiments All data were analyzed and fitted using the 
programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et 
al., 2015) and plotted using the program GUSSI (Brautigam, 2015). 
In summary, new potent PhzB ligands were identified and characterized using calorimetric 
and structural methods. The experiments revealed that the N-piperidinyl-anthranilic acid-
derived "mavericks" are weaker binding ligands. In addition, fusion of two small 
"mavericks" into a larger one alters the binding properties, leading to endothermic 
binding behavior. In contrast, "phenazistatins" with affinities up to the nM-range are 
strong binding ligands. As mainly their two carboxylic acid groups facilitate binding, even 
large substitutions at other positions of the aromatic ring do not drastically alter affinity. 
Yet, even bioisosteres with tetrazole- or oxadiazolone groups replacing one of the 
A B 
KD = 11.3 ± 0.1 µM 
KD = 6.1 ± 0.2 µM 
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carboxylates exhibit µM-affinities. Furthermore, cis- as well as trans-stereoisomers were 
found to bind to the enzyme from B. cepacia.  
6.2.2. In vitro inhibition of PhzB catalysis by synthetic product analogs  
The in vitro inhibitory potency of synthetic ligands against PhzB catalysis was addressed 
utilizing the enzymatic assay previously described (q.v. chapter II). When using 1 mM 
DHHA and up to 100 µM compound, no or only a very weak inhibitory effect against 
BcPhz(A)/B could be detected for the tested N-piperidinyl anthranilic acid derivatives 
("mavericks"; Scheme 16).  
 
Scheme 16: Chemical structures of all N-piperidinyl ("mavericks") and N-phenyl anthranilic acid derivatives.   
Schematic overview over all "maverick"- and N-phenyl anthranilic acid derivatives tested for in vitro PhzB-inhibition. 
Except WB021-WB023, all ligands are shown without absolute stereochemistry, indicating racemic mixtures. 
The only significant inhibitory effect was observed for WB085 (60 % residual activity at 
100 µM, Figure 46). Even when reducing the substrate concentration to 125 µM, no 
significant increase in enzyme inhibition could be detected. Most "mavericks" show 
approximately 10 to 50 % inhibition (80 % for WB085), but only at their highest tested 
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concentration, i.e. 100 µM (Figure A25). As expected from the complex structures (see 
before), the increase in potency when less substrate is used confirms that these 
compounds act as (weak) competitive inhibitors. This weak inhibitory effect indeed 
correlates with the reduced hydrogen-bonding network observed in the crystal structures 
and with the weak affinities determined by ITC. In comparison to the substrate/product 
of the reaction, "maverick" compounds lack a second carboxylic acid moiety which is 
found to be highly coordinated in these complex structures (Ahuja et al., 2008).   
The three N-phenyl anthranilic acid derivatives (WB021 – WB023; Mentel, 2008), show 
similar tendencies (Figure 46 and Figure A25). 
 
Figure 46: Residual enzymatic activity of BcPhz(A)/B in presence of N-piperidinyl or N-phenyl anthranilic acid-derived 
inhibitors   
The plot shows the residual enzymatic activity of Phz(A)/B from B. cepacia in presence of 1 mM DHHA and either 
10 (light colors) or 100 µM (dark colors) inhibitor compared to the uninhibited reaction (R). The numbers represent the 
individual compound, e.g. 14 = WB014. BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final 
concentration in all assays. The data, obtained in 50 mM sodium phosphate buffer pH 7.5, supplemented with 2 % (v/v) 
DMSO, at 25 °C, were normalized to zero, corrected, and averaged from three independent measurements. 
In contrast, the majority of N-carboxycycloalkyl anthranilic acid derivatives 
("phenazistatins", Scheme 17) are very potent inhibitors (Figure 47). Compared to an 
inhibitor-free reference, the residual activities in presence of most derivatives are less 
than 20 %, even when only 10 µM inhibitor was used. In presence of 1 mM substrate IC50-
values can be estimated to be in the low µM-range (for details see below and 
Figure A26A - C in the appendix).  
The inhibitory potency is even more pronounced when less substrate (125 µM) is used 
(data not shown) and supports the competitive mode of inhibition, which was suggested 
by the binding modes observed in crystal structures (see before). However, some 
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"phenazistatins", such as WB035 or WB067, show no inhibition at high substrate 
concentrations and only 50 % inhibition at lower ones (for WB067/WB068), indicating 
IC50–values above 100 µM. These results are consistent with the fact that no ligand 
binding could be observed for these two compounds neither by ITC experiments nor by 
crystal structures. 
 
Scheme 17: Chemical structures of N-carboxycycloalkyl anthranilic acid-derived compounds ("phenazistatins").  
Schematic overview over all "phenazistatin" derivatives tested for in vitro PhzB-inhibition. Except WB001, all ligands are 
shown without absolute configuration, as these compounds were only available as racemic mixtures of cis- and/or trans-
isomers. 
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For some other compounds, such as carboxyethyl-phenazistatin (WB071/WB072), phenyl-
phenazistatin (WB073/WB074) or phenylethynyl-phenazistatin (WB075/WB076), distinct 
differences between their cis- and trans-isomers could be observed (Figure 47). 
In fact, assay data for these three diastereoisomers systematically reveal more efficient 
enzyme inhibition by ligands in cis-configuration. The IC50 of the two latter cis-isomers can 
be estimated below 10 µM (at 1 mM substrate). Under similar conditions, WB071 exhibits 
an IC50 of approx. 100 µM, while the corresponding trans-isomer (WB072) shows no 
inhibition (Figure 47). This finding is again in agreement with results from ITC experiments, 
whereupon no binding for WB071 could be observed (q.v. paragraph 6.2.1.).  
 
Figure 47: Residual enzymatic activity of BcPhz(A)/B in presence of N-carboxycycloalkyl anthranilic acid-derived 
inhibitors ("phenazistatins").  
The residual enzymatic activity of BcPhz(A)/B in presence of 1 mM DHHA and either 10 (light colors) or 100 µM (dark 
colors) inhibitor is compared to the uninhibited reaction (R). The numbers represent the individual compounds, e.g. 
11 = WB011. BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final concentration. After 
normalization to zero and background correction, the data from three independent measurements in 50 mM sodium 
phosphate pH 7.5 buffer, supplemented with 2 % (v/v) DMSO, at 25 °C were averaged. The experiments for WB001 were 
repeated and individual triplicates are depicted as 01a and 01b. 
Penta-phenazistatin (WB047/WB048) represents another peculiarity among the tested 
compounds. Despite similar activity of both racemic mixtures against BcPhz(A)/B, the 
overall efficiency of these derivatives, with IC50-values of approximately 100 µM (in 
presence of 1 mM substrate), is almost 100-fold reduced compared to similar compounds, 
such as WB001 or WB084. While comparison of the corresponding complex structures 
does not provide any rational explanation for differing behavior among "phenazistatin" 
derivatives, ITC data for WB047 revealed unusual biphasic binding curves, potentially 
indicating different/multiple binding modes. 
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As anticipated from affinity titrations (q.v. paragraph 6.2.1.), tetrazole- and oxadiazolone- 
phenazistatins also show inhibitory effects on PhzB catalysis (Figure 48). However, the 
oxadiazolones (WB026/WB027), with estimated IC50-values of approximately 100 µM (at 
1 mM substrate), are 10-fold less potent than the tetrazoles, which is in agreement with 
their respective binding affinities (see before). Yet, as seen for WB028, the inhibitory 
potency is drastically reduced when other groups such as tetrazoles or methyl ester 
replace both carboxylic acid moieties of the "phenazistatins" (Figure 48). In general, 
prodrugs or other bioisosteres (Scheme A1) with methyl esters, pivaloyloxymethyl esters 
(WB087/WB088), phosphoryl moieties (WB063), or methylsulfonylamide groups (WB090) 
show no inhibition in the in vitro assay (Figure A27), even when the substrate 
concentration is reduced to 125 µM (data not shown).  
 
Figure 48: Residual enzymatic activity of BcPhz(A)/B in presence of different potential bioisosteric inhibitors.  
The residual enzymatic activity of BcPhz(A)/B in presence of 1 mM DHHA and either 10 (light colors) or 100 µM (dark 
colors) inhibitor is compared to the uninhibited reaction (R). The numbers represent the individual compounds, e.g. 
24 = WB024. Green colors indicate simple tetrazole- or oxadiazolone derivatives, while orange represents compounds 
bearing at least one ester modification. A previously reported PhzB-inhibitor, raloxifene (RAL; Ho Sui et al., 2012) was 
tested as well. BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final concentration. After 
normalization to zero and background correction the data from three independent measurements in 50 mM sodium 
phosphate buffer pH 7.5, supplemented with 2 % (v/v) DMSO, at 25 °C were averaged.  
Besides "maverick" and "phenazistatin" derivatives, the inhibitory potency of another 
previously described inhibitor of PhzB, raloxifene (Ho Sui et al., 2012), was tested. In the 
frame of their drug repurposing study, the authors showed that the selective estrogen 
receptor modulator raloxifene (RAL) leads to a dose-dependent reduction of pyocyanin 
levels in Pseudomonas aeruginosa which they attributed to the inhibition of PhzB2 (Ho Sui 
et al., 2012). Indeed, although it was not possible to determine affinity data for raloxifene, 
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binding of this compound to PhzB (here Phz(A)/B from B. cepacia R18194) could be 
confirmed by crystal structures (Figure 49).  
 
Figure 49: Crystal structures of BcPhz(A)/B in complex with raloxifene.  
A Close-up on the active site of BcPhz(A)/B (chain B) co-crystallized with 5 mM raloxifene (RAL). The ligand, in gray, is 
highlighted as balls and sticks and depicted in its Fourier difference density (mFo-DFc) omit map contoured at 3σ (green). 
The protein is shown as cartoon and the coordinating active site residues as balls and sticks colored in gold and forest 
(for residues belonging to the second chain, depicted with *). Hydrogen bonds (- - -) and coordinating water (red balls) 
are highlighted as well. B Structural comparison of the raloxifene (RAL) complexes obtained either by co-crystallization 
with 5 mM (gray) or overnight soaking with 10 mM (white) compound, with the phenazistatin A complex (WB001, PDB 
entry 3JUM, Mentel et al., 2009a). The superposition reveals a conserved benzaldehyde moiety as common structural 
feature between both inhibitors (⁞), which can be considered as pharmacophore.  
The crystallographic data reveal that raloxifene binds directly to the active site and suggest 
a competitive mode of inhibition similar to the other studied compounds. This is further 
supported by assay data which showed improved inhibitory potency for raloxifene at 
lower substrate concentrations (estimated IC50 ≈ 100 µM at 125 µM DHHA vs. no 
detectable inhibition at 1 mM DHHA; Figure 48). In comparison to complex structures with 
other inhibitors, such as WB001 (PDB entry 3JUM, Mentel et al., 2009a), binding of 
raloxifene induces a displacement of the C-terminal arm and, more generally, a 
distortion/opening of the active site presumably in adaptation to the bulky ligand 
(Figure 49B). Five to six hydrogen bonds are also formed between RAL and active site 
residues or conserved waters (Figure 49A). Interestingly, the central benzaldehyde moiety 
of the ligand binds in a similar position as the anthranilic acid group of "phenazistatin" or 
"maverick" derivatives and thus marks this central moiety as a conserved pharmacophore 
(Figure 49B).  
Since "phenazistatins" turned out to be very potent inhibitors of the enzyme from 
B. cepacia, phenazistatin A (WB001) and the bioisostere WB024 were also tested against 
the dimeric enzymes PhzBB and HeteroPhzAB from P. fluorescens 2-79 (Figure 50).  
A B 
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Figure 50: Residual enzymatic activity of different PhzB para- and orthologues in dependency of phenazistatin A 
(WB001) and WB024.  
The residual enzymatic activity of BcPhz(A)/B (  and  ), PhzBB (  ) and HeteroPhzAB (  ) in presence of 1 mM 
DHHA and increasing phenazistatin A (WB001) (A) or WB024 (B) concentrations (0.1, 1, 10, and 100 µM) is represented. 
PhzB para- and orthologues as well as the coupled enzyme PhzF were used at 1 mM (dimer) final concentration. After 
normalization to zero and background correction the data from three independent measurements in 50 mM sodium 
phosphate pH 7.5, supplemented with 2 % (v/v) DMSO, at 25 °C were averaged. The insets show the chemical formulas 
of the ligands. 
As expected from the high structural similarity and sequence identity, dose-response 
curves for both ligands against the PhzB orthologues display inhibition tendencies similar 
to the one observed for BcPhz(A)/B. All enzymes show approximately 60 % inhibition at 
10 µM WB024 and 1 mM substrate (Figure 50B). Since small differences can be observed 
between the three PhzB para- and orthologues in response to WB001 (Figure 50A), a more 
rigorous IC50-determination was carried out (WB001; Figure 51).  
These experiments yielded IC50-values of 1.9 ± 0.1 µM, 13.9 ± 1.2 µM and 6.9 ± 1.1 µM for 
BcPhz(A)/B, PhzBB and HeteroPhzAB respectively. As such, phenazistatin A is most 
efficient against the enzyme from B. cepacia. This is in good agreement with affinity 
titrations (q.v. paragraph 6.2.1), as the KD for this complex was found to be 64 nM while 
the affinity of phenazistatin A to PhzBB was determined to 1.5 µM (see chapter II). The 
differing inhibitory potency of WB001 against PhzBB and HeteroPhzAB can also be 
explained in context of the previously presented kinetic studies (q.v. chapter II). The 
heterodimer is comprised of one active PhzB subunit and an inactive PhzA subunit. 
Structural as well as binding data verified that the inhibitor shows no or only weak affinity 
to the inactive PhzA subunit. As such, less inhibitor is needed to reach the half-maximal 
inhibitory concentration for the heterodimer than is needed for the homodimer (6.9 vs. 
13.9 µM). Under physiological conditions where the heterodimer might be the prevalent 
form, this should lead to an increased inhibitory potency of phenazistatin A.  
A B 
6. PhzB-inhibitors Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 
150 
 
Figure 51: IC50-determination of phenazistatin A towards different PhzB para- and orthologues.  
Concentration dependent inhibition of BcPhz(A)/B ( ), PhzBB ( ), and HeteroPhzAB ( ) by phenazistatin A (WB001). 
PhzB para- and orthologues as well as the coupled enzyme PhzF were used at 1 mM (dimer) final concentration. After 
normalization to zero and background correction, data from three independent measurements in 50 mM sodium 
phosphate pH 7.5, supplemented with 2 % (v/v) DMSO, at 25 °C were averaged and fitted using GraFit5 (Erithacus 
Software Ltd.). 
As a potential universal PhzB-inhibitor in pseudomonads, the inhibitory potency of 
raloxifene was also tested against PhzBB and HeteroPhzAB (Figure 52). In contrast to the 
two "phenazistatins", at 1 mM substrate, PhzB para- and orthologues are only weakly 
inhibited by raloxifene (Figure 52A). Yet, when the substrate concentration is decreased 
to 125 µM, up to 65 % inhibition (HeteroPhzAB) can be observed at the highest compound 
concentration of 100 µM (Figure 52B). 
   
Figure 52: Residual enzymatic activity of different PhzB para- and orthologues in dependency of raloxifene.  
The residual enzymatic activity of BcPhz(A)/B (  ), PhzBB (  ), and HeteroPhzAB (  ) on presence of A 1 mM or 
B 125 µM DHHA is plotted as dose-response of 0.1, 1, 10, and 100 µM inhibitor. PhzB para- and orthologues as well as 
the coupled enzyme PhzF were used at 1 mM (dimer) final concentration. After normalization to zero and background 
correction, data from three independent measurements in 50 mM sodium phosphate pH 7.5, supplemented with 
2 % (v/v) DMSO, at 25 °C were averaged. The inset depicts the chemical formula of raloxifene (RAL). 
This partially contradicts the results of the recent study, where the authors attributed the 
reduction of pyocyanin levels in P. aeruginosa (PA14 and PAO1 strains) and the 
attenuated virulence in a Caenorhabditis elegans infection model (Ho Sui et al., 2012) to 
A B
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the inhibition of PhzB2 by raloxifene. Indeed, although binding of raloxifene to BcPhz(A)/B 
could be confirmed by crystal structures, in context of the presented in vitro assay the 
inhibitory potency of raloxifene appears to be weaker than proposed by the authors.  
Finally, this in vitro study provides solid evidence for the higher inhibitory potency of the 
newly developed N-carboxycycloalkyl anthranilic acid derivatives ("phenazistatins") 
compared to raloxifene. 
6.2.3. In cellulo compound screening towards inhibition of pyocyanin production 
In order to confirm the low µM-range inhibition potency of some of the "phenazistatins" 
determined by the in vitro study, their in cellulo effect was addressed. Initially, the 
influence on pyocyanin production in bacterial cultures of five "phenazistatins" (WB001, 
WB011, WB012, WB013, and WB047), seven bioisosteres/prodrugs (WB024, WB025, 
WB027, WB028, WB031, WB045, and WB050) as well as two "mavericks" (WB014 and 
WB015) and raloxifene (RAL) was evaluated.   
When tested towards inhibition of pyocyanin production in P. aeruginosa PA14, only RAL 
showed up to 30 % inhibition, while other compounds had no effect. Some of them, such 
as WB011 or WB047, seemingly even induced pyocyanin production (Figure 53). However, 
a control comprised of the buffer (200 mM TRIS/HCl pH 9.0), in which some ligands 
(WB011-WB015) were dissolved, showed similar tendencies (B) and thus might have 
caused this observation, at least to some extent.   
As these effects were unexpected and the data (measured as triplicates) exhibited low 
accuracy, the experiment was repeated including a PqsR inhibitor (HIPS 918), whose IC50-
value is 130 nM (internal communication), as reference. Whereas this inhibitor showed 
the expected effect, namely reduction of pyocyanin levels by 50 % (Figure 44), the other 
compounds showed similar tendencies as before or even reduced effects as in case of 
raloxifene. Even when the potential inhibitors were tested against another bacterial strain 
(PAO1), which, in comparison to PA14, represents a chronic model of infection, no reliable 
data could be obtained (Figure A28 in appendix A3). Similarly, using a different medium 
(M63), which is known to enhance pyocyanin production (internal communication), no 
inhibitory effect on phenazine biosynthesis could be observed either (Figure A29).  
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Figure 53: In cellulo inhibition studies of pyocyanin production in P. aeruginosa PA14. 
Phenazine biosynthesis inhibition was analyzed in presence of 100 µM inhibitor by quantification of pyocyanin levels in 
P. aeruginosa PA14 cultures in PPGAS-medium after incubation overnight. After growth correction, data were averaged 
from triplicates and plotted in relation to a compound free control (C1-3). The numbers represent the individual 
compounds, e.g. 01 = WB001. B represents a buffer control (final concentration: 2 mM TRIS/HCl pH 9.0). Blue and red 
bars indicate independent replicas (each n = 3). Compound HIPS 918 was used as positive control at its known IC50-
value. 
One possibility for the absence of in cellulo inhibition could be limited membrane 
permeability caused by the presence of the potentially negatively charged carboxylic acid 
moieties on the unmodified "phenazistatins" and "mavericks".   
Consequently, two additional modified compounds, the prodrug ester WB087 as well as 
the bioisostere WB090, were tested in parallel to phenazistatin A (WB001) and its simple 
methyl ester (WB031). In contrast to previous experiments, all tested compounds 
exhibited detectable reduction of pyocyanin levels in this assay (Figure 54).   
However, as the experimental data were very inaccurate, the experiment was repeated 
twice. Both repetitions showed similar tendencies, but the variance between data from 
all three measurements (each individual triplicates) was too big to allow reliable 
quantification. Thus, although it is not possible to draw a definite conclusion, the general 
trend indicates in cellulo inhibition of pyocyanin production by the tested "phenazistatin" 
derivatives ranging from 30 to 40 % (Figure 54 left). 
Moreover, in cellulo dose-response experiments for phenazistatin A show a distinct 
tendency, whereupon higher compound concentrations lead to increased inhibition, with 
an estimated IC50 ≥ 1 mM. Yet, it should be noted, that these data were also very noisy 
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and showed high variance when repeated. Furthermore, complete inhibition of pyocyanin 
production could never be achieved (Figure 54). 
 
Figure 54: Dose-response inhibition of pyocyanin production in P. aeruginosa PA14.  
Phenazine biosynthesis inhibition was analyzed in presence of 100 µM inhibitor (left) or as dose-response of 
phenazistatin A (right) by quantification of pyocyanin levels in P. aeruginosa PA14 cultures in PPGAS-medium after 
incubation overnight. After growth correction, data were averaged from triplicates and plotted in relation to a 
compound free control (C1-2). The numbers represent the individual compounds, e.g. 01 = WB001. Blue, turquoise, and 
orange bars indicate independent replicas (each triplicates). The inset depicts the structural formula of phenazistatin A 
(WB001).  
Thus, the high inhibitory potency of "phenazistatin" compounds against PhzB observed in 
the in vitro assay could not fully be confirmed regarding pyocyanin production in cellulo. 
Two possible causes of an absent effect in bacterial cell cultures can be hypothesized: 
either uptake of the potential inhibitors is limited, or they are rapidly exported via multi-
drug efflux pumps or other pore-forming proteins. Florian Gräf, who carried out 
permeability experiments in an artificial membrane transwell system, addressed the first 
hypothesis. It could be shown that all three tested compounds (WB001, WB050, and 
WB090) are able to cross the bacterial outer membrane barrier (Figure A30). He further 
observed that the substance flux (J) for the "phenazistatin" bioisostere carrying two 
methylsulfonylamides (WB090) instead of carboxylic acid moieties was exceeding the 
ones of WB050 (with two tetrazole-moieties) and the original compound, carrying two 
free acids (WB001) (J = 14.8 ± 3.6, 13.2 ± 2.8 and 7.2 ± 2.4 µg cm-2 h respectively). 
Nevertheless, these data should be considered with caution as strong solubility and 
adsorption issues were observed. 
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Altogether, "phenazistatins" appear to be inhibitors of phenazine biosynthesis even in 
cellulo, although further optimization of the ligand as well as of the assay will have to be 
performed to achieve satisfying potency not only in vitro but in bacterial cell cultures as 
well. 
6.3. Conclusion 
Phenazines are important virulence factors in human infections caused by phenazine 
producing pathogens such as Pseudomonas aeruginosa. For this reason, their biosynthesis 
seems to be a promising drug target.   
PhzB, an enzyme of the core biosynthetic pathway, was chosen as target for its special 
role in phenazine biosynthesis. In fact, previous data revealed that PhzB is not necessary 
for phenazine production in vitro. However, it seems to accelerate biosynthesis in vivo. 
This peculiarity renders PhzB a promising target for antibiotic or anti-infective 
development (Scheme 18).  
 
Scheme 18: Simplified representation of the anticipated mode of PhzB-inhibition by synthetic product analogs.  
PhzB catalyzes the symmetrical head-to-tail condensation of two identical ketamine precursors (AOCHC). The reaction 
product HHPDC is further converted to the product of core phenazine biosynthesis, PCA. In Pseudomonas aeruginosa, 
additional Phz-enzymes convert PCA further into the virulence factor pyocyanin (PYO). The synthetic product analogs, 
here represented by a crystal structure of BcPhz(A)/B in complex with phenazistatin A (PDB entry 3JUM, Mentel et al., 
2009a), are proposed to inhibit PhzB catalysis and, in turn, lead to reduction of pyocyanin levels and finally reduced 
virulence.  
The first strategy focuses on triggering bacterial self-intoxication via the activity of the 
ketamine substrate, which can potentially react with primary amines, such as the Nζ-group 
of lysine. In contrast, the latter anti-infective approach aims at impairing virulence rather 
than killing the pathogen and consequently avoiding rapid occurrence of antibiotic 
resistance. 
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Previous ITC experiments by Matthias Mentel yielded promising inhibitor candidates. 
Here, these compounds were further characterized regarding their inhibitory potency 
in vitro and in cellulo. Additionally, a new library of synthetic PhzB product analogs was 
synthesized (Jakob Pletz). Based on the chemical 
structure of a previously determined strong PhzB 
binder, phenazistatin A (WB001), different 
modifications on the central anthranilic acid core 
were introduced (Scheme 19). These modifications 
were mainly comprised either of the exchange of the 
bromine group at position five (M1) or alterations of 
the N-linked moiety (M2) with different ring-systems, 
leading to a variety of likewise potent yet structurally 
different "phenazistatins". For future potential in vivo application, bioisosteres and 
prodrugs of phenazistatin A were synthesized as well (M3 and M4).  
In addition to investigation of the binding affinities of roughly 30 new compounds 
belonging to either the group of "phenazistatins" or a second, structurally related group 
(N-piperidinyl anthranilic acids, so-called "mavericks"), 25 complex structures of different 
ligands could be obtained. Moreover, overall 81 compounds were tested towards their 
inhibitory potency in vitro. Together, these results allowed a detailed analysis of structure 
activity relationships. The data revealed that two carboxylic acid moieties that are also 
found in the substrates/product of PhzB, are crucial for binding and consequently for 
function. These two groups mainly mediate hydrogen bonding to active site residues and 
waters, docking the ligand tightly to the active site. This explains why the majority of N-
carboxycycloalkyl-derived compounds ("phenazistatins") are very strong binders up to 
nM-affinity. Furthermore, "phenazistatins" turned out to be potent inhibitors of PhzB in 
vitro. With few exceptions, all "phenazistatins" exhibit IC50-values in low µM-range, e.g. 
phenazistatin A, one of the tightest PhzB binders, inhibits the homodimeric enzymes from 
B. cepacia and P. fluorescens with an IC50 of 1.9 and 13.9 µM respectively (6.9 µM for the 
heterodimer of the latter bacterium).  
In contrast, the N-piperidinyl anthranilic acid derivatives ("mavericks") turned out to be 
weak binders in ITC experiments and exhibited no inhibition in vitro. These observations 
Scheme 19: Chemical structure of 
phenazistatin A (WB001) as starting point 
for further inhibitor development.  
Synthetically introduced modifications are 
highlighted in different colors. 
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can be explained by the lack of the second carboxylic acid moiety attached to the 
cycloalkyl-ring in "phenazistatins". Another peculiarity of this ligand class was the 
endothermic binding behavior of large fused "mavericks" in isothermal titration 
experiments.  
Surprisingly, also "phenazistatin" derivatives with different stereochemical configuration 
than the original compound (cis-/trans-isomers) or bioisosteres, such as tetrazole-
phenazistatins, exhibited high binding affinity and inhibitory potency against Phz(A)/B 
from B. cepacia R18194 (Figure 55).  
 
Figure 55: Overview of the individual steps of the experimental characterization of synthetic product analogs towards 
their inhibitory potency of PhzB catalysis.  
A Measuring macromolecule-ligand affinity with isothermal titration calorimetry for trans-tetrazole-phenazistatin 
(WB024) and BcPhz(A)/B. B Complex structure determination between WB024 and BcPhz(A)/B after overnight soaking 
of the ligand using X-ray crystallography. C Dose-dependent enzyme inhibition assay for evaluation of the inhibitory 
potency of WB024 towards PhzB (here BcPhz(A)/B) catalysis in vitro.  
The latter compounds even showed an altered binding mode to the enzyme, leading to 
endothermic thermograms and binding profiles in ITC measurements. Analysis of the 
corresponding crystal structures revealed that PhzB is very flexible and can adopt even 
larger ligands in its active site. This observation is additionally supported by crystal 
structures with a previously reported PhzB2 inhibitor, raloxifene. This ligand is not only 
A B 
C
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much larger than typical product analogs, but also binds mainly via hydrophobic 
interactions. Despite the distinct structural differences of raloxifene and the inhibitors 
derived from product analogs ("phenazistatins"), a common structural benzaldehyde 
motif could be identified, which seems to represent the pharmacophore. Based on this 
observation, ligand chimeras, combining features of both ligands and sharing the 
conserved benzaldehyde moiety, ought to be generated (Scheme 20).  
 
Scheme 20: Graphical overview of potential ligand chimeras derived from raloxifene and phenazistatin A.  
The central part of this scheme shows the two original compounds, raloxifene (blue) and phenazistatin A (black), 
surrounded by potential chimeras, carrying characteristic elements of both parental compounds (highlighted in 
corresponding colors). The essential carbonyl moiety together with different linker elements is highlighted in red. 
It is anticipated that, due to their size, these chimeras will increase ligand specificity and 
hence inhibitory potency against PhzB. However, this hypothesis requires experimental 
validation.   
Some of the most potent in vitro inhibitors were additionally characterized in cellulo. 
However, these experiments turned out to be challenging, as for most ligands no distinct 
inhibition effect could be demonstrated in liquid bacterial culture. This might be owed to 
the high variance in experimental data or in fact to intrinsic properties of the ligands 
and/or the tested bacteria (P. aeruginosa PA14). First, it was hypothesized that ligand 
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uptake is inefficient, however additional membrane permeability studies (Florian Gräf) 
rendered this hypothesis unlikely. The absent (or weak) inhibitory effect in cellulo might 
thus be related to an unspecific efflux of the compounds by highly efficient multidrug 
efflux pumps, which are known to be abundantly present in P. aeruginosa.  
Yet, additional experiments using e.g. transposon mutants or knockout strains of 
P. aeruginosa, which lack one or more of these pumps, are necessary to confirm this 
assumption. Furthermore, continuative rational drug development is needed to optimize 
the inhibitors especially regarding in cellulo efficacy.  
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7. Summary & Outlook 
7.1. Summary 
The present study aimed at gaining a deeper understanding of the fundamental 
biosynthesis pathway of phenazines. The small nitrogen-containing pigments exhibit 
multifaceted roles not only in the producing microorganisms themselves but also in their 
hosts. For instance, phenazines, in particular the blue pigment pyocyanin produced by the 
human pathogen P. aeruginosa, were identified to be important virulence factors in 
human infectious diseases. As such, understanding their biosynthesis is crucial to be able 
to target and inhibit this important metabolic pathway.  
Two enzymes, PhzF and PhzB were selected and their catalytic reactions analyzed in detail.  
The isomerase PhzF catalyzes the conversion of DHHA to the reactive amino ketone 
AOCHC. Initially different pathways were hypothesized for this catalysis, one following 
classic acid-base catalysis, the second proceeding via a concerted pericyclic [1,5]-
hydrogen shift, not observed for any enzyme so far. Furthermore, it was suggested that 
the enzyme assists in the subsequent tautomerization yielding the final reaction product 
AOCHC as well. In this work, enzyme kinetics were employed to measure kinetic isotope 
effects, which allow identification of the rate-limiting step of a reaction and thus 
potentially to distinguish between different catalytic mechanisms. Indeed, following the 
PhzF-catalyzed reaction using either the natural substrate DHHA or a specifically 
synthesized deuterated substrate analog revealed a significant rate difference in their 
enzymatic turnover (Figure 56A). The relative kinetic isotope effect was determined to 9.5 
regarding kcat, which strongly indicates that the first step of DHHA isomerization, namely 
the proton abstraction, is in fact rate limiting and even suggests that proton tunneling 
might play an important role in catalysis. Yet, these data alone do not allow an 
unequivocal proposition for the mechanism. For this reason, collaborators employed 
QC/MM calculations to simulate different reaction paths and to determine the activation 
energy of the individual steps. In doing so, an acid-base catalyzed proton abstraction with 
E45 acting as proton shuttle, which is first abstracting the proton from the C3-atom of the 
substrate and then redonating it to the C1-atom, turned out to be energetically most 
favorable (Figure 56C).  
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Figure 56: Mechanistic studies of the phenazine biosynthesis protein PhzF.  
Kinetic plots showing A the turnover of the natural, light substrate DHHA ( ) and of the heavy isotopologue d-DHHA ( ) 
or B the turnover of DHHA ( ), trans-2S,3S-O-methylated DHHA (O-Me-DHHA, ), and racemic O-ethylated DHHA (O-
Et-DHHA, ) by PhzF. C Overall catalytic mechanism of PhzF. The zwitterionic DHHA is converted into AOCHC via a two-
step mechanism: an initial base-catalyzed proton abstraction from position C3 (H) leads to formation of an anionic 
intermediate, which, after reprotonation, yields the reaction intermediate AHCDC. In the next step, this intermediate 
undergoes enzyme-catalyzed keto-enol tautomerization facilitated via an E45-water relay (H and H) to yield the final 
reaction product AOCHC. Figure adapted from Diederich et al., 2017. 
The nature of the enzymatic assay did not allow direct addressing of the subsequent 
tautomerization either. Therefore, this pathway was computationally simulated as well 
and these calculations favored a tautomerization that involves PhzF in form of a proton 
relay between the substrate, a conserved active site water and E45 (Figure 56C). The 
enzymatic assay that was developed in this study, however, allowed further investigations 
of the pH-, temperature or buffer dependency of the kinetic parameters and shed more 
light on the isomerization reaction catalyzed by PhzF. Moreover, by using several synthetic 
substrate analogs insights into the specificity of the enzyme could be obtained. It could 
notably be shown that the size of the C3-alkoxy group directs enzymatic specificity, as 
larger groups such as ethoxy- or propyloxy yield poor or no substrates respectively 
(Figure 56B). A crystal structure with O-ethylated DHHA confirmed that the spatial 
requirements of these larger substrates are incompatible with the topology of the active 
site. A substrate analog that could not be converted by PhzF turned out to be a weak 
inhibitor of the enzyme and as such represents a promising starting point for further 
inhibitor development.  
A B 
C 
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The second main project of this study concerned downstream conversion of the reactive 
ketamine product of PhzF, AOCHC. Despite its ability to undergo self-condensation in vitro, 
previous studies indicated that PhzB catalyzes and thereby accelerates the reaction in 
vivo. Since AOCHC is a highly reactive ketamine, which potentially can react with other 
free amines, e.g. in proteins, and thus lead to self-intoxication in vivo, PhzB may be an 
attractive drug target.   
Particularly relevant to human health, pseudomonads carry a second copy of the phzB-
gene in their biosynthesis operon. The product of this gene, termed PhzA, however, is not 
able to accelerate the condensation reaction due to two active site mutations. Although 
it could be shown that, after heterologous co-expression in E. coli, a heterodimer 
consisting of PhzA and PhzB can be isolated and even crystallized (Figure 57A), the role of 
this dimer remained unclear. To this aim, a specific activity assay was developed, which 
allowed determination and comparison of the kinetic parameters of the different dimers. 
This demonstrates that PhzAB dimers are as efficient as PhzBB homodimers (Figure 57B); 
at low substrate concentrations, heterodimers might even outperform homodimers.  
          
Figure 57: Relevance of PhzAB heterodimerization.  
A Overall structure of the PhzAB heterodimer from P. fluorescens 2-79 with the inactive and active monomers, PhzA 
and PhzB, shown in deepteal and raspberry respectively. The co-crystallized ligand (gray) is found only in the active B-
subunit. B Specific activity of PhzAA and PhzBB homodimers compared to the one of PhzAB heterodimers. PhzAA 
homodimers are inactive, while PhzBB homodimers and heterodimers show similar activity up to approximately 400 µM 
substrate.  
Since dimer stability was also shown to be very similar, these results strongly support the 
physiological relevance of PhzAB heterodimerization, which might be of particular 
importance under environmental conditions when substrate availability is limited.  
Prior to this study, PhzB was already investigated as potential drug target and synthetic 
substrate and product analogs, used for mechanistic studies, demonstrated µM-affinities 
A B 
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towards the enzyme from B. cepacia. However, no activity assay was available to screen 
the inhibitory potency of these compounds and newly synthesized analogs in vitro. To this 
aim, a specific coupled enzymatic assay for PhzB was developed and used for screening of 
approximately 80 compounds. In addition, ITC experiments and X-ray crystallography 
were employed to enable full investigation of the compounds’ structure-activity 
relationships. Of the tested compounds, one class, the so-called "phenazistatins", 
comprised of very tight binders with up to nM-affinities, which were also very potent in 
vitro inhibitors of the PhzB-catalyzed reaction (Figure 58).  
 
Figure 58: Development and characterization of PhzB-inhibitors.  
A Affinity titration of WB069 (cis-fluoro-phenazistatin) to BcPhz(A)/B obtained by ITC. The ligand binds with a KD of 
1.0 ± 0.2 µM. B Dose-dependent enzyme inhibition assay of WB069 towards BcPhz(A)/B in vitro. The IC50 can be 
estimated between 1 and 10 µM. 
Some of these promising candidates were tested in cellulo against P. aeruginosa as well. 
Although a positive tendency towards inhibition of phenazine biosynthesis could be 
observed, none of the tested ligands proved to be particularly potent under the tested 
conditions, emphasizing the need for further ligand development especially regarding 
compound uptake and bioavailability.  
By combining binding measurements, X-ray crystallography and enzyme activity assays, 
this study provides a detailed description of various PhzB-inhibitors. For the first time 
endothermic PhzB binders were identified and it could furthermore be shown that 
"phenazistatins" can bind in different stereoconfigurations, i.e. in cis- and trans-
configuration. Future drug-development projects will benefit from these new insights into 
PhzB-inhibition.  
Altogether, this study provided a deeper understanding of two unique mechanisms within 
the phenazine biosynthesis pathway. The work greatly benefited from the combination of 
KD = 1.0 ± 0.2 µM 
A B
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multiple methods and from the collaboration with organic chemists, who synthesized 
tailor-made mechanistic probes and ligands, and with theoretical biochemists, who 
provided decisive complementary information to the kinetic experiments.  
7.2. Outlook 
As this study aimed at exploring the basic mechanistics of the "core" phenazine 
biosynthesis pathway, in particular, the unique steps catalyzed by the isomerase PhzF and 
the subsequent enzyme PhzB, the acquired knowledge may allow targeting and thus 
controlling this important metabolic pathway. This work contributed to the evaluation of 
the druggability of important catalytic intermediates that are required for production of 
the building blocks of all strain specific phenazines. This is of special interest in pathogenic 
phenazine producers, such as P. aeruginosa.  
In general, two ways for the druggability of phenazine biosynthesis are possible, the first 
being the reduction of the virulence factor production by inhibiting essential regulatory 
or synthetic routes. This method will primarily disarm the bacteria rather than killing them 
and hence might be an interesting approach for combination therapy with other already 
established antibiotics. The second idea, particularly interesting in terms of PhzB catalysis, 
is aiming at directly killing the bacteria by triggering self-intoxication. However, since 
phenazines play multiple important roles in their producers, resistance towards these 
drugs might develop rapidly.  
By making use of the new insights into the catalytic mechanism of PhzF, enzyme specific 
inhibitors/modulators could be developed. PhzF catalysis generates the highly reactive 
and potentially toxic intermediate AOCHC, hence modulating this enzyme might allow 
control over AOCHC production and thus of the overall phenazine biosynthesis. The 
approach could be used to inhibit PhzF, leading to complete abortion of phenazine 
biosynthesis and thus virulence factor production. In general, it might also be possible to 
enhance AOCHC production and consequently increase the intracellular levels of this toxic 
intermediate, which could potentially cause negative side effects harming the bacteria. 
The substrate analog ent-H2-DHHA used in this study shows a decent inhibitory potency 
and could be further developed into more-potent inhibitors. In addition, screening for 
other PhzF specific inhibitors, which are chemically not directly related to the substrate or 
7. Summary & Outlook Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 
164 
product of the reaction, represents a potential future perspective. The assay developed 
in this work allows a semi high-throughput method to screen a large number of candidates 
in a time- and material-efficient way. 
Prior to this work, PhzB was already considered a potential drug target. Yet, the newly 
identified and characterized inhibitors require further development. Some ligands with 
µM-affinities were found to be very potent inhibitors in vitro but failed to inhibit 
phenazine biosynthesis in vivo, probably due to limited bioavailability or metabolic 
degradation. Hence, the in cellulo efficiency needs further investigation. Drug delivery, in 
particular, seems to require optimization. This might be achieved by further 
varying/optimizing the ester groups of the prodrugs or by development of specific carriers 
or chaperones that are able to transport the inhibitors efficiently across the bacterial 
membrane. In addition, if further optimization of these substrate/product analogs fails, 
generation of chimeras with other known PhzB-inhibitors, such as raloxifene, might be a 
possibility to overcome metabolization or unspecific efflux by phenazine transporting 
pumps.  
Finally, the regulation of PhzB catalysis, especially the actual abundance and role of PhzAB 
heterodimerization in vivo needs to be evaluated in further detail. This knowledge could 
be used to adapt inhibitor development to certain environmental conditions, such as 
biofilm formation, or to link it to potential stress induced responses. 
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8. Side projects 
In parallel to the main projects presented in the previous chapters of this thesis, three 
additional side projects were pursued. All three projects constituted the de novo-structure 
determination of bacterial proteins: 
― The antibacterial type VI secretion effector Tse1 from P. aeruginosa PA7 
― The novel halohydrin dehalogenase HheG from I. coccineus YM16-304 
― Two lignin-degrading enzymes, the β-etherase LigF2 from N. aromaticivorans 
  DSM1244 and the glutathione-lyase LigG2 from T. denitrificans ATCC 25259. 
The latter projects were carried out in collaboration with Julia Koopmeiners and Hauke 
Voß from the group of Prof. Dr. Anett Schallmey of the Technical University Braunschweig.  
In the following paragraphs, a brief overview of the topic and major achievements 
regarding structural biology for each of these projects is presented.  
8.1. Atomic resolution structure of the bacteriolytic effector protein Tse1 from 
Pseudomonas aeruginosa PA7ǂ 
Introduction  
Like many Gram-negative and Gram-positive bacteria, the opportunistic human pathogen 
Pseudomonas aeruginosa features up to seven different secretion systems (type I-VII) for 
the export of diverse biomolecules. These systems are characterized either by their 
effector/substrate specificity, their target, or by the efficacy of substrate delivery (Chou 
et al., 2012). Upon human infection they are involved in host colonization; in competition 
with other bacteria they provide a fitness advantage (Kapitein and Mogk, 2013). One of 
them, the type VI secretion system (T6SS), discovered by Mekalanos and co-workers in 
Vibrio cholerae, provides bacteria with the ability to deliver specific bacteriocins to other 
prokaryotic cells via direct translocation (Pukatzki et al., 2007; Hood et al., 2010; Chou et 
al., 2012). The architecture of this secretion system is comparable to bacteriophage 
infection proteins or R-type pyocins (Cascales and Cambillau, 2012). Haemolysin co-
regulated proteins (Hcp) and valine-glycine repeat proteins G (VgrG) assemble to form a 
contractile phage-tail-like apparatus for effector delivery (Leiman et al., 2009). Initially, 
three delivered proteins, all secreted under post-translational control, were identified and 
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called type VI secretion exported proteins 1 – 3 (Tse1-3) accordingly (Hood et al., 2010). 
Nowadays, additional secreted effectors such as Tse4-6 are known (Whitney et al., 2014). 
In order to prevent intercellular self-intoxication by an active secretion machinery, the 
bacteria co-express an immunity protein from the same bicistronic operon as the effector. 
Inhibition of the effector is accomplished by a physical association with the cognate 
immunity protein (type VI secretion immunity proteins 1-6 = Tsi1-6; Hood et al., 2010).  
In order to elucidate the distinct roles of these effector/immunity protein systems in 
pathogenicity and interbacterial competition, this project aimed at the structural 
characterization of the individual proteins as well as their corresponding complexes. As a 
start, the structure determination of the bacteriolytic effector Tse1 was attempted. This 
bacteriocin is secreted into the periplasm of other Gram-negative bacteria where it 
hydrolyzes peptidoglycan and thus induces cell lysis (Russell et al., 2011). 
Results and Discussion  
The recombinantly expressed wild type protein from P. aeruginosa PA7 (UniProt-entry: 
A6V6X3 (A6V6X3_PSEA7)) could be obtained in high purity following standard purification 
procedures (as described in paragraph 3.2.3.) and crystallized from 0.1 - 0.25 M NaF and 
14 – 16 % (w/v) PEG 3350 at 20 °C via hanging-drop vapor diffusion method. Crystals of 
two different morphologies grew to a maximum size of 140*15*15 µm (rod-shaped, 
WT-1) or 300*150*150 µm (diamond-shaped, WT-2) within a few days (Figure 59 insets A 
and B). Diffraction data to a resolution of 1.64 Å and 1.16 Å could be collected for each 
crystal form respectively. The crystals belonged to the same orthorhombic space group 
P212121, but exhibited different unit-cell parameters.   
Since no significantly similar protein structures could be found in the protein data bank 
(PDB), experimental phasing using the SIRAS (single isomorphous replacement with 
anomalous signal) method was employed. To this aim, a native, rod-shaped crystal was 
soaked with 1 mM mercury chloride and diffraction data to a resolution of 2 Å were 
collected. Initial phases for the WT-1 crystal form were obtained using the data of the 
mercury derivative in combination with the native dataset in PHENIX AutoSol (Terwilliger 
et al., 2009). The program located two heavy atom sites and built an initial model with 
55 % of the residues that was later completed to 98 % by automatic model building with 
ARP/wARP (Langer et al., 2008). The model was completed and optimized by alternating 
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rounds of manual adjustment in COOT (Emsley et al., 2010) and maximum-likelihood 
refinement by phenix.refine (Afonine et al., 2012). Subsequently, it was used as an initial 
search model to solve the structure of the WT-2 crystal form by molecular replacement 
using Phaser (McCoy et al., 2007) of the PHENIX software suite (Adams et al., 2010).  
While in the WT-1 crystal form, one monomer per asymmetric unit is present, the 
asymmetric unit of the WT-2 form contains three monomers, all exhibiting very similar 
conformation compared to the monomer found in the first form (r.m.s.d. 0.19 – 0.26; 
Figure 59). Yet, the near atomic resolution of 1.16 Å allowed a more detailed analysis of 
the structure.  
The overall structure of Tse1 is characterized by a central, slightly twisted, six-stranded 
anti-parallel β-sheet, surrounded by α-helices. Three α-helices (α1-α3) flank the central 
sheet on one side, α-helix 4 on the other side. An additional small α-helix (α5) as well as 
two 310-helices (η1 and η2) span diagonal across the central sheet (Figure 59A). 
 
Figure 59: Structure of the bacteriolytic effector protein Tse1 from P. aeruginosa PA7 in two crystal forms.  
A Overall topology of the Tse1 monomer with its secondary structure elements in cartoon representation (skyblue). The 
catalytic dyad comprised of cysteine 30 and histidine 93 is highlighted as balls and sticks. Inset A: Rod-shaped crystal of 
Tse1 that diffracted to 1.64 Å resolution and contains one monomer per asymmetric unit. B Atomic resolution structure 
of Tse1 in cartoon representation. The structure was obtained from a diamond-shaped crystal (inset B) that diffracted 
to 1.16 Å and comprised three protein chains per asymmetric unit (chain A = skyblue, chain B = green and chain 
C = limon).  
A structural alignment related this fold, the αβ-papain-like amidase fold, to proteins of the 
N1pC/P60-peptidase family and hence identifies Tse1 as a cysteine peptidase. Yet, in 
comparison to other related proteins, Tse1 consists of a single domain only.   
The active site is located at the interface between α2 and β3, which are conserved 
structural elements among this family. The catalytic dyad, residues C30 and H93, are both 
part of two highly conserved amino acid patterns, CSGF and HV, and the thiol-group of the 
cysteine is further stabilized by the positive helix dipole of α2. The active site of Tse1 seems 
A B
catalytic 
dyad 
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to be much more accessible for the substrate compared to other proteins of similar fold, 
which might be due to the higher flexibility of surrounding loops. However, attempts to 
obtain complexes of wild type Tse1 or a catalytically inactive variant with a substrate 
analog, the muramyl tripeptide M-TriDAP, or the cognate immunity protein remained 
unsuccessful. 
Conclusion  
Since, a variety of structures of T6S effector/immunity protein complexes from different 
bacteria were solved by other groups including the complex of Tse1/Tsi1 (Benz et al., 
2012; Ding et al., 2012; Shang et al., 2012). Furthermore, additional effector/immunity 
protein systems transported by the T6SS were discovered (reviewed by Benz and 
Meinhart, 2014). The variety of structural data, including the work presented here, 
provides a comprehensive insight in the structure and function of bacteriolytic effectors 
delivered by the T6SS and hence bacterial competition and pathogenicity. This knowledge 
might allow the development of specific small molecule compounds that modulate the 
activity of this machinery and possibly fight infectious diseases caused by different 
bacteria.  
ǂDiederich, C. & Blankenfeldt, W.: Tse1 - Kristallstruktur eines bakteriolytischen Effektorproteins aus Pseudomonas 
aeruginosa (Talk). 30. Rabensteiner Kolleg Pottenstein, Germany, June 2012 
ǂDiederich, C. & Blankenfeldt, W.: Atomic resolution structure of the bacteriolytic effector protein Tse1 from 
Pseudomonas aeruginosa PA7 (Poster). 5th BZMB-PhD-Symposium, Selb, Germany, October 2012 
8.2. Crystal structure determination of the novel halohydrin dehalogenase HheG from 
Ilumatobacter coccineus YM16-304* 
Introduction  
Halohydrin dehalogenases (HHDHs) are a rare class of bacterial enzymes that catalyze the 
reversible dehalogenation of β-haloalcohols via epoxide formation (Janssen et al., 2006; 
You et al., 2013). Their natural role is the degradation of toxic halogenated compounds 
such as epichlorhydrin or 1,3-dichloro-3-propanol. Originally, three different phylogenetic 
subtypes (type A-C), all belonging to the short-chain dehydrogenase/ reductase (SDR) 
superfamily, were classified based on sequence identities and activity profiles of known 
HHDHs (van Hylckama Vlieg et al., 2001; Kavanagh et al., 2008). Within each subtype, the 
members share over 90 % sequence identity on the protein level, however between the 
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subtypes the similarity decreases below 30 % (van Hylckama Vlieg et al., 2001). In 2014, 
Schallmey and co-workers identified 37 novel HHDHs using sequence database mining 
based on the two conserved motifs SX12YX3R, the residues forming the catalytic triad, and 
TX4(F/Y)XG. Beside this consensus sequence, the overall sequence identity to known 
HHDHs was very low (below 30 %). As some of the new enzymes exhibited broader 
substrate spectra than previously known members of this class or demonstrated 
enhanced thermostability, the authors subsequently attributed these novel enzymes to 
four new subtypes, type D-G (Schallmey et al., 2014).   
The particular catalytic activity of HHDHs renders them promising candidates for 
biotechnology applications like the production of diverse enantiopure vicinal haloalcohols 
or epoxides, especially since, beside halides, a variety of other nucleophiles such as 
cyanide, azide, nitrite (Fuchs et al., 2009) or formate (Hasnaoui-Dijoux et al., 2008) can be 
employed for epoxide ring-opening. This allows industrial production of β-azidoalcohols, 
which are precursors for β-aminoalcohols, or of the important statin precursor (R)-4-
cyano-3-hydroxybutyrate (Schallmey and Schallmey, 2016). 
Among the HHDHs newly identified by Schallmey and co-workers, one enzyme, the single 
member of the G-subtype, HheG from Ilumatobacter coccineus YM16-304, exhibited 
higher activities on the conversion of cyclic epoxides or haloalcohols in contrast to other 
tested halohydrin dehalogenases. In order to understand this catalytic peculiarity and to 
obtain deeper insights into substrate binding and conversion, X-ray structure 
determination of HheG was pursued.  
Results and Discussion  
Hexagonal-shaped crystals of native N-terminally hexahistidine-tagged HheG, which 
belonged to the trigonal space group P3121, were obtained from a condition containing 
0.1 M sodium acetate pH 4.5 and 1 M ammonium phosphate dibasic. Since phasing of the 
structure using molecular replacement remained unsuccessful, the structure was solved 
by SAD (single wavelength anomalous dispersion) experimental phasing using a 
selenomethionine derivative. The moderate resolution of 2.7 Å and the high number of 
protein chains in the asymmetric unit complicated structure determination, yet collection 
of a very high redundancy dataset (5760 degree) and the identification of 108 selenium 
sites by SHELXD (Sheldrick, 2010) eventually yielded a reasonable solution. Moreover, the 
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derivatized crystals were isomorphous to the native ones, allowing phase extension of the 
anomalous data to a maximum resolution of 2.3 Å.   
Ten copies of the protein constitute the asymmetric unit by forming either a complete 
tetramer (chain ABCD; Figure 60A) or three individual dimers (chain EF, GH and IJ). In the 
latter case, the biological assembly of the tetramer is reconstituted by crystallographic 
two-fold symmetry. 
 
Figure 60: Structure of the novel halohydrin dehalogenase HheG from I. coccineus YM16-304.  
A Overall topology of the tetrameric biological assembly of HheG shown as cartoon and surface (transparent) 
representation. The individual chains are colored in dark purple (chain A), dark gray (chain B), gray (chain C) and white 
(chain D) respectively. B The HheG monomer depicted with its secondary structure elements. The residues of the 
catalytic triad are highlighted as balls and sticks. C Close-up on the electropositive active site cleft of HheG. The 
electrostatic potential was calculated using the ABPS plugin (Baker et al., 2001) of PyMOL (The PyMOL Molecular 
Graphics System, Version 1.8, Schrödinger, LLC.) and is represented on the molecular surface with a scale ranging from 
-10 (red) to 10 (blue) KbT/Ec. The residues of the catalytic triad S152, Y165 and R169, as well as the conserved residues 
T13 and G20 are shown as balls and sticks.  
Within a HheG monomer, six α-helices arrange around a central, twisted, seven-stranded 
parallel β-sheet (β1-β7); the three helices α1, α2 and α8 are found on one side, another 
small (α3) as well as two longer α-helices (α4 and α5) on the other side. Two additional 
α-helices (α6 and α7) and three 310-helices (η1-η3) are located on top of the β-sheet. HheG, 
like other HHDHs, exhibits a Rossmann-fold like architecture (Figure 60B). The active site 
is comprised of the catalytic triad S152, Y165 and R169 and is located at the bottom of a 
long and partially electropositive cleft adjacent to the halide binding site, which is 
occupied by a water molecule (Figure 60C).   
HheG was crystallized in absence of any ligand, nevertheless residual electron density was 
A B
C 
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observed in the active site (data not shown), indicating a covalent modification of S152. 
However, the quality of the data did not allow unambiguous attribution of this density to 
a specific substrate.  
A structural comparison of HheG with other previously published halohydrin 
dehalogenases/lyases (Jong et al., 2006; Schallmey et al., 2015; Watanabe et al., 2015) 
revealed that HheG features a large open active site cleft, while other HHDHs have narrow 
substrate tunnels leading to the active site. This large cleft suggests that HheG is able to 
accommodate larger substrate molecules and hence explain why this enzyme 
preferentially converts cyclic epoxides/haloalcohols over smaller aliphatic substrates. 
Conclusion  
The newly determined structure of the first member of the G-subtype of halohydrin 
dehalogenases, HheG from I. coccineus, revealed a distinct difference in the accessibility 
and volume of the active site compared to known HHDHs such as HheA2 from 
Arthrobacter sp. strain AD2 (Jong et al., 2006) or HheC from Agrobacterium tumefaciens 
(Jong et al., 2003). The ability to accommodate and convert more bulky, cyclic substrates 
does not only distinguish HheG from other members of this class, but also opens new 
biocatalytic routes for industrial applications, including synthesis of chiral tertiary or cyclic 
haloalcohols. Furthermore, the detailed structural insight enables additional protein 
engineering of HheG and thus potential further expansion of the product range.  
*Koopmeiners, J., Diederich, C., Solarczek, J., Voß, H., Mayer, J., Blankenfeldt, W. & Schallmey, A.: HheG, a Halohydrin 
Dehalogenase with Activity on Cyclic Epoxides. ACS Catal. 2017, 7 (10), pp 6877–6886.  
8.3. Structural studies of the two bacterial lignin-degrading enzymes LigF2 from 
Novosphingobium aromaticivorans DSM1244 and LigG2 from Thiobacillus denitrificans 
ATCC 25259 
Introduction  
The heterogeneous aromatic biopolymer lignin is assembled from three different 
monolignols, p-coumarylalcohol (H), coniferylalcohol (G) and sinapylalcohol (S) via 
oxidative coupling and, together with other biopolymers such as cellulose, hemicellulose 
or pectic polysaccharides, lignin composes the cell wall of plants (Hendriks and Zeeman, 
2009). As such, it constitutes one-third of all non-fossil organic carbon on earth (Austin 
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and Ballaré, 2010). At present, it is mainly used as heat and energy source being a 
byproduct in paper industry (Zakzeski et al., 2010). However, carrying different aromatic 
building blocks, lignin is considered a potential source for production of biofuel or 
aromatic fine chemicals (De los Santos Ramos et al., 2009). Still, its exploitation and the 
development of specific catalysts is challenging due to the complexity of this 
heteropolymer. Typically, industrial lignin depolymerization is achieved by chemical 
methods like thermolysis or chemical oxidation that have the disadvantage of yielding a 
complex mixture of degraded and partially repolymerized products (Pandey and Kim, 
2011). Therefore, enzymatic routes for selective lignin depolymerization are investigated. 
In fact, some fungi and bacteria, in particular sphingomonads, possess enzymes for lignin 
degradation, including peroxidases, laccases and β-etherases. While the former employ 
unselective radical-based mechanisms, β-etherases offer the possibility to generate pure 
enantiomeric low-molecular mass aromatics from the "achiral" lignin polymer using an 
unusual non-radical glutathione-dependent reductive catalytic mechanism to cleave β-O-
4-aryl ether bonds (Picart et al., 2015). Natural β-etherases, termed LigE, LigF, or LigP, 
cleave β-aryl ether adjacent to a carbonyl group under chirality inversion using glutathione 
(GSH) as co-substrate. Whilst LigE and LigP selectively cleave the R-enantiomer of a model 
compound (β-guaiacyl-α-veratrylglycerone, β-GVG), LigF exclusively cleaves the S-
enantiomer yielding the inverse product enantiomers as GSH-adducts (GS-β-(S/R)-VG). 
Subsequently, the highly selective GSH-lyase LigG processes the R-enantiomer of the GSH-
adduct yielding oxidized glutathione (GSSG) and veratrylglycerone (VG). In nature, 
stereospecific NADH-dependent alcohol dehydrogenases initially have to oxidize the α-
hydroxy group adjacent to the β-aryl ether to yield a ketone that is essential for β-etherase 
activity. Furthermore, yet uncharacterized racemases are suggested to convert the 
products of LigE and LigP into substrates for LigG (Masai et al., 2003; Gall et al., 2014).  
The β-O-4-aryl ether bond represents up to two-thirds of all linkages in lignin, hence 
bacterial β-etherases and the associated enzymes constitute promising candidates for 
valuable biomass degradation under mild conditions. To understand the molecular details 
of enzymatic lignin depolymerization better, this work aimed at the crystal structure 
determination of two novel enzymes involved in lignin degradation, the β-etherase LigF2 
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from N. aromaticivorans DSM1244 and the GSH-lyase LigG2 from T. denitrificans ATCC 
25259.  
Results and Discussion  
After size-exclusion chromatography the purified N-terminally hexahistidine-tagged 
proteins LigF2 and LigG2 were subjected to crystallization in presence or absence of 
10 mM reduced glutathione. Diffraction quality crystals of both enzymes could be 
obtained within a week from conditions containing 0.1 M HEPES pH 7.5, 2 M ammonium 
sulfate and 2 % (v/v) PEG 400 or 0.1 M TRIS/HCl pH 7.6 – 7.8, 10 – 12 % (w/v) PEG 8000 
and 0.2 mM MgCl2 for LigF2 and LigG2 respectively. Whilst for LigF2 only a single crystal, 
belonging to the trigonal space group P3221 with two monomers in the asymmetric unit, 
could be obtained in presence of GSH, LigG2 crystallized from conditions with or without 
GSH present. Both crystals contained six monomers per asymmetric unit, but belonged to 
two different orthorhombic space groups, namely P22121 and P212121 for apo- and GSH-
bound LigG2 respectively.  
Diffraction data to 3.1 Å for LigF2 or 2.13 Å (apo) and 2.8 Å (GSH-complex) for LigG2 could 
be collected. Since homologous structures for both proteins were available from the PDB, 
structure determination was done via molecular replacement using PDB entry 4XT0 (59 % 
sequence identity to LigF2) or 4G10 (51 % sequence identity to LigG2) as initial models. 
The GSH-complex of LigG2 was solved using the apo-structure as model. Model 
optimization was carried out by alternating rounds of manual adjustment in COOT (Emsley 
et al., 2010) and maximum-likelihood refinement by phenix.refine (Afonine et al., 2012). 
Both proteins form homodimers (Figure 61) and exhibit a typical glutathione S-transferase 
(GST)-fold with an N-terminal thioredoxin-like domain and a C-terminal α-helical domain 
comprised of 5 (α4 - α8; LigG2) or 8 α-helices (α4 - α11; LigF2). The former domain is 
comprised of a central, four-stranded mixed β-sheet (β1-β4) packing against parallel 
α-helices (α1 and α3) and is completed by an additional small α- (α2) as well as a 310-helix 
(η1).   
Similar to the published structure from Sphingobium sp. SYK-6 and GSTs of the ω-class 
(Meux et al., 2012), LigG2 has an additional long loop at its C-terminus, which, due to its 
flexibility might be involved in substrate binding and product release. However, no distinct 
8. Side projects Exploring and Controlling Phenazine Biosynthesis with Chemical and Structural Biology 
174 
structural differences could be observed between apo- and GSH-bound LigG2 to support 
this hypothesis.  
 
Figure 61: Crystal structures of the two novel lignin-degrading enzymes LigF2 from N. aromaticivorans DSM1244 and 
LigG2 from T. denitrificans ATCC 25259.  
Overall topology of the homodimeric biological assembly of the β-etherase LigF2 (A) and the GSH-lyase LigG2 (B) shown 
as surface representation. The individual chains are colored in light green (chain A) and lime (chain B; the gray region, 
poorly defined in the electron density maps, was modelled based on the other monomer) or ruby (chain A) and salmon 
(chain B) for LigF2 and LigG2 respectively. Both proteins exhibit a typical glutathione S-transferase fold and could be 
crystallized in presence of the co-factor GSH.  
Structure determination and analysis of LigF2 turned out to be challenging due to the 
moderate resolution of 3.1 Å. Nevertheless, a reasonable model could ultimately be 
obtained. The most striking difference to a previously published LigF-structure (Helmich 
et al., 2016) is the orientation of the helix-loop-helix motif involving α5 and α6, which is 
flipped out and hence opens the active site in LigF2. However, at this point no conclusive 
statement can be made, since this region is poorly defined in the structure, especially in 
chain B.  
Conclusion  
In this work, the crystal structures of two novel lignin-degrading enzymes, LigF2 and LigG2, 
could be determined. Although, in particular for the former, improvement of the crystals 
might be necessary before obtaining further potential substrate complex structures, the 
data on LigF2 and LigG2 give valuable structural insights and, together with biochemical 
data from collaborators, allow for a better understanding of the enzymes activities and 
specificities as well as provide a rational for future protein engineering. 
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A1. Additional results for PhzF 
A1.1. Additional figures 
 
Figure A1: Standard curve for determination of the extinction coefficient of DHHA in aqueous buffer at 275 nm.  
Serial dilutions of 1 mM of the two substrate isotopologues DHHA and d-DHHA in both, standard assay and 
crystallization buffer were prepared and the absorption at 275 nm of each dilution measured in an Infinite® M200 
microplate reader (Tecan Group Ltd.) using a five point readout per well. The plotted absorption values are average data 
from every readout with the corresponding error. Each of the four dilution series was measured in triplicates and 
individually fitted by linear regression using GraFit 5. The slopes from each regression curve were averaged and yielded 
an extinction coefficient of 6499 ± 180 M-1 cm-1. 
 
  
Figure A2: PhzF-catalyzed DHHA/d-DHHA isomerization in dependency of increasing concentrations of sodium 
phosphate.  
A The turnover number kcat (  = DHHA,  = d-DHHA) and B the Michaelis-constant KM (  = DHHA,  = d-DHHA) 
were plotted against different sodium phosphate concentrations ranging from 10 to 500 mM. The plotted values were 
derived by fitting normalized, background corrected, and averaged data of three independent measurements to a 
Michaelis-Menten model using GraFit 5. All data were obtained at 25 °C. 
  
 ε275 = 6499 ± 180 M-1 cm-1 
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Figure A3: Schiff base formation - a potential spontaneous side reaction that the highly reactive amino ketone AOCHC, 
as product of DHHA isomerization, could undergo in TRIS buffer.  
A PhzF catalyzed DHHA isomerization leads to formation of AOCHC. This amino ketone can react with the primary amine 
of TRIS and after water elimination an imine derivative, a so-called Schiff base, is formed. B Stereoscopic view of the 
potential binding mode of the Schiff base, synthesized from AOCHC and TRIS, to the active site of PhzF (P. fl 2-79). The 
molecule was modelled in an open structure of PhzF E45Q in complex with O-ethylated DHHA (PDB entry 5IWE, this 
study) and superimposed with the active complex PhzF/DHHA (PDB entry 1U1X, Blankenfeldt et al., 2004). The active 
site residues of the model as well as the ligand are shown in palegreen, while the original ligand O-Et-DHHA is shown in 
aquamarine. The active site residues and ligand of the DHHA complex are shown in paleyellow. The Schiff base is shown 
as balls and sticks, all other residues only as stick representation. 
 
 
Figure A4: pH-dependency of PhzF-catalyzed DHHA/d-DHHA isomerization in 50 mM Bis-TRIS propane buffer.   
The overall catalytic efficiency kcat/KM (  = DHHA,  = d-DHHA) is plotted against different pH-values ranging from 
pH 6.5 to 7.5 in steps of 0.1 pH-units. The plotted values were derived by fitting normalized, background corrected, and 
averaged data of three independent measurements to a Michaelis-Menten model using GraFit 5. All data were obtained 
at 25 °C. 
A 
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Figure A5: ITC profiles for affinity titrations of different PhzF substrates, substrate analogs, and inhibitors against wild 
type PhzF or variant E45Q.   
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). A shows profiles for 
individual titrations of 450 µM (  and ) or 1 mM ( ) DHHA to 50 or 100 µM PhzF E45Q respectively. The three other 
plots show titrations of 450 µM of either DHHS (B:  and ), H2-DHHA (C:  and ), and ent-H2-DHHA (D: ) to 50 µM 
PhzF WT. No binding event could be observed for any of the titrated compounds. All data were analyzed and fitted using 
the programs NITPIC (Keller et al., 2012) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the 
program GUSSI (Brautigam, 2015). 
E45Q WT 
WT WT 
C D 
A B 
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Figure A6: ITC profiles for affinity titrations of 3OHAA and AA against wild type PhzF and variant E45Q.   
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). Upper profiles: 
Titration of 450 µM 3OHAA to A 50 µM wild type PhzF ( , , and  for individual experiments) and B variant E45Q ( , 
, and ). Binding of 3OHAA to PhzF WT and E45Q was exothermic, with 1:1 stoichiometry and occurred with KD values 
of 1.07 ± 0.21 µM and 2.56 ± 0.07 µM respectively. Lower profiles: Titration of 450 µM AA to C 50 µM wild type PhzF 
(  and ) and D variant E45Q ( , , and ). Binding of AA to PhzF WT and E45Q was exothermic, with 1:1 stoichiometry 
and occurred with KD values of 14.10 ± 0.46 µM and 26.34 ± 2.42 µM respectively. All data were analyzed and fitted 
using the programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; 
Zhao et al., 2015) and plotted using the program GUSSI (Brautigam, 2015). 
KD = 1.07 ± 0.21 µM KD = 2.56 ± 0.07 µM 
KD = 14.10 ± 0.46 µM KD = 26.34 ± 2.42 µM 
WT E45Q 
WT E45Q 
A B 
C D 
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Figure A7: ITC profiles for affinity titrations of 3OHAA against wild type PhzF and variant E45Q.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). A and C show profiles 
for titrations of 450 µM 3OHAA to PhzF WT (A:  and  for individual experiments) or E45Q (C: , , and ). Binding is 
exothermic, with 1:1 stoichiometry and affinities of 993.2 ± 5.0 nM (WT) and 4.0 ± 1.2 µM (E45Q). B and D: Comparison 
of binding curves from different subsets of titration experiments showing reproducibility of the binding event. B 450 µM 
3OHAA to 50 µM PhzF WT ( and for a single experiment of each subset), D 450 µM ( , ) or 1 mM 3OHAA ( ) to 
50 µM or 100 µM PhzF E45Q respectively. All data were analyzed and fitted using the programs NITPIC (Keller et al., 
2012) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI (Brautigam, 2015). 
KD = 993.2 ± 5.0 nM 
WT 
KD = 4.01 ± 1.2 µM 
E45Q E45Q 
A B 
C D 
WT 
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Figure A8: ITC profile for affinity titrations of AA against PhzF variant E45Q.   
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). Comparison of binding 
curves from different titration experiments of 450 µM ( , single subset) and 1 mM ( ) AA to 50 µM or 100 µM PhzF 
E45Q respectively, showing reproducibility of the binding event. The data were analyzed and fitted using the programs 
NITPIC (Keller et al., 2012) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI 
(Brautigam, 2015). 
 
 
Figure A9: Active site of PhzF (P. fl 2-79) at near atomic resolution of 1.18 Å.   
Close-up on the active site of wild type PhzF in its open conformation with the active site residues shown as balls and 
sticks in their 2mFo-DFc density map, contoured at 1σ. The protein was crystallized in presence of H2-DHHA, however 
the displayed Fourier difference density (mFo-DFc) omit map contoured at 3σ cannot unambiguously be attributed to 
the co-crystallized ligand. Instead, residual phosphate from the purification buffer was built. 
 
E45Q 
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Figure A10: Amino acids at the dimer interface as targets for mutagenesis to probe the influence of dimerization on 
PhzF activity.   
Cartoon representation of a PhzF dimer in paleyellow (chain A) and gray (chain B). The active site residues E45, H74, 
D208 and S213 as well as the dimer interface residues Y4 and N42 are shown as balls and sticks. In chain A, the active 
site residues are depicted in paleyellow, while Y4 and N42 are highlighted in green and blue respectively. Their 
counterparts in chain B are shown in gray. Y4 and N42 mediate important hydrogen-bonding interactions with the 
corresponding amino acid of the second chain. Exchange of these interface residues with a smaller amino acid, e.g. 
alanine, is supposed to impede dimerization and thus potentially influence catalytic activity. N42 is particularly 
interesting as it is located in close proximity to the active site cleft of PhzF.  
 
A1.2. Additional tables 
Table A1: Enzyme kinetic parameters for the conversion of the heavy substrate isotopologue d-DHHA by PhzF 
(P. fl 2-79) in presence of increasing sodium phosphate concentrations.* 
sodium phosphate pH 7.5 kcat (s-1) KM (µM) kcat/KM (M-1s-1) 
10 mM 0.41 ± 0.01 513 ± 27 804 ± 52 
20 mM 0.36 ± 0.01 341 ± 17 1050 ± 63 
50 mM 0.55 ± 0.03 769 ± 55 720± 67 
100 mM 0.47 ± 0.02 729 ± 47 650± 52 
200 mM 0.49 ± 0.03 1037 ± 71 469 ± 41 
500 mM 0.47 ± 0.02 1014 ± 60 462 ± 35 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
 
Table A2: Primary kinetic isotope effects (KIE) for the DHHA isomerization catalyzed by PhzF (P. fl 2-79) in dependency 
of increasing sodium phosphate concentrations.* 
sodium phosphate pH 7.5 KIEapp (kcat) KIEapp (kcat/KM) 
10 mM 7.4 ± 0.4 6.6 ± 0.7 
20 mM 7.2 ± 1.0 7.9 ± 1.9 
50 mM 4.6 ± 0.3 5.7 ± 0.7 
100 mM 7.6 ± 0.6 7.1 ± 0.9 
200 mM 5.4 ± 0.3 7.8 ± 0.8 
500 mM 6.1 ± 0.3 7.2 ± 0.7 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected.  
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Table A3: Enzyme kinetic parameters for the conversion of light (DHHA) and heavy substrate isotopologue (d-DHHA) 
by PhzF (P. fl 2-79) in 50 mM sodium phosphate buffer at different pH-values.* 
50 mM sodium 
phosphate 
 kcat (s-1) KM (µM) kcat/KM (M-1s-1) KIEapp (kcat) KIEapp (kcat/KM) 
pH 6.5 
DHHA 1.06 ± 0.09 442 ± 115 2402 ± 658 
- - 
d-DHHA - - - 
pH 6.75 
DHHA 4.88 ± 0.89 2800 ± 640 1743 ± 510 
5.7 ± 1.2 9.8 ± 3.4 
d-DHHA 0.86 ± 0.10 4839 ± 660 178 ± 32 
pH 7.0 
DHHA 5.00 ± 0.20 1411 ± 75 3539 ± 237 
8.1 ± 0.5 6.9 ± 0.8 
d-DHHA 0.62 ± 0.03 1203 ± 94 512 ± 46 
pH 7.25 
DHHA 4.80 ± 0.78 1379 ± 248 3485 ± 845 
13.3 ± 2.2 4.5 ± 1.1 
d-DHHA 0.36 ± 0.01 461 ± 19 780 ± 40 
pH 7.5 
DHHA 2.83 ± 0.30 532 ± 68 5329 ± 888 
6.3 ± 0.8 11.2 ± 2.1 
d-DHHA 0.45 ± 0.03 945 ± 63 475 ± 43 
pH 7.75 
DHHA 3.42 ± 0.37 632 ± 83 5407 ± 918 
7.4 ± 0.9 4.9 ± 1.0 
d-DHHA 0.46 ± 0.03 419 ± 34 1095 ± 113 
pH 8.0 
DHHA 3.13 ± 0.42 893 ± 159 3506 ± 784 
5.7 ± 1.0 3.4 ± 1.0 
d-DHHA 0.55 ± 0.07 536 ± 79 1023 ± 196 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
 
Table A4: Enzyme kinetic parameters for the conversion of light (DHHA) and heavy substrate isotopologue (d-DHHA) 
by PhzF (P. fl 2-79) in 50 mM Bis-TRIS propane buffer at different pH-values.* 
50 mM Bis-TRIS 
propane 
 kcat (s-1) KM (µM) kcat/KM (M-1s-1) KIEapp (kcat) KIEapp (kcat/KM) 
pH 6.5 
DHHA 2.11 ± 0.17 810 ± 93 2608 ± 363 
5.6 ± 0.7 9.5 ± 1.9 
d-DHHA 0.38 ± 0.03 1382 ± 157 274 ± 39 
pH 6.6 
DHHA 2.41 ± 0.17 1117 ± 113 2156 ± 267 
7.0 ± 0.7 6.7 ± 1.3 
d-DHHA 0.34 ± 0.03 1059 ± 136 324 ± 48 
pH 6.7 
DHHA 2.82 ± 0.21 713 ± 81 3961 ± 535 
3.9 ± 0.9 9.1 ± 3.0 
d-DHHA 0.72 ± 0.15 1659 ± 366 435 ± 132 
pH 6.8 
DHHA 2.85 ± 0.19 701 ± 76 4062 ± 521 
7.5 ± 0.8 8.8 ± 1.7 
d-DHHA 0.38 ± 0.03 821 ± 92 462 ± 66 
pH 6.9 
DHHA 2.26 ± 0.03 558 ± 15 4052 ± 117 
7.1 ± 0.2 6.0 ± 0.4 
d-DHHA 0.32 ± 0.01 471 ± 24 677 ± 41 
pH 7.0 
DHHA 2.41 ± 0.09 646 ± 46 3735 ± 297 
7.6 ± 0.4 5.3 ± 0.6 
d-DHHA 0.32 ± 0.01 448 ± 31 710 ± 56 
pH 7.1 
DHHA 2.45 ± 0.11 659 ± 36 3716 ± 267 
8.4 ± 0.5 6.8 ± 0.6 
d-DHHA 0.29 ± 0.01 531 ± 24 550 ± 31 
pH 7.2 
DHHA 1.68 ± 0.07 603 ± 65 2780 ± 320 
5.2 ± 0.3 5.2 ± 0.7 
d-DHHA 0.32 ± 0.01 605 ± 30 530 ± 32 
pH 7.3 
DHHA - - - 
- - 
d-DHHA 0.26 ± 0.11 2235 ± 1160 114 ± 78 
pH 7.4 
DHHA 3.57 ± 0.92 2647 ± 731 1349 ± 510 
12.0 ± 3.1 2.2 ± 0.9 
d-DHHA 0.30 ± 0.01 494 ± 23 603 ± 36 
pH 7.5 
DHHA 3.07 ± 0.09 1826 ± 66 1679 ± 77 
9.2 ± 1.0 2.3 ± 0.4 
d-DHHA 0.33 ± 0.03 453 ± 53 732 ± 112 
* The obtained values are averaged data of three independent measurements fitted to a Michaelis-Menten model. All data were obtained in the respective 
buffer at 25 °C, normalized to zero, and background corrected. 
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Table A5: Data collection and preliminary refinement statistics for a wild type PhzF (P. fl 2-79) dataset at near atomic 
resolution.ǂ 
 putative complex with H2-DHHA1 
Data collection2  
Beamline† X06DA (PXIII), SLS 
Wavelength (Å) 1.00002 
Resolution range (Å) 77.97 – 1.18 (1.20 – 1. 18) 
Space group P3221 
unit cell dimensions  
a, b, c (Å) 56.29, 56.29, 155.95 
α, β, γ (°) 90, 90, 120 
Mosaicity (°)‡ 0.10 
Measured reflections 1791273 (71681) 
Unique reflections 95255 (4676) 
Multiplicity 18.8 (15.3) 
Mean I/σ(I) 27.2 (2.0) 
CC1/2* 1.000 (0.621) 
Completeness (%) 100.0 (99.9) 
Rmeas
§ 6.0 (157.5) 
Rp.i.m.
¶ 1.4 (39.9) 
  
Refinement³  
Resolution range (Å) 51.98 – 1.18 (1.19 – 1.18) 
Rcryst (%) 12.50 (23.48) 
Rfree (%) 14.44 (23.52) 
No. of non H-atoms  
    Protein 2194 
    Ligand / Ion 5 
    Water 273 
Average B-factors (Å²)  
    Protein 16.4 
    Ligand / Ion 20.4 
    Water 30.9 
R.m.s deviations  
    Bond lengths (Å) 0.009 
    Bond angles (°) 1.071 
Ramachandran plot (%)  
   Favored regions 98.2 
   Outliers 0 
MolProbity score # 0.87 
ǂValues in parentheses are for the highest resolution shell. - 
1 Careful inspection of the electron density map in the active site did not convincingly support the presence of the ligand, but rather suggests that a 
phosphate ion from the purification buffer is bound to the active site.   
2 The dataset was collected from a single crystal.  
† SLS: Swiss Light Source, Paul Scherrer Institute (PSI), Villigen, Switzerland. 
‡ Mosaicity values reported by XDS (Kabsch, 2010).  
* CC1/2 is the correlation coefficient between two random half datasets (Karplus and Diederichs, 2012)  
§	a? = ∑ nIℎL/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|C123 /∑ ∑ gCC123 IℎL, where N(hkl is the number of observations of the reflection with  
  index hkl and Ii(hkl) is the intensity of its ith observation (Diederichs and Karplus, 1997);   
¶	t.C.. = ∑ n1/IℎL − 1
q*/'∑ |gCIℎL − 〈gIℎL〉|/∑ ∑ gCIℎLC123C123  (Weiss, 2001)  
3 Refinement was not conducted until final convergence.  
# As reported by MolProbity (http://molprobity.biochem.duke.edu/ (Chen et al., 2010) 
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A2. Additional results for the PhzAB heterodimerization 
A2.1. Additional figures 
 
Figure A11: Sequence alignment of PhzB para- and orthologues from different phenazine producing species.   
Using the enzyme from Burkholderia cepacia R18194 (BcPhz(A)/B) as reference, the orthologous proteins PhzA and PhzB 
from two Pseudomonas spp., P. fluorescens 2-79 (P. fl 2-79) and P. aeruginosa PAO1 (PhzA/B1 and PhzA/B2) were 
compared regarding their sequence identity. Residues important for ligand binding ( ) or catalysis ( ) are highlighted. 
Filled symbols represent strict conservation, whilst empty symbols indicate single amino acid mutations, which impede 
activity and/or binding. The alignment was generated using PROMALS3d (Pei and Grishin, 2007). 
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Figure A12: Time traces of the PhzB catalyzed condensation of AOCHC.  
The time traces of A the uncatalyzed reaction and B-D the reaction using 1 µM of the respective dimer (B: PhzAA; 
C: BcPhz(A)/B and D: PhzBB) in presence of 1 µM PhzF dimer as coupled enzyme are shown at different substrate 
concentrations ranging from  = 0 mM to  = 1 mM DHHA. Formation of a downstream product of the condensation 
was followed at 330 nm. All data were obtained in 50 mM sodium phosphate buffer at 25 °C and normalized to zero. 
 
  
Figure A13: Crystal structures of BcPhz(A)/B in complex with 2ACHCA after soaking with different concentrations.  
Close-ups on the active site (chain B) of two different BcPhz(A)/B complex structures each with two molecules of the 
substrate analog 2ACHCA bound to the active site. The complex structures of BcPhz(A)/B and the analog were obtained 
after soaking with A 5 mM or B 50 mM of the ligand overnight. The ligands as well as the coordinating active site residues 
are shown as ball and stick representation (* indicates that this residue is belonging to the second protein chain). The 
ligands are additionally depicted in their Fourier difference density (mFo-DFc) omit map contoured at 3σ in green. 
Hydrogen bonds (- - -) and coordinating water (red balls) are highlighted as well. 
  
A B 
C D 
A B 
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Figure A14: Temperature dependent unfolding transitions of different PhzB para- and orthologues.   
The melting curves of BcPhz(A)/B ( ), HeteroPhzAB with ( ) and without N-terminal hexahistidine-tag ( ), PhzBB ( ) 
as well as PhzAA ( ) were recorded within a temperature range from 10 to 60 °C using the CD signal at 212 nm and 
converted to mean residue ellipticity [Θ]MRW. 
 
 
Figure A15: Comparison of the "active site" pockets of HeteroPhzAB.  
Overlay of the two chains (PhzA and PhzB) of the PhzAB heterodimer. The volumes of their active site/binding cavities 
were calculated using the program KVFinder (Oliveira et al., 2014), which yielded volumes of 765 Å³ and 500 Å³ for PhzA 
(light gray) and PhzB (dark gray) respectively. The extension of the pocket in the A-monomer is caused by mutation of 
tyrosine 117 (PhzB) to cysteine, a residue bearing a smaller side chain. Furthermore, the displacement of the C-terminus 
of the second monomer that - via arm-exchange - provides a residue (R157*) to the binding pocket leads to an opening 
of the pocket.   
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A2.2. Additional tables 
Table A6: Overview of the refined occupancy and temperature factors for the crystal structures of BcPhz(A)/B in 
complex with different concentrations of two substrate analogs, 3OCHCA and 2ACHCA* 
3OCHCA  chain A high chain A low chain B high chain B low 
50 mM 
occupancy 1.00 0.99 1.00 1.00 
average B-factor (Å²) 22.8 46.2 23.7 37.1 
20 mM 
occupancy 1.00 0.89 1.00 0.99 
average B-factor (Å²) 25.7 52.7 25.5 40.3 
10 mM 
occupancy 0.92 0.89 1.00 0.96 
average B-factor (Å²) 29.4 58.2 28.0 46.6 
5 mM 
occupancy 0.93 0.94 0.94 0.89 
average B-factor (Å²) 32.1 58.9 30.9 47.9 
2ACHCA      
50 mM 
occupancy 0.85 0.67 0.84 0.66 
average B-factor (Å²) 21.7 48.2 25.9 40.5 
20 mM 
occupancy 0.92 0.86 1.00 0.76 
average B-factor (Å²) 20.2 49.7 27.0 39.0 
10 mM 
occupancy 1.00 0.67 1.00 0.72 
average B-factor (Å²) 24.4 82.6 33.8 63.6 
5 mM 
occupancy 0.94 0.71 0.90 0.80 
average B-factor (Å²) 29.5 64.0 29.5 56.4 
*Data refinement was carried out using phenix.refine (Afonine et al., 2012) of the PHENIX software suite (Adams et al., 2010). The occupancy was analyzed 
in coot (Emsley et al., 2010) and the temperature factors calculated with the program BAVERGAE implemented in the CCP4 suite (Winn et al., 2011). 
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A3. Additional results for PhzB-inhibitors 
A3.1. Additional figures and schemes 
 
  
Figure A16: ITC profiles for affinity titrations of WB003 (A), WB012 (B), WB013 (C), and WB014 (D) against BcPhz(A)/B. 
For a detailed description of these plots please refer to the legend of Figure A17.  
A B 
C D 
KD = 119.0 ± 17.4 µM KD = 5.8 ± 0.2 µM 
KD = 1.7 ± 0.2 µM 
KD = 27.7 ± 0.7 µM 
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Figure A17: ITC profiles for affinity titrations of WB015 (A), WB018 (B), WB019 (C), and WB020 (D) against BcPhz(A)/B. 
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for all titrated ligands in Figure 
A16 and Figure A17 except for WB014 in Figure A16D, which exhibits an endothermic binding curve. The corresponding 
binding affinities are depicted in the plots unless fitting of the data failed, e.g. Figure A17C and D. The symbols ,  and 
 (and ) represent individual experiments All data were analyzed and fitted using the programs NITPIC (Keller et al., 
2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the 
program GUSSI (Brautigam, 2015). 
KD = 12.4 ± 0.5 µM KD = 36.4 ± 9.4 µM 
A B 
C D 
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Figure A18: ITC profiles for affinity titrations of WB025 (A), WB027 (B), WB026 (C), and WB028 (D) against BcPhz(A)/B. 
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is endothermic for all titrated ligands except 
for WB028 (D), which exhibits an exothermic binding curve. The corresponding binding affinities are depicted in the 
plots. The symbols , , and  represent individual experiments All data were analyzed and fitted using the programs 
NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) 
and plotted using the program GUSSI (Brautigam, 2015). 
KD = 399.3 ± 55.4 nM KD = 13.0 ± 0.1µM 
KD = 16.9 ± 1.8 µM 
KD = 17.4 ± 1.0 µM 
A B
C D 
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Figure A19: ITC profiles for affinity titrations of WB035 (A), WB047 (B), WB050 (C), and WB067 (D) against BcPhz(A)/B. 
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for WB047 (B) and endothermic 
for WB050 (C), although the former ligand exhibits an unusual binding curve. The corresponding binding affinities are 
depicted in the plots unless fitting of the data failed, e.g. WB035 (A) and WB067 (D). The symbols , , and  represent 
individual experiments All data were analyzed and fitted using the programs NITPIC (Keller et al., 2012; Scheuermann 
and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI 
(Brautigam, 2015). 
KD = 81.2 ± 12.8 µM 
KD = 473.3 ± 31.4 nM 
A B 
C D 
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Figure A20: ITC profiles for affinity titrations of WB069 (A), WB071 (B), WB073 (C), and WB083 (D) against BcPhz(A)/B. 
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for all tested compounds, 
except WB071 (B) where no binding could be detected. The corresponding binding affinities are depicted in the plots 
unless fitting of the data failed, e.g. WB071 (B). The symbols , , and  represent individual experiments All data were 
analyzed and fitted using the programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT 
(Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI (Brautigam, 2015). 
KD = 1.0 ± 0.2 µM 
KD = 3.4 ± 0.2 µM KD = 122.2 ± 26.4 nM 
A B 
C D 
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Figure A21: ITC profiles for affinity titrations of WB084 (A), WB086 (B), and WB089 (C) against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for individual titration experiments (middle panel), and the quality of the fit (lower panel). All profiles represent 
titrations of 2 mM of the respective analog to 100 µM BcPhz(A)/B. Binding is exothermic for all tested compounds and 
the corresponding binding affinities are depicted in the plots. The symbols , , and  represent individual experiments 
All data were analyzed and fitted using the programs NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) 
and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) and plotted using the program GUSSI (Brautigam, 2015). 
 
KD = 130.4 ± 22.7 nM 
KD = 452.2 ± 33.3 nM KD = 22.9 ± 0.5 µM 
A B 
C 
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Figure A22: ITC profiles for the individual fits of affinity titrations of WB011 against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for (individual) titration experiments (middle panel), and the quality of the fit (lower panel). Titrations of 2 mM 
WB011 to 100 µM BcPhz(A)/B reveal an exothermic binding behavior of the compound. The curves in A were all fitted 
individually and the associated binding constants averaged. In the plots B-D, the data from three individual titrations 
(triplicate) were fitted together, either as single (B) or as individual transition curves (C and D). The corresponding 
binding affinities with the standard deviation (A) or a confidence level, i.e. an affinity range (B-D) are depicted in the 
plots. The symbols , , and  represent individual experiments All data were analyzed and fitted using the programs 
NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) 
and plotted using the program GUSSI (Brautigam, 2015). 
KD = 9.4 ± 1.5 µM 
KD = 1.9 (1.7, 2.1) µM KD = 2.1 (1.4, 3.4) µM 
KD = 7.3 (4.4, 11.5) µM 
A B
C D 
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Figure A23: ITC profiles for the individual fits of affinity titrations of WB077 against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for (individual) titration experiments (middle panel), and the quality of the fit (lower panel). Titrations of 2 mM 
WB077 to 100 µM BcPhz(A)/B reveal an exothermic binding behavior of the compound. The curves in A were all fitted 
individually and the associated binding constants averaged. In the plots B-D, the data from three individual titrations 
(triplicate) were fitted together, either as single (B) or as individual transition curves (C and D). The corresponding 
binding affinities with the standard deviation (A) or a confidence level, i.e. an affinity range (B-D) are depicted in the 
plots. The symbols , , and  represent individual experiments All data were analyzed and fitted using the programs 
NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) 
and plotted using the program GUSSI (Brautigam, 2015). 
KD = 5.6 ± 0.4 µM 
KD = 1.0 (0.8, 1.2) µM KD = 3.3 (2.9, 3.8) µM 
KD = 5.6 (4.3, 7.3) µM 
A B
C D 
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Figure A24: ITC profiles for the individual fits of affinity titrations of WB082 against BcPhz(A)/B.  
The individual plots show the generated heat per injection at different time points (upper panel), the fitted binding 
curves for (individual) titration experiments (middle panel), and the quality of the fit (lower panel). Titrations of 2 mM 
WB082 to 100 µM BcPhz(A)/B reveal an exothermic binding behavior of the compound. The curves in A were all fitted 
individually and the associated binding constants averaged. In the plots B-D, the data from three individual titrations 
(triplicate) were fitted together, either as single (B) or as individual transition curves (C and D). The corresponding 
binding affinities with the standard deviation (A) or a confidence level, i.e. an affinity range (B-D) are depicted in the 
plots. The symbols , , and  represent individual experiments All data were analyzed and fitted using the programs 
NITPIC (Keller et al., 2012; Scheuermann and Brautigam, 2015) and SEDPHAT (Houtman et al., 2007; Zhao et al., 2015) 
and plotted using the program GUSSI (Brautigam, 2015). 
KD = 3.6 ± 0.4 µM 
KD = 1.2 (0.9, 1.6) µM KD = 1.5 (1.2, 2.0) µM 
KD = 4.5 (3.4, 5.8) µM 
A B 
C D 
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Figure A25: Residual enzymatic activity of BcPhz(A)/B in presence of N-piperidinyl or N-phenyl anthranilic acid-
derived inhibitors and 125 µM DHHA.    
The plot shows the residual enzymatic activity of Phz(A)/B from B. cepacia in presence of 125 µM DHHA and either 
10 (light colors) or 100 µM (dark colors) inhibitor compared to the uninhibited reaction (R). The numbers represent the 
individual compound, e.g. 14 = WB014. BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final 
concentration in all assays. The data, obtained in 50 mM sodium phosphate buffer pH 7.5, supplemented with 2 % (v/v) 
DMSO, at 25 °C, were normalized to zero, corrected, and averaged from three independent measurements. 
 
 
 
Figure A26: Residual enzymatic activity of BcPhz(A)/B in presence of different concentrations of N-carboxycycloalkyl 
anthranilic acid-derived inhibitors.  
The plot shows the residual enzymatic activity of Phz(A)/B from B. cepacia in presence of 1 mM DHHA and inhibitor 
concentrations from 0.1 – 100 µM (from light to dark colors) compared to the uninhibited reaction (R) allowing 
approximation of the corresponding IC50-values. The numbers represent the individual compound, e.g. 47 = WB047. 
BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final concentration in all assays. The data, 
obtained in 50 mM sodium phosphate buffer pH 7.5, supplemented with 2 % (v/v) DMSO, at 25 °C, were normalized to 
zero, corrected, and averaged from three independent measurements. 
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Scheme A1: Chemical structures of bioisosteres and prodrug esters of the N-carboxycycloalkyl anthranilic acid-derived compounds ("phenazistatins"). 
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Figure A27: Residual enzymatic activity of BcPhz(A)/B in presence of bioisosteres and prodrug esters of N-carboxy-
cycloalky anthranilic acid-derived inhibitors.  
The plot shows the residual enzymatic activity of Phz(A)/B from B. cepacia in presence of 1 mM DHHA and either 10 (light 
colors) or 100 µM (dark colors) inhibitor compared to the uninhibited reaction (R). The numbers represent the individual 
compound, e.g. 02 = WB002. BcPhz(A)/B and the coupled enzyme PhzF were used at 1 mM (dimer) final concentration 
in all assays. The data, obtained in 50 mM sodium phosphate buffer pH 7.5, supplemented with 2 % (v/v) DMSO, at 
25 °C, were normalized to zero, corrected, and averaged from three independent measurements. 
 
 
Figure A28: In cellulo inhibition studies of pyocyanin production in P. aeruginosa PAO1.  
Phenazine biosynthesis inhibition was analyzed in presence of 100 µM inhibitor by quantification of pyocyanin levels in 
P. aeruginosa PAO1 cultures in PPGAS-medium after incubation overnight. After growth correction, data were averaged 
from triplicates and plotted in relation to a compound free control (C1-3). The numbers represent the individual 
compounds, e.g. 01 = WB001. B represents a buffer control (final concentration: 2 mM TRIS/HCl pH 9.0). Each bar 
indicates an independent replica (each n = 3). Compound HIPS 918 was used as positive control at its known IC50-value 
(determined against P. aeruginosa PA14 in PPGAS-medium, internal communication).  
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Figure A29: In cellulo inhibition studies of pyocyanin production in P. aeruginosa PA14 in M63-medium.  
Phenazine biosynthesis inhibition was analyzed in presence of 100 µM inhibitor by quantification of pyocyanin levels in 
P. aeruginosa PA14 cultures in M63-medium after incubation overnight. After growth correction, data were averaged 
from triplicates and plotted in relation to a compound free control (C1-3). The numbers represent the individual 
compounds, e.g. 01 = WB001. B represents a buffer control (final concentration: 2 mM TRIS/HCl pH 9.0). Each bar 
indicates an independent replica (each n = 3). The compounds HIPS 918 and HIPS 209 were used as positive control at 
their known IC50-value (determined against P. aeruginosa PA14 in PPGAS- or M63-medium for HIPS 918 and HIPS 209 
respectively; internal communication). 
 
 
Figure A30: Kinetically resolved permeability of three "phenazistatin"-derivatives using an in vitro permeation model. 
Membrane permeability of three "phenazistatin"-derivatives, WB001 (), WB050 (), WB090 (), was evaluated in a 
specifically coated Transwell®-filter system mimicking the bacterial outer membrane. The substance flux J was 
quantified using the UV-signal of the compounds on an UHPLC-system and amounted to 7.2 ± 2.4, 13.2 ± 2.8, and 
14.8 ± 3.6 µg cm-2 h-1 for WB001, WB050, and WB090 respectively. All permeability measurements were performed by 
Florian Gräf (Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken). 
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Figure A31: Crystal structures of BcPhz(A)/B in complex with different synthetic "phenazistatin" derivatives.  
Close-ups on the active site (chain A or B) of different BcPhz(A)/B complex structures with potential PhzB-inhibitors of 
the "phenazistatin"-class after soaking with 10 mM of the respective ligand overnight. The ligands are highlighted as 
balls and sticks in different colors and depicted in their Fourier difference density (mFo-DFc) omit map contoured at 3σ 
in green: A WB002, B WB003, C cis-chloro-phenazistatin (WB011), D cis-iodo-phenazistatin (WB012), E trans-
oxadiazolone-phenazistatin (WB026), and F: cis-fluoro-phenazistatin (WB069). The protein is shown as cartoon and the 
coordinating active site residues as balls and sticks colored in yellow and forest (for residues belonging to the second 
chain, depicted with *). Hydrogen bonds (- - -) and coordinating water (red balls) are highlighted as well. 
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Figure A32: Crystal structures of BcPhz(A)/B in complex with different synthetic "phenazistatin" derivatives or 
raloxifene .  
Close-ups on the active site (chain A or B) of different BcPhz(A)/B complex structures with potential PhzB-inhibitors of 
the "phenazistatin"-class or raloxifene after soaking with 10 mM of the respective ligand overnight. The ligands are 
highlighted as balls and sticks in different colors and depicted in their Fourier difference density (mFo-DFc) omit map 
contoured at 3σ in green: A trans-fluoro-phenazistatin (WB070), B cis-carboxyethyl-phenazistatin (WB071), C cis-
phenyl-phenazistatin (WB073), D cis-hydro-phenazistatin (WB082), E trans-hydro-phenazistatin (WB083), and 
F: raloxifene (RAL). The protein is shown as cartoon and the coordinating active site residues as balls and sticks colored 
in yellow (gold for raloxifene in F) and forest (for residues belonging to the second chain, depicted with *). Hydrogen 
bonds (- - -) and coordinating water (red balls) are highlighted as well.  
A B 
C D 
E F 
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A3.2. Additional tables 
Table A9: Overview over thermodynamic binding parameters obtained from ITC affinity titrations against BcPhz(A)/B 
for a variety of newly synthesized PhzB ligands.# 
Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
 
WB001 (cis) 
6.4 ± 1.1 • 10-2 -9.8 ± 0.1 -10.3 ± 0.2 0.5 ± 0.2 1.8 ± 0.1 1610.6 ± 242.7 
 
WB003 (racemic, cis) 
119.0 ± 17.4 -5.4 ± 0.1 -4.2 ± 0.1 -1.2 ± 0.2 1.5 ± 0.3 0.9 ± 0.1 
 
WB011 (racemic, cis) 
9.4 ± 1.5 
7.3 (4.8, 11.5) 
-6.9 ± 0.1 
-7.0 
-10.2 ± 0.5 
-8.4 
3.4 ± 0.6 
-1.4 
2.4 ± 0.0 
2.3 
10.9 ± 1.8 
13.7 
 
WB012 (racemic, cis) 
5.8 ± 0.2 -7.1 ± 0.0 -9.4 ± 0.2 2.3 ± 0.2 2.8 ± 0.0 17.3 ± 0.7 
 
WB013 (racemic, cis) 
1.7 ± 0.2 -7.9 ± 0.1 -8.7 ± 0.4 0.8 ± 0.4 1.9 ± 0.0 58.4 ± 5.8 
 
WB014 (racemic) 
27.7 ± 0.7 -6.2 ± 0.0 8.1 ± 0.2 -14.3 ± 0.2 1.8 ± 0.0 3.6 ± 0.1 
 
WB015 (racemic) 
2.4 ± 0.5 -7.7 ± 0.1 -6.7 ± 0.9 -1.0 ± 1.0 4.2 ± 0.5 43.1 ± 8.0 
 
WB017 (racemic) 
11.3 ± 0.1 -6.7 ± 0.0 -10.8 ± 0.1 4.0 ± 0.1 2.6 ± 0.1 8.8 ± 0.1 
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Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
 
WB018 (racemic) 
36.4 ± 9.4 -6.1 ± 0.1 -9.5 ± 0.6 3.5 ± 0.8 3.7 ± 0.9 2.9 ± 0.7 
 
WB024 (racemic, trans) 
5.1 ± 0.4 -7.2 ± 0.0 4.3 ± 0.1 -11.5 ± 0.1 1.3 ± 0.0 19.7 ± 1.5 
 
WB025 (racemic, cis) 
4.0 ± 0.6 • 10-1 -8.7 ± 0.1 1.3 ± 0.0 -10.0 ± 0.1 1.0 ± 0.0 255.8 ± 39.0 
 
WB026 (racemic, trans) 
13.0 ± 0.1 -6.7 ± 0.0 5.0 ± 0.0 -11.7 ± 0.0 1.9 ± 0.2 7.7 ± 0.1 
 
WB027 (racemic, cis) 
16.9 ± 1.8 -6.5 ± 0.1 3.3 ± 0.2 -9.8 ± 0.3 2.4 ± 0.1 6.0 ± 0.7 
 
WB028 (racemic, cis) 
17.4 ± 1.0 -6.5 ± 0.0 -4.1 ± 0.1 -2.4 ± 0.0 1.2 ± 0.1 5.8 ± 0.3 
 
WB047 (racemic, cis) 
4.7 ± 0.3 • 10-1 -8.6 ± 0.0 -1.3 ± 0.0 -7.3 ± 0.1 3.0 ± 0.1 212.2 ± 14.1 
 
WB050 (racemic, cis) 
81.2 ± 12.8 -5.6 ± 0.1 2.6 ± 0.2 -8.2 ± 0.1 1.6 ± 0.1 1.3 ± 0.2 
 
WB069 (racemic, cis) 
1.0 ± 0.2 -8.2 ± 0.1 -10.8 ± 0.4 2.6 ± 0.3 1.3 ± 0.0 103.7 ± 16.2 
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Ligand KD (µM) 
ΔG 
(kcal mol-1) 
ΔH 
(kcal mol-1) 
-T*ΔS 
(kcal mol-1) 
N c 
 
WB070 (racemic, trans) 
4.7 ± 0.1 • 10-2 -10.0 ± 0.0 -5.0 ± 0.3 -5.0 ± 0.3 1.1 ± 0.1 2126.1 ± 41.9 
 
WB073 (racemic, cis) 
3.4 ± 0.2 -7.5 ± 0.0 -7.6 ± 0.0 0.2 ± 0.1 1.8 ± 0.0 29.7 ± 1.6 
 
WB077 (racemic, cis) 
5.6 ± 0.4 
5.6 (4.3, 7.3) 
-7.2 ± 0.0 
-7.2 
-8.0 ± 0.4 
-8.0 
0.9 ± 0.4 
0.8 
1.7 ± 0.0 
1.7 
17.9 ± 1.2 
17.8 
 
WB082 (racemic, cis) 
3.6 ± 0.4 
4.5 (3.4, 5.8) 
-7.4 ± 0.1 
-7.3 
-8.4 ± 0.3 
-9.0 
1.0 ± 0.3 
1.7 
1.3 ± 0.1 
1.3 
28.5 ± 3.4 
22.3 
 
WB083 (racemic, trans) 
1.2 ± 0.3 • 10-1 -9.4 ± 0.1 -3.2 ± 0.0 -6.3 ± 0.1 1.2 ± 0.0 855.8 ± 176.9 
 
WB084 (racemic, cis) 
4.5 ± 0.3 • 10-1 -8.7 ± 0.0 -7.3 ± 0.1 -1.3 ± 0.1 0.9 ± 0.0 222.3 ± 16.0 
 
WB085 (racemic) 
6.1 ± 0.2 -7.1 ± 0.0 4.7 ± 0.1 -11.9 ± 0.1 1.7 ± 0.1 16.5 ± 0.5 
 
WB086 (racemic) 
22.9 ± 0.5 -6.3 ± 0.0 -8.9 ± 0.1 2.6 ± 0.2 3.3 ± 0.1 4.4 ± 0.1 
 
WB089 (racemic, trans) 
1.3 ± 0.2 • 10-1 -9.4 ± 0.1 -4.5 ± 0.1 -4.9 ± 0.1 1.1 ± 0.0 793.6 ± 151.9 
# All ITC experiments were carried out at 25 °C in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl (if necessary supplemented with up to 1 % DMSO). 2 mM of the 
respective compound were titrated to 100 µM BcPhz(A)/B. The data are averaged from at least two independent measurements. 
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Table A10: Individual thermodynamic binding parameters for double transition binding curves obtained from ITC 
affinity titrations against BcPhz(A)/B for the Phenazistatin derivatives WB011, WB077, and WB082.# 
Ligand KD (µM) 
∆G 
(kcal mol-1) 
∆H 
(kcal mol-1) 
-T*∆S 
(kcal mol-1) 
N c 
 
 
WB011 (racemic, cis) 
7.3 (4.8, 11.5) 
1.9 (1.7, 2.1) 
2.1 (1.4, 3.4) 
-7.0 
-7.8 
-7.8 
-8.4 
-5.1 
-6.3 
1.4 
-2.7 
-1.5 
2.3 
13.7 
52.4 
48.6 
 
 
WB077 (racemic, cis) 
5.6 (4.3, 7.3) 
3.3 (2.9, 3.8) 
1.0 (0.8, 1.2) 
-7.2 
-7.5 
-8.2 
-8.0 
-7.0 
-5.3 
0.8 
-0.5 
-3.0 
1.7 
17.8 
30.7 
101.9 
 
 
WB082 (racemic, cis) 
4.5 (3.4, 5.8) 
1.5 (1.2, 2.0) 
1.2 (0.9, 1.6) 
-7.3 
-7.9 
-8.1 
-9.0 
-6.1 
-4.1 
1.7 
-1.8 
-4.0 
1.3 
22.3 
64.6 
84.2 
# All ITC experiments were carried out at 25 °C in 20 mM TRIS/HCl pH 8.0, 150 mM NaCl (if necessary supplemented with up to 1 % DMSO). 2 mM of the 
respective compound were titrated to 100 µM BcPhz(A)/B. The data are averaged from at least two independent measurements.  
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